Reshaping human antibodies for therapy View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1988-03

AUTHORS

Lutz Riechmann, Michael Clark, Herman Waldmann, Greg Winter

ABSTRACT

A human IgGI antibody has been reshaped for serotherapy in humans by introducing the six hypervariable regions from the heavy- and light-chain variable domains of a rat antibody directed against human lymphocytes. The reshaped human antibody is as effective as the rat antibody in complement and is more effective in cell-mediated lysis of human lymphocytes. More... »

PAGES

323-327

Journal

TITLE

Nature

ISSUE

6162

VOLUME

332

Related Patents

  • Chimeric Ospa Proteins And Methods Of Use Thereof
  • Reducing Immunogenicities Of Immunoglobulins By Framework-Patching
  • Detection Human Integrin Associated Protein
  • Nucleic Acid Encoding An Anti-Epcam Protein; Binds Human Epithelial Cell Adhesion Molecule; Immunoglobulin Light Chain Region Modified To Reduce Immunogenicity; Diagnosis, Prognosis And Treatment Of Cancer
  • Bi-Specific Monovalent Diabodies That Are Capable Of Binding Cd123 And Cd3, And Uses Thereof
  • Polypeptides With Protected Or Unprotected Terminal Amino And Carboxy Group; Anticoagulants
  • Treatment Of Cancer Using Anti-Tgf-Beta And Pd-1 Antibodies
  • Induces Mammalian Cancer Cell Apoptosis; Used To Treat Cancer
  • Purified Flt4 Receptor Tyrosine Kinase Polypeptides And Fragments Thereof, Polynucleotides Encoding Such Polypeptides, And Antibodies That Specifically Bind Such Polypeptides; Anticarcinogenic, Antimetastatic, And Antiproliferative Agents; Autoimmuned Disorders, Inflammation
  • Antibodies Directed Against Amyloid-Beta Peptide And Methods Using Same
  • Multispecific Antibodies
  • Rm2 Antigens And Use Thereof
  • Methods For Treating Vascular Leak Syndrome
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Methods For Enhanced Protein Production
  • Methods For Cancer Management Targeting Co-029
  • Anti-Cd3 Antibodies, Anti-Cd123 Antibodies And Bispecific Antibodies Specifically Binding To Cd3 And/Or Cd123
  • Dna Molecules, Expression Vectors And Host Cells Expressing Antigenized Antibodies
  • Methods And Formulations For Reducing Reconstitution Time Of Lyophilized Polypeptides
  • Neuropilin Antagonists
  • Combination Therapy For The Treatment Of Cancer
  • Anti-Fgfr3 Antibodies And Methods Using Same
  • Therapeutic Agent For Hematopoietic Tumors
  • Human Protein Tyrosine Phosphatase Inhibitors And Methods Of Use
  • Microporous Materials, Methods, And Articles For Localizing And Quantifying Analytes
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Recombinant Anti-Vla4 Antibody Molecules
  • Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
  • Automatic Stent Detection
  • Antibody Specifically Binding To Insulin-Like Growth Factor-1
  • Polynucleotides Encoding Vegf/Dll4 Binding Agents
  • Antibodies That Bind Cd40 And Methods Of Treating Cancer And Enhancing Immune Responses
  • Methods Of Determining Responsiveness To Anti-Tnfα Therapy In Inflammatory Bowel Disease
  • Method Of Forming A Fiber Made Of Peptide Nanostructures
  • System And Method For Instant And Automatic Border Detection
  • Humanized Anti-Hepcidin Antibodies And Uses Thereof
  • Anti-Dll4/Vegf Dual Variable Domain Immunoglobulin And Uses Thereof
  • Influenza Treatment And/Or Characterization, Human-Adapted Ha Polypeptides; Vaccines
  • Anti-Ige Antibodies And Method Of Improving Polypeptides
  • Agonist Of A Mutant Human Thrombopoietin Receptor; Have Agonistic Activity To Receptors That Have Almost Completely Lost Responsiveness To Their Natural Ligands Because Of Gene Mutations And Which Can Transduce Signals By Interacting With These Mutant Receptors At Levels Comparable To Normal
  • Il-1 Binding Proteins
  • Flt4 (Vegfr-3) As A Target For Tumor Imaging And Anti-Tumor Therapy
  • Staphylococcus Aureus Materials And Methods
  • Compositions Comprising Chimeric Ospa Molecules And Methods Of Use Thereof
  • Conferring Donor Complementary Determining Region Binding Affinity Onto An Antibody Acceptor Variable Region Framework
  • Methods Of Using Chimeric Antigen Receptors Targeting B-Cell Maturation Antigen And Uses Thereof
  • Comprises Chimeric Antibodies For Diagnosis And Treatment Of Lymphomas; Antitumor Agents
  • Administering Antibody
  • Monoclonal Antibody
  • Heterodimeric Antibodies That Bind Somatostatin Receptor 2
  • Anti-Sortilin Antibodies And Methods Of Use Thereof
  • Antibodies Binding To Steap-1
  • Methods For Generating Radioimmunoconjugates
  • Her2 Diagnostic Methods
  • Alpha-Fetoprotein Immu31 Antibodies And Fusion Proteins And Methods Of Use Thereof
  • Pharmaceutical Composition For Treatment And Prevention Of Cancers
  • Methods For Producing Members Of Specific Binding Pairs
  • Method For Treating Psoriasis
  • Antiallergens; Viricides
  • Agent, Uses And Methods For Treatment
  • Trailr2 Cdh17 Binding Molecules For The Treatment Of Cancer
  • Inhibitors Of The Epidermal Growth Factor Receptor-Heat Shock Protein 90 Binding Interaction
  • Methods For Viral Inactivation And Other Adventitious Agents
  • Modulation Of T Cells With Bispecific Antibodies And Fc Fusions
  • Her2/Neu-Specific Antibodies And Methods Of Using Same
  • "Chimeric" Antibodies In Which An Animal Antigen-Binding Variable Domain Is Coupled To A Human Constant Domain
  • Elucidation Of Ion Exchange Chromatography Input Optimization
  • Aβ Conformer Selective Anti-Aβ Globulomer Monoclonal Antibodies
  • Telescopic Side Port Catheter Device With Imaging System And Method For Accessing Side Branch Occlusions
  • Fluorophore Chelated Lanthanide Luminescent Probes With Improved Quantum Efficiency
  • Antibodies To Human Il-1Β
  • Humanized Immunoglobulins And Methods Of Making The Same
  • Anti-Human B7-H4 Antibodies And Their Uses
  • Antigen-Binding Proteins Targeting Cd56 And Uses Thereof
  • Antibodies Against Signal-Regulatory Protein Alpha And Methods Of Use
  • Agents For Influenza Neutralization
  • Methods For Producing Recombinant Proteins
  • Nucleic Acids Encoding Anti-Factor D Antibodies
  • Antibodies To Insulin-Like Growth Factor I Receptor
  • Antibody-Drug Conjugates And Uses Thereof
  • Interleukin-13 Binding Proteins
  • Bispecific Checkpoint Inhibitor Antibodies
  • Humanized Anti-Tumor Necrosis Factor Alpha Receptor 2 (Anti-Tnfr2) Antibodies And Methods Of Use Thereof To Elicit An Immune Response Against A Tumor
  • Compositions And Methods For Targeted In Vitro And In Vivo Drug Delivery To Mammalian Cells Via Bacterially Derived Intact Minicells
  • Production Of Anti-Self Antibodies From Antibody Segment Repertoires And Displayed On Phage
  • Apo-2 Receptor Polypeptides
  • Multivalent Antibodies And Uses Therefor
  • Method For Treating Ige-Mediated Disorders
  • Antibodies To Cytosolic Peptides
  • Formulations With Reduced Degradation Of Polysorbate
  • Anti-Cd74 Immunoconjugates And Methods Of Use
  • Method For Making Monoclonal Antibodies And Cross-Reactive Antibodies Obtainable By The Method
  • Antibodies That Bind Il-4 And/Or Il-13 And Their Uses
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Tau Imaging Ligands And Their Uses In The Diagnosis And Treatment Of Tauopathy
  • Combination Of Fcγriib-Specific Antibodies And Cd20-Specific Antibodies And Methods Of Use Thereof
  • Super Humanized Antibodies
  • Interleukin-13 Binding Proteins
  • Gdf-15 As A Diagnostic Marker For Melanoma
  • Rationally Designed, Synthetic Antibody Libraries And Uses Therefor
  • Anti-Vegf Antibodies
  • Il-1 Binding Proteins
  • Humanised Antibodies
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Anti-Tnfα Antibody
  • Anti-Hepcidin Antibodies And Uses Thereof
  • Antibodies For The Treatment Of Synucleinopathy
  • Aldo-Keto Reductase Specific Immunoglobulin For Use In Diagnosis, Classification And Imaging Of Cell Proliferative Disorders
  • Aptamer Therapeutics Useful In The Treatment Of Complement-Related Disorders
  • Tlr3 Binding Agents
  • Methods Of Treating Rheumatoid Arthritis Using Antibodies To Matrix Metalloproteinase 9
  • Antigen-Binding Constructs Targeting Her2
  • Antibodies To Carcinoembryonic Antigen-Related Cell Adhesion Molecule (Ceacam)
  • Method For The Treatment Of Inflammatory Disorders
  • Humanized Immunoglobulins
  • Porphyromonas Gingivalis Polypeptides Useful In The Prevention Of Periodontal Disease
  • Antibodies Against Il-7r Alpha Subunit And Uses Thereof
  • Endomucin Inhibitor As An Anti-Angiogenic Agent
  • Aβ Conformer Selective Anti-Aβ Globulomer Monoclonal Antibodies
  • Monitoring And Identifying Drugs Which Serve As Neuroprotectants In The Prevention Of Alzheimer's Disease; Drug Screening
  • Anti-Pmel17 Antibodies And Immunoconjugates
  • Human Monoclonal Antibodies To Ctla-4
  • Single Cell Bar-Coding For Antibody Discovery
  • Stimulus Responsive Polymers For The Purification Of Biomolecules
  • Chimeric Antigen Receptors Targeting Cd70
  • Human Adaptation Of H7 Ha
  • Humanized Antibodies
  • Method For Producing Recombinant Antibody And Antibody Fragment Thereof
  • Bispecific T Cell Engaging Antibody Constructs
  • Nucleic Acid Sequences Containing A Coding Sequence For A Light Chain Of An Anti-Vla-1 Antibody Or Antigen Binding Fragment, And A Coding Sequence For A Heavy Chain Of An Anti-Vla-1 Antibody Or Fragment; The Light Chain And The Heavy Chain Form An Antibody Or Fragment That Binds Vla-1
  • Methods Of Neutralizing Il-8 Biological Activity
  • Isolated B7-H4 Specific Compositions And Methods Of Use Thereof
  • Anti-Ceacam5 Antibodies And Uses Thereof
  • Methods Of Treatment Using Antibodies Which Bind Il-17a And Il-17f
  • Antagonizing The Function Of Vascular Endothelial Growth Factor (Vegf) Receptors, Platelet Derived Growth Factor (Pdgf) Receptors And Other Receptors; For Inhibition Of Aberrant Angiogenesis And Lymphangiogenesis, And Inhibition Of Other Effects Of Members Of The Pdgf/Vegf Family Of Growth Factors
  • Modified Polynucleotides For Treating Galactosylceramidase Protein Deficiency
  • Heterodimeric Proteins
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Systems And Methods For Diagnosing Coronary Microvascular Disease
  • Chemokine Receptor Antibodies Binding Sulfated Trd Motifs
  • Methods For Treating Progressive Multiple Sclerosis
  • Antibody For Use In The Treatment Of Rheumatic And Osteoarthritis
  • Neutralizing Antibodies And Fragments Thereof Directed Against Platelet Factor-4 Variant 1 (Pf4v1)
  • Covalent Diabodies And Uses Thereof
  • Multiple Signaling Pathways Induced By Hexavalent, Monospecific And Bispecific Antibodies For Enhanced Toxicity To B-Cell Lymphomas And Other Diseases
  • Methods And Compositions For The Generation And Use Of Conformation-Specific Antibodies
  • Prevention And Treatment Of Amyloidgenic Disease
  • Methods Of Treatments Using Chimeric Antigen Receptors Targeting G-Protein Coupled Receptor
  • Target Cell-Specific Portion; Inactivating Portion; Allows Prolonged Action Of Agent At Tumor Sites While Protecting Normal Tissues
  • Deimmunized Serum-Binding Domains And Their Use For Extending Serum Half-Life
  • Administering To A Patient An Effective Dosage Of A Polypeptide Comprising An N-Terminal Segment Of A Beta , The Segment Beginning At Residue 1-3 Of A Beta And Ending At Residues 7-11 Of A Beta To Treat Disease Associated With Amyloid Deposit Of A Beta In The Brain Alzheimer's Disease, Down's Syndrome
  • Tgf-Beta-Specific Antibodies And Methods Of Use Thereof For Treatment
  • Compositions And Methods For Cancer
  • Polynucleotides Encoding Anti-Amyloid Beta Monoclonal Antibodies
  • Methods For Viral Inactivation Using Eco-Friendly Detergents
  • Antibody Molecules Which Bind Il-17a And Il-17f
  • Pd-1 And Lag-3 Binding Molecules And Methods Of Use Thereof
  • A Human/Mouse Chimeric Antibody With Low Immunogenicity To Humans; Therapy For Inflammatory Diseases, Respiratory Diseases, Psoriasis, Crohn's Disease And Uclers
  • Peptide Nanostructures Encapsulating A Foreign Material And Method Of Manufacturing Same
  • For Diagnosis, Treatment, And Prevention Of Apoptosis Associated Disorders Using Animal Models; For Drug Screening; Chimeras; Genetic Engineering, Cancer
  • Formulations That Interact With And Alter Expression Of Epithelial Cell Tyrosine Kinase
  • Antibodies To Receptor For Advanced Glycation End Products (Rage) And Uses Thereof
  • Glycopeptide And Uses Thereof
  • Culturing A Host Cell To Express A Nucleic Acid Encoding Beta (1,4)-N- Acetylglucosaminyltransferase Iii Under Conditions For Production Of A Polypeptide; Can Use To Provide Proteins With Improved Therapeutic Properties
  • Cdna Encoding A Gene Bog (B5t Over-Expressed Gene) And Its Protein Product
  • Therapeutic Combination And Methods Of Treatment With A Dll4 Antagonist And An Anti-Hypertensive Agent
  • Immunobinders Directed Against Sclerostin
  • Parathyroid Hormone Receptor 1 (Pth1r) Antibodies And Uses Thereof
  • Pharmaceutical Composition For Treatment And/Or Prophylaxis Of Cancer
  • Automatic Image Playback
  • Antibody Capable Of Catalyzing The Hydrolysis Of Cocaine At Benzoyl Ester Group And Against Specific Structural Compounds Listed; For Decreasing Concentration Of Cocaine In A Subject
  • Chimeric Antibodies Comprising Variable Domain Peptides, Dna Codes For The Antibodies, Expression Vectors, Host Cells And A Process Of Culturing The Host Cells To Produce The Monoclonal Antibodies, Used For Immunotherapy; Nonimmunogenic
  • Power-Efficient Optical Circuit
  • Nucleic Acids Encoding Humanized Anti-Tag 72 Cc49 Antbodies
  • Compositions And Methods For Phagocyte Delivery Of Anti-Staphylococcal Agents
  • Bgl7 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Humanized Antibodies To Fc Receptors For Immunoglobulin G On Human Mononuclear Phagocytes
  • Reconstituted Human Antibody Against Human Interleukin 6 Receptor
  • Cd3-Binding Molecules Capable Of Binding To Human And Non-Human Cd3
  • Untagged Antigen Is Used In Conjunction With A Polyclonal Antibody To Isolate Cells Recognizing The Antigen; For Cancers, Autoimmune Or Inflammatory Disorders
  • A Novel And Efficient Method For Reprogramming Blood To Induced Pluripotent Stem Cells
  • Anti-Cea Antibodies
  • Compositions And Methods For Simultaneous Bivalent And Monovalent Co-Engagement Of Antigens
  • Epha2 As A Therapeutic Target For Cancer
  • Immunoglobulins And Variants Directed Against Pathogenic Microbes
  • Human Protein Tyrosine Phosphatase Inhibitors And Methods Of Use
  • Binding Domain-Immunoglobulin Fusion Proteins
  • Monoclonal Antibodies Binding To The Cd160 Transmembrane Isoform
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Method For Making Humanized Antibodies
  • Methods Of Administering/Dosing Anti-Rsv Antibodies For Prophylaxis And Treatment
  • Cd37 Immunotherapeutic And Combination With Bifunctional Chemotherapeutic Thereof
  • Method For Multiple Chemokine Receptor Screening For Antagonists Using Ram Assay
  • Method For Inducing Cell Death In Acute Lymphoblastic Leukemic System Cells
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Methods Of Treating Hiv Infection Using Antibodies To The U2 Small Nuclear Ribonuclear Protein
  • Taurine Supplemented Cell Culture Medium And Methods Of Use
  • Transforming Cells With Gene Expression Vector; Genetic Engineering
  • Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens
  • Modified Polynucleotides For The Production Of Biologics And Proteins Associated With Human Disease
  • Methods For Inhibiting The Binding Of Endosialin To Ligands
  • Anti-T. Cruzi Antibodies And Methods Of Use
  • Heterodimeric Proteins
  • Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use Thereof
  • Preparing Multicomponent Polypeptide In Hybrid Cell Formed From Fusion Of Two Or More Cells, Each Of Which Cell Is Engineered To Express One Component Of Polypeptide; Bioreactors And Genetic Engineering
  • Compositions And Methods For Treating Fibrosis
  • Vessel Assembly
  • T Cell Receptor-Like Antibodies Specific For A Wt1 Peptide Presented By Hla-A2
  • Heterodimeric Antibodies That Bind Cd3 And Psma
  • Transferrin Receptor Antibodies
  • Fgf21 Polypeptides Comprising Two Or More Mutations
  • Apo-2 Ligand
  • Anti-Cd151 Antibodies And Their Use In The Treatment Of Cancer
  • A Site Directed Mutagenic Immunoglobulin Having A Mutations In The Variable Region That Changes The Glycosylation Pattern; Diagnosis And Therapy For Autoimmune Diseases, Cancers And Viral Diseases
  • Anti-Clusterin Antibodies And Antigen Binding Fragments And Their Use To Reduce Tumor Volume
  • Methods For Formulating Antibody Drug Conjugate Compositions
  • Monoclonal Antibodies To Growth And Differentiation Factor 15 (Gdf-15), And Uses Thereof For Treating Cancer Cachexia And Cancer
  • Complement Inhibition For Improved Nerve Regeneration
  • Nucleotide Sequences Coding Polypeptide For Use In The Treatment, Prevention And Diagnosis Of Cell Proliferative And Tumor Disorders
  • Monoclonal Antibodies Targeting Neutralizing Epitopes On H7 Influenza Viruses
  • Targeted Delivery Of Drugs, Therapeutic Nucleic Acids And Functional Nucleic Acids To Mammalian Cells Via Intact Killed Bacterial Cells
  • Lgals3bp Antibody-Drug-Conjugate And Its Use For The Treatment Of Cancer
  • Glycan Arrays And Method Of Use
  • Bacterially Derived Intact Minicells That Encompass Plasmid Free Functional Nucleic Acid For In Vivo Delivery To Mammalian Cells
  • Compositions For Treating Amyloid Associated Diseases
  • Antibody Formulations
  • Simultaneous Imaging, Monitoring, And Therapy
  • Method Of Screening For Compounds That Disaggregate Amyloid Aggregates
  • Human Protein Tyrosine Phosphatase Inhibitors And Methods Of Use
  • Specific Expression Of Half-Trna In Cancers
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Monoclonal Anti-Idiotypic Antibody; Antitumor Agents; Anticarcinogenic Agents; Antiproliferative Agents; Immunotherapy; Hormone Antagonist Therapy
  • Human G-Protein Chemokine Receptor Hsatu68
  • Glycan-Interacting Compounds
  • Compositions And Methods For Tcr Reprogramming Using Fusion Proteins
  • Anti-Idiotypic Antibody Neutralizing The Inhibitor Activity Of A Factor Viii Inhibitor Antibody
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Therapeutic Combination And Methods Of Treatment With A Dll4 Antagonist And An Anti-Hypertensive Agent
  • Heterodimeric Antibodies That Bind Cd3 And Cd38
  • Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Mek Inhibitors
  • Bgl5 Β-Glucosidase And Nucleic Acids Encoding The Same
  • Antibody-Drug Conjugates And Uses Thereof
  • Subcutaneous Administration Of Antibody-Drug Conjugates For Cancer Therapy
  • Treating Essential Tremor Using (R)-2-(4-Isopropylphenyl)-N-(1-(5-(2,2,2-Trifluoroethoxy)Pyridin-2-Yl)Ethyl)Acetamide
  • Single-Domain Antibodies And Variants Thereof Against Ctla-4
  • Composition And Method For The Diagnosis And Treatment Of Diseases Associated With Neurite Degeneration
  • Glycosynthase Variants For Glycoprotein Engineering And Methods Of Use
  • Notch1 Receptor Binding Agents And Methods Of Use Thereof
  • Antibodies And Pharmaceutical Compositions Containing Same Useful For Inhibiting Activity Of Metalloproteins
  • Cancer Therapy
  • Anti-Claudin 18.2 Antibodies
  • Cell-Permeable Probes For Identification And Imaging Of Sialidases
  • Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Mek Inhibitors
  • Ephb3-Specific Antibody And Uses Thereof
  • Degraded Tpo Agonist Antibody
  • Pharmaceutical Composition For Treatment And/Or Prophylaxis Of Cancer
  • Anti-Pmel17 Antibodies And Immunoconjugates
  • Variants Of Humanized Anti-Carcinoma Mab Cc49
  • Pharmaceutical Composition For Treatment Of Cancer Comprising An Anti-Caprin-1 Peptide Antibody
  • Using Binding Substance To Connect Antibodies To Target That They Normally Have No Functional Specificity For
  • Methods And Compositions For Chimeric Antigen Receptor Targeting Cancer Cells
  • Combination Therapies Employing Gitr Binding Molecules
  • Anti-Hulrrc15 Antibody Drug Conjugates And Methods For Their Use
  • Methods And Assays For Measuring P95 And/Or P95 Complexes In A Sample And Antibodies Specific For P95
  • Methods Of Treating Stroke And Traumatic Brain Injury Using Humanized Aqc2 Anti-Vla-1 Antibodies
  • Human Anti-Opgl Neutralizing Antibodies As Selective Opgl Pathway Inhibitors
  • Method To Improve Virus Filtration Capacity
  • Modular Point-Of-Care Devices, Systems, And Uses Thereof
  • Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation
  • Anti-Trop-2 Antibody-Drug Conjugates And Uses Thereof
  • Compositions Comprising Anti-Ceacam1 And Anti-Pd Antibodies For Cancer Therapy
  • Method Of Classifying And Diagnosing Cancer
  • Fluorophore Chelated Lanthanide Luminescent Probes With Improved Quantum Efficiency
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Yersinia Spp. Polypeptides And Methods Of Use
  • Notch1 Binding Agents And Methods Of Use Thereof
  • Methods For Producing Humanized Antibodies And Improving Yield Of Antibodies Or Antigen Binding Fragments In Cell Culture
  • Human Rhinovirus (Hrv) Antibodies
  • Enhancing The Circulating Half-Life Of Antibody-Based Fusion Proteins
  • Antibodies Against Human Csf-1r And Uses Thereof
  • Methods For Inactivating Viruses During A Protein Purification Process
  • Anti-Sortilin Antibodies And Methods Of Use Thereof
  • Bispecific Immunomodulatory Antibodies That Bind Costimulatory And Checkpoint Receptors
  • Humanized Monoclonal Or Polyclonal Antibodies Covalently Attached To A Drug Or Fluorescent Marker, That Specifically Binds To Proteins, Used To Screen For Agents That Modulate Estrogen Signaling
  • Methods For Analyzing Dna
  • Interferon Receptor 1 Antibodies And Their Uses
  • Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes
  • Method Of Overcoming Therapeutic Limitations Of Non-Uniform Distribution Of Radiopharmaceuticals And Chemotherapy Drugs
  • Ultrapurified Dsba And Dsbc And Methods Of Making And Using The Same
  • Heterodimeric Antibodies To Cd3 X Cd123
  • Generating Preferential Immunoglobulin; Obtain Expression Vectors Separately Containing Heavy And Light Chain Sequences, Transform Cells Fuse Cells And Recover Immunoglobulin
  • Modified Antibodies With Human Milk Fat Globule Specificity And Uses
  • Agents For Influenza Neutralization
  • Smooth Transition Catheters
  • Rsv Specific Binding Molecule
  • High Throughput Bh3 Profiling: A Rapid And Scalable Technology To Bh3 Profile On Low Numbers Of Cells
  • Multispecific Antibodies
  • Anti-Dll4/Vegf Dual Variable Domain Immunoglobulin And Uses Thereof
  • Anti-Cd47 Antibodies And Methods Of Use Thereof
  • Methods Of Controlling Proliferation And Differentiation Of Stem And Progenitor Cells
  • Targeted Delivery To Legumain-Expressing Cells
  • Antibodies Against And Methods For Producing Vaccines For Respiratory Syncytial Virus
  • Binding Compounds For Il-27
  • Cys80 Conjugated Immunoglobulins
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Cd44 Polypeptides, Polynucleotides Encoding Same, Antibodies Directed Thereagainst And Method Of Using Same For Diagnosing And Treating Inflammatory Diseases
  • Reagents And Methods For Detecting A Polymorphic Protein
  • 4-[2-(S)-(4-Ethylthiazol-2-Yl)-2-(2-Phenylacetylamido)Ethyl]Phenyl}Sulfamic Acid; Anticarcinogenic, Antitumor, Antidiabrtic Agent; Angiogenesis Inhibitor; Sarcoid, Syphilis, Paget's Disease, Vein Occlusion, Artery Occlusion, Carotid Obstructive Disease, Chronic Uveitis/Vitritis
  • Conjugates Of Il13rα2 Binding Agents And Use Thereof In Cancer Treatment
  • Recombinant Protein Production In A Human Cell Comprising At Least One E1 Protein Of Adenovirus
  • Bgl7 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Cancer Markers And Methods Of Use Thereof
  • Methods And Compositions Relating To Leptin Antagonists
  • Compositions And Methods For The Treatment And Prevention Of Neurological Disorders
  • Filters With Echogenic Characteristics
  • Humanized Antibodies Against Light And Uses Thereof
  • Vaccine Candidates Against Johne's Disease
  • Immunoglobulins Insertions, Deletions, And Substitutions
  • Smoothened Polypeptides For Binding Patched
  • Selective Peptide Antagonists
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Method Of Treatment Of Leukemia With Anti-Il1rap Antibodies
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Complementarity Determining Regions; Immunoglobulins; Cell Line, Host Cells; Transgenic Animals, Plants
  • Delivering Functional Nucleic Acids To Mammalian Cells Via Bacterially-Derived, Intact Minicells
  • Variable Domain Comprising Non-Human Complementarity Determining Region (Cdr) Amino Acid Residues Which Bind An Antigen Incorporated Into A Human Antibody Variable Domain, And Further Comprising A Framework Region (Fr) Amino Acid
  • Complement Factor Based Affinity Chromatography
  • Tumor-Selective Ctla-4 Antagonists
  • Recombinant Antibody And Antibody Fragment
  • Antibody Constructs With Cdr Switched Variable Regions
  • Glycan-Interacting Compounds
  • Methods For Modifying Human Antibodies By Glycan Engineering
  • Antibodies With Modified Isoelectric Points
  • Filip1l Nucleic Acid Fragments
  • Methods And Compositions For Chimeric Antigen Receptor Targeting Cancer Cells
  • Antibodies Directed Against Amyloid-Beta Peptide And Methods Using Same
  • Monoclonal Anti-Il-1racp Antibodies
  • Neutralizing Anti-Tl1a Monoclonal Antibodies
  • Rationally Designed, Synthetic Antibody Libraries And Uses Therefor
  • Humanized Antibody Against S-Surface Antigen Of Hepatitis B Virus
  • Binds Human Interleukin-5 Antigen Comprising A Composite Heavy Chain And A Composite Light Chain, Therapy
  • Using Immunoglobulins To Inactivate Viricidal And Antitumor Activities Of Huma N Type Interferon For Preventing Autoimmunity And Graft Rejection; Immunosuppressants; Culturing A Hybridoma That Produces A Monoclonal Antibody
  • Interleukin-13 Binding Proteins
  • Cell Engaging Binding Molecules
  • Tes7 And Antibodies That Bind Thereto
  • Compositions And Methods For Treating Pancreatic Cancer
  • Systems And Methods For Growth Of Intestinal Cells In Microfluidic Devices
  • Compositions And Methods For Treatment Of Cancer
  • Polarization Sensitive Optical Coherence Tomography System
  • Glycolipopeptide Antibodies
  • Generation And Profiling Of Fully Human Hucal Gold-Derived Therapeutic Antibodies Specific For Human Cd38
  • Antibody Constructs For Dll3 And Cd3
  • Useful For Producing Infectious Virus Which Is Used For Identifying And Developing Therapeutically Effective Compositions For Treatment And/Or Prevention Of Human Parvovirus B19 Infections
  • Glycan Arrays For High Throughput Screening Of Viruses
  • Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
  • Covalent Diabodies And Uses Thereof
  • Antibody-Drug Conjugates And Uses Thereof
  • Treatment Of Cancer Using Anti-Tgf-Β And Anti-Pd-1 Antibodies
  • Method For Assessing Metastatic Properties Of Breast Cancer
  • Formulations With Reduced Degradation Of Polysorbate
  • Amyloid-Beta Binding Proteins
  • Chimeric Antigen Receptors Recognizing Cancer-Specific Tn Glycopeptide Variants
  • Rationally Designed, Synthetic Antibody Libraries And Uses Therefor
  • Methods For Inhibiting Fibrosis In A Subject In Need Thereof
  • Immunoactive Peptides And Antibodies And Their Use In Anti-Allergy Treatment
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Methods Of Blocking Cancer Stem Cell Growth
  • Pd-1 Specific Antibodies And Uses Thereof
  • Administering An Antibody To An Integrin Or Fragment Thereof.
  • Pharmaceutical Composition For Treatment And/Or Prevention Of Cancer
  • Pcsk9 Antibody, And Pharmaceutical Composition And Use Thereof
  • Modified Antibody Variable Domains And Therapeutic Uses Thereof
  • Methods For The Therapy Of Inflammatory Bowel Disease Using A Type-1 Interferon Antagonist
  • Bgl7 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Trispecific Proteins And Methods Of Use
  • Human Monoclonal Antibodies To Ctla-4
  • Bi-Specific Monovalent Fc Diabodies That Are Capable Of Binding Cd32b And Cd79b And Uses Thereof
  • Reshaped Human Anti-Hm 1.24 Antibody
  • Ddr1-Binding Agents And Methods Of Use Thereof
  • Anti-Aβ Globulomer 4d10 Antibodies
  • Methods Of Detecting A Solid Tumor With Anti-Il1rap Antibodies
  • Therapeutic Use Of Anti-Cd22 Antibodies For Inducing Trogocytosis
  • Antibodies To Insulin-Like Growth Factor I Receptor
  • Compositions And Methods For Diagnosing And Treating Phenylketonuria (Pku)
  • Tau Imaging Ligands And Their Uses In The Diagnosis And Treatment Of Tauopathy
  • Anti-Cd79b Antibodies And Immunoconjugates And Methods Of Use
  • Constructs Targeting Histone H3 Peptide/Mhc Complexes And Uses Thereof
  • Minimum Recognition Unit Of A Pem Mucin Tandem Repeat Specific Monoclonal Antibody
  • Monoclonal Antibodies Against Tumor-Associated Antigens, Processes For The Preparation Thereof And The Use Thereof
  • Antibodies That Bind Il-4 And/Or Il-13 And Their Uses
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Methods Of Treating Cancer By Administering Anti-Gpr49 Antibodies
  • Immunoglobulin Insertions, Deletions, And Substitutions
  • Monoclonal Antibody To Human Line-1 Orf2 Protein And Method For Early Detection Of Transforming Cells In Pre-Neoplastic Tissues Of A Human Subject
  • Compositions And Methods For Treating Multiple Myeloma
  • Systems For Correcting Distortions In A Medical Image And Methods Of Use Thereof
  • Human Fgf Receptor And Β-Klotho Binding Proteins
  • Diagnosis And Treatments Relating To Th2 Inhibition
  • Antibodies Against Mica And/Or Micb And Uses Thereof
  • Klebsiella Antigens
  • Antibody Specifically Binding To Insulin-Like Growth Factor-1
  • Assays For Detecting Antibodies Specific To Therapeutic Anti-Ige Antibodies And Their Use In Anaphylaxis
  • Isolation, Detection, Diagnosis And/Or Characterization Of Circulating Trop-2-Positive Cancer Cells
  • Uses Of A Dual V Region Antibody-Like Protein
  • Polypeptide Comprising An Amino Acid Sequence And Having Endoglucanase Activity; Detergent With Building Agent, A Bleaching Agent, A Caking Inhibitor
  • Inhibitors Of Il-11 Or Il-11ra For Use In The Treatment Of Abnormal Uterine Bleeding
  • Methods For Improving Memory And Cognition And For Treating Memory And Cognitive Disorders
  • Immunocytokine Sequences And Uses Thereof
  • Use Of Alginate Formulation For Intraincisional Drug Delivery
  • Cd44 Polypeptides, Polynucleotides Encoding Same, Antibodies Directed Thereagainst And Method Of Using Same For Diagnosing And Treating Inflammatory Diseases
  • Methods Of Treating Cancer Using Anti Human Interleukin-1 Receptor Accessory Protein (Il1 Rap) Antibodies
  • Yersinia Spp. Polypeptides And Methods Of Use
  • Il-12 Heterodimeric Fc-Fusion Proteins
  • Compositions And Methods For Recombinant Biosynthesis Of Propane
  • Peptides Protective Against S. Pneumoniae And Compositions, Methods And Uses Relating Thereto
  • Albumin Binding Antibodies And Binding Fragments Thereof
  • Modified Polynucleotides For The Production Of Secreted Proteins
  • Antibodies Against Human Csf-1r And Uses Thereof
  • Combination Therapy For Treatment Of Disease
  • B7-H4 Antibodies And Methods Of Use Thereof
  • Humanized Antibodies To Amyloid Beta
  • Vitamin D-Ghrelin Conjugates
  • Anti-Tissue Factor Antibodies, Antibody-Drug Conjugates, And Related Methods
  • Covalent Diabodies And Uses Thereof
  • Dual Specific Binding Proteins Directed Against Il-1 And/Or Il-17
  • Multispecific Antibodies
  • Heterodimeric Proteins
  • Anti-Trem-1 Antibodies And Uses Thereof
  • Carriers For Improved Drug Delivery
  • To Identify Antagonists Of Human Antigen Luca2 A Disease And Cancer-Associated Antigen; Anticancer Agents
  • Humanised Antibodies
  • Identification And Characterization Of A Disease And Cancer-Associated Antigen Kid24; Antibodies That Bind To Kid24
  • Camptothecin Conjugates Of Anti-Cd22 Antibodies For Treatment Of B Cell Diseases
  • Oct-Ivus Catheter For Concurrent Luminal Imaging
  • Anti-B7-H4 Antibodies And Immunoconjugates
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Antibodies To Madcam
  • Antibodies And Their Use In The Treatment, Prevention And Diagnosis Of A Disease Associated With Sod1 Abnormalities
  • Bispecific Antibodies And Uses Thereof
  • Method And Composition For Treatment Of Renal Failure With Antibodies And Their Equivalents As Partial Or Complete Replacement For Dialysis
  • Cellulases; Beta-Glucosidases; Hydrolases; Conversion Of Cellulose To Sugars And/Or Ethanol; Laundry Detergents
  • Antibody Molecules For Cancer Treatment
  • Amyloid-Beta Binding Proteins
  • Therapeutic Combination And Methods Of Treatment With A Dll4 Antagonist And An Anti-Hypertensive Agent
  • Optimized Anti-Cd3 Variable Regions
  • Human Il-23 Antigen Binding Proteins
  • Gitr-Binding Antibodies
  • Compounds, Compositions, And Methods For Preventing Metastasis Of Cancer Cells
  • Human Antibody Specific To Human Metapneumovirus, Or Antigen-Binding Fragment Thereof
  • Antibodies Targeting G-Protein Coupled Receptor And Methods Of Use
  • Diagnosing Tumorigenicity Comprising: Measuring The Expression Or Level Of The Full-Length Protein Encoded By A Specific Polypeptide In A Specimen And Measuring The Expression Or Level Of The Protein In Normalspecimen
  • Crystal Structures Of Heterodimeric Fc Domains
  • Nucleotide Sequences Coding Enzymatic Polypeptide For Use In The Treatment Of Psychological Disorders
  • Recombinant Glycoproteins Related To Feline Thyrotropin
  • Antibody Variants
  • Isolated Nucleic Acid Molecules Encoding Antigen Binding Sites Of Antibody Molecules Specific For Cancer Antigens
  • Anti-Siglec-9 Antibodies And Methods Of Use Thereof
  • Compositions And Methods For Targeting Stromal Cells For The Treatment Of Cancer
  • Hybrid Antibodies
  • Compositions And Methods For Treating Multiple Myeloma
  • Antibody-Nanoparticle Conjugates For The Treatment Of Drug Abuse
  • Monoclonal Antibodies To Growth And Differentiation Factor 15 (Gdf-15)
  • Targeted Gene Delivery To Non-Phagocytic Mammalian Cells Via Bacterially Derived Intact Minicells
  • Bispecific Antibodies Against Cd3 And Bcma
  • Agr2 Blocking Antibody And Use Thereof
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Fcγriib Specific Antibodies And Methods Of Use Thereof
  • Human Il-23 Antigen Binding Proteins
  • Single-Chain Antibodies And Other Heteromultimers
  • Methods Of Treating Ocular Disease Associated With Amyloid-Beta-Related Pathology Using An Anti-Amyloid-Beta Antibody
  • Deep Vein Thrombosis Therapeutic Methods
  • Il-17 Binding Proteins
  • Hybrid Proteins
  • Method For The Treatment Of Inflammatory Disorders
  • Antibodies To Dcr3 Polypeptide, A Tnfr Homolog
  • Production Of Proteins In Glutamine-Free Cell Culture Media
  • Targeted Delivery Of Drugs, Therapeutic Nucleic Acids And Functional Nucleic Acids To Mammalian Cells Via Intact Killed Bacterial Cells
  • Cadherin-11 Inhibitors And Methods Of Use Thereof
  • Humanized Anti-Beta7 Antagonists And Uses Therefor
  • Glycan-Interacting Compounds And Methods Of Use
  • Humanized Anti-Cd11a Antibodies
  • Shortened Tetranectin-Apolipoprotein A-I Fusion Protein, A Lipid Particle Containing It, And Uses Thereof
  • Cd3-Binding Molecules Capable Of Binding To Human And Non-Human Cd3
  • Combining Anti-Hla-Dr Or Anti-Trop-2 Antibodies With Microtubule Inhibitors, Parp Inhibitors, Bruton Kinase Inhibitors Or Phosphoinositide 3-Kinase Inhibitors Significantly Improves Therapeutic Outcome In Cancer
  • Human Anti-Opgl Neutralizing Antibodies As Selective Opgl Pathway Inhibitors
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation
  • Isolated B7-H4 Specific Compositions And Methods Of Use Thereof
  • Amyloid-Beta Binding Proteins
  • Single Chain Multivalent Binding Proteins With Effector Function
  • Humanized Antibodies That Bind Lgr5
  • Hiv Immunotherapeutics
  • Cbh1 Homologs And Varian Cbh1 Cellulase
  • Humanized Immunoglobulins
  • Anti-Met Fab-Fc For The Treatment Of A Tumor And/Or Metastasis
  • Chimeric Immunoglobulin For Prevention And Treatment Blood, Tumor, Cardiovascular And Urogenital Disorders
  • Antibody And Use Thereof
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Humanized Anti-Cd79b Antibodies And Immunoconjugates And Methods Of Use
  • Pro 1384 Antibodies
  • Nucleic Acid Encoding Chimeric Il-1 Receptor Type I Antagonists
  • Diagnosis And Treatment Of Viral Diseases
  • Methods For Treating Obesity Using Fibroblast Growth Factor-Like Polypeptides
  • Transgenic Cells Comprising Nucleotide Sequences Coding Glycoprotein-Modifying Glycosyltransferase For Use As Tool In Prevention And Treatment Of Cell Proliferative Disorders; Tissue Targeted Therapy
  • Il-6 Binding Molecules
  • Monoclonal Antibodies Against The Interferon Receptor, With Neutralizing Activity Against Type I Interferon
  • Selectively Bind Human Fcyriib, With Little Or No Binding To Other Human Fc Gamma Rs, E.G., Human Fc Gamma Riia; Atherosclerosis; Leukocyte Adhesion Deficiency; Rheumatoid Arthritis; Systemic Lupus Erythematosus (Sle); Diabetes Mellitus; Multiple Sclerosis; Reynaud's Syndrome; Autoimmune Thyroiditis;
  • Antitumour Combinations Of Antisense Oligonucleotides And Anticancer Agents
  • Efficacy Of Anti-Trop-2-Sn-38 Antibody Drug Conjugates For Therapy Of Tumors Relapsed/Refractory To Checkpoint Inhibitors
  • Pharmaceutical Compositions Containing Sc(Fv)2
  • Using A Substance Capable Of Inhibiting The Binding Between Parathyroid Hormone-Related Peptide (Pthrp) And A Receptor; Humanized Anti-Parathyroid Hormone Related Protein 1-34 (Anti-Pthrp (1-34)) Antibody
  • Treatment Of Amyloidogenic Diseases
  • Anti-Alpha Synuclein Antibodies
  • Anti-Hepcidin Antibodies And Uses Thereof
  • Tau-Binding Antibodies
  • Cd4 Specific Recombinant Antibody
  • Antiarthritic Agent
  • Amyloid-Beta Binding Proteins
  • Human Anti-Pd-1, Pd-L1, And Pd-L2 Antibodies And Uses Therefor
  • Compositions And Methods Relating To Universal Glycoforms For Enhanced Antibody Efficacy
  • Methods For Treating Cancer In Patients With Elevated Levels Of Bim
  • Calicheamicin Derivative-Carrier Conjugates
  • Stability-Modulating Linkers For Use With Antibody Drug Conjugates
  • Diagnostic Antibody Assay
  • Catalytic Antibodies Against Cocaine And Methods Of Using And Producing Same
  • Human Protein Tyrosine Phosphatase Inhibitors And Method Of Use
  • Extracellular Matrix Metalloproteinase Inducer (Emmprin) Peptides And Binding Antibodies
  • Dosages For Treatment With Anti-Erbb2 Antibodies
  • Pharmaceutical Composition For Treatment And/Or Prevention Of Cancer
  • Pharmaceutical Composition For Treatment And/Or Prevention Of Pancreatic Cancer
  • Method Of Isolating Cytotoxic Heterocomplex Associated With Multiple Sclerosis
  • Methods Of Screening For Neoplastic Disease States
  • Anti-Vegf Antibodies
  • Modified Polynucleotides Encoding Granulysin
  • Devices, Systems, And Methods For Targeted Cannulation
  • Cell-Based Assay For Detecting Anti-Cd3 Homodimers
  • Pulmonary Administration Of Immunoglobulin Single Variable Domains And Constructs Thereof
  • Fcγriib Specific Antibodies And Methods Of Use Thereof
  • Cd16a Binding Proteins And Use For The Treatment Of Immune Disorders
  • Monoclonal Antibodies That Bind To Antigen Oncostatin M Receptor Beta Subunit (Osm-R.Beta); Cancers
  • Human Protein Tyrosine Phosphatase Inhibitors And Methods Of Use
  • Use Of Dr6 And P75 Antagonists To Promote Survival Of Cells Of The Nervous System
  • Rapid Clearance Of Antigen Complexes Using Novel Antibodies
  • Heterodimeric Proteins
  • Heterodimeric Proteins
  • Monoclonal Antibodies Against The Interferon Receptor, With Neutralizing Activity Against Type I Interferon
  • Nucleotide Sequences Coding Polypeptides For Use In The Treatment And Prevention Of Cell Proliferation Disorders
  • Methods Of Use Of Anti-Sortilin Antibodies For Treating A Disease, Disorder, Or Injury
  • Uses Of Vegf Or Vegf Receptor Agonists For The Up-Regulation Of Endothelial Nitric Oxide Synthase Expression For Treating Hypertension, Diabetes, Angina, Thrombosis, Atherosclerosis, And Heart Failure
  • Humanized Antibodies Transmigrating The Blood-Brain Barrier And Uses Thereof
  • Humanized Anti-Cd4 Antibody With Immunosuppressive Properties
  • Enzymatic Conjugation Of Polypeptides
  • Anti-Pd-L1 Antibodies, Compositions And Articles Of Manufacture
  • Human Inkt Cell Activation Using Glycolipids With Altered Glycosyl Groups
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Immunotoxins Comprising Ribosome-Inactivating Proteins
  • Humanized Anti-Beta7 Antagonists And Uses Therefor
  • Single Domain Serum Albumin Binding Protein
  • Humanised Antibodies
  • Compositions Comprising Purified Anti-Abeta Monoclonal Antibodies
  • Humanized Antibodies That Recognize Beta Amyloid Peptide
  • Human Inkt Cell Activation Using Glycolipids With Altered Glycosyl Groups
  • Cytotoxicity Mediation Of Cells Evidencing Surface Expression Of Cd44
  • (R)-[1-Methylcarbamoyl-2-(4-Sulfoamino-Phenyl)-Ethyl]-Carbamic Acid Tert-Butyl Ester As Human Protein Tyrosine Phosphatases-Beta (Hptp) Inhibitor
  • Vegf Binding Antibodies
  • Interferon Receptor 1 Antibodies And Their Uses
  • Producing Vector Libraries Capable Of Expressing Variable Heavy And Light Chain Polypeptides By Synthesizing Variable Chains, Amplify And Join The Variable Heavy Chain To The Light Chain Into Expression Vectors And Screen The Libraries
  • Anti-Clusterin Antibodies And Antigen Binding Fragments And Their Use To Reduce Tumor Volume
  • Polynucleotides Encoding Humanized Anti-Factor D Antibodies
  • Optimized Variants Of Anti-Vegf Antibodies And Methods Of Use Thereof In Treatment
  • Isolated Peptide Or Polypeptide Of The Extracellular Portion Of The Human Interferon Receptor (Ifn-R).
  • Time-Resolved Laser-Induced Fluorescence Spectroscopy Systems And Uses Thereof
  • Biomarkers
  • Methods For Inhibiting The Binding Of Endosialin To Ligands
  • Iconic Communication
  • Gene Constructs Coding For Cd40-Binding Activating Antibodies
  • Chimeric Ospa Genes, Proteins And Methods Of Use Thereof
  • Protective Proteins Of S. Agalactiae, Combinations Thereof And Methods Of Using The Same
  • Compositions And Methods For Tcr Reprogramming Using Fusion Proteins
  • Antigen-Presenting Complex-Binding Compositions And Uses Thereof
  • Use Of Anti-Endoglin Antibodies For Treating Ocular Fibrosis
  • Humanized Antibodies That Recognize Beta Amyloid Peptide
  • Methods For Expressing And Recovering Human Monoclonal Antibodies To Ctla-4
  • Cytotoxic Peptides And Antibody Drug Conjugates Thereof
  • Bgl6 Β-Glucosidase And Nucleic Acids Encoding The Same
  • Therapy Of Cancers
  • Polypeptides And Immunizing Compositions Containing Burkholderia Polypeptides And Methods Of Use
  • Methods For Diagnosing And Treating Inflammatory Bowel Disease
  • Antibody Specificity Transfer Using Minimal Essential Binding Determinants
  • Time-Resolved Laser-Induced Fluorescence Spectroscopy Systems And Uses Thereof
  • Methods And Systems For Transforming Luminal Images
  • Anti Cxcr4 Antibodies And Their Use For The Treatment Of Cancer
  • Method Of Treating Type 1 Diabetes By Administering Nkp46 Polypeptide
  • Formulation For Anti-Α4Β7 Antibody
  • Anti-Mesothelin Antibodies
  • Preparing Human Antibody; Insertion Of Expression Vectors Coding Heavy Chain Pepties Into Cells, Insertion Of Expression Vectors That Code Light Chain Peptides Into Cells, Generate Hybrid Cells And Recover Antibodies
  • Anti-Dengue Virus Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use
  • Compositions Capable Of Specifically Binding Particular Human Antigen Presenting Molecule/Pathogen-Derived Antigen Complexes And Uses Thereof
  • Anti-Epidermal Growth Factor Receptor (Egfr) Antibodies
  • Filters With Echogenic Characteristics
  • Designed Deimmunized Monoclonal Antibodies For Protection Against Hiv Exposure And Treatment Of Hiv Infection
  • Nucleotide Sequences Coding Interleukin Fusion For Use In Regulating Activation, Development, Differentiation, And Function Of Various Cell Types
  • Anti-B7-H4 Antibodies And Immunoconjugates
  • Amyloid-Beta Binding Proteins
  • Covalently Linked Helicar-Anti-Helicar Antibody Conjugates And Uses Thereof
  • Anti-Igf-Ir Antibodies And Uses Thereof
  • Anticancer Agents
  • Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens
  • Antibody Molecules Which Bind Tnf Alpha
  • Modified Polynucleotides Encoding Cited4
  • Compositions And Methods For Growth Factor Modulation
  • Anti-Trem2 Antibodies And Methods Of Use Thereof
  • Monoclonal Antibody For Use In Prevention And Treatment Of Osteoarthritic And Surgical Pain; Immunotherapy
  • Antigen Binding Region Comprises Complementarity Determining Regions Of Light And Heavy Chains Of Murine Act-1 Monoclonal Antibody; Fab Fragments; For Treament Of Inflammatory Bowel Disease, Ulcerative Colitis, And Crohn's Disease; Host Cells
  • Method For Treating The Th2-Mediated Disease
  • Antibody Variants Transmigrating The Blood-Brain Barrier And Uses Thereof
  • Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use Thereof
  • Antibodies To Tgf-Beta
  • Methods For Modifying Human Antibodies By Glycan Engineering
  • Antibodies To Matrix Metalloproteinase 9
  • Method For Producing Polymers Having A Preselected Activity
  • Method Of Screening For Anti-Garp Antibodies
  • Using Allelic Variation Aristaless Homeobox Gene (Arx) As Diagnostic Tool In Detection Of Convulsive And Learning Disorders
  • Monoclonal Antibodies That Specifically Block Biological Activity Of A Tumor Antigen
  • Anti-H7cr Antibodies
  • Antibodies To Lymphotoxin-Alpha
  • Depth Filters For Disposable Biotechnological Processes
  • Methods For The Therapy Of Inflammatory Bowel Disease Using A Type-1 Interferon Antagonist
  • Nucleic Acids Encoding Interleukin-5 Specific Recombinant Antibodies
  • Compositions And Methods Using Same For Treating Amyloid-Associated Diseases
  • Heterodimeric Proteins
  • Profiling Peptides And Methods For Sensitivity Profiling
  • Antibodies For Siglec-15 And Methods Of Use Thereof
  • Fgf 21 Polypeptides Comprising Two Or More Mutations And Uses Thereof
  • Heterodimeric Antibodies That Bind Cd3 And Cd38
  • Flt4 (Vegfr-3) As A Target For Tumor Imaging And Anti-Tumor Therapy
  • Enzymatic Antibody Processing
  • Anti-Glycoprotein Vi Scfv Fragment For Treatment Of Thrombosis
  • Variable Region Of Light And Heavy Chains Of Humanized Antibody, The Humanized Antibody And Process For Its Preparation, Dna, Vector, Host Cell, And Therapeutic Agent
  • Bacterially-Derived, Intact Minicells That Encompass Plasmid-Free Functional Nucleic Acid For In Vivo Delivery To Mammalian Cells
  • Methods Of Determining Patient Response By Measurement Of Her-3
  • Antibodies To The Human Prolactin Receptor
  • Systems And Methods For Producing An Image From A Rotational Intravascular Ultrasound Device
  • Anti-Gpr49 Monoclonal Antibodies
  • Tri-Specific Binding Molecules And Methods Of Use Thereof
  • Method For Using Boc/Cdo To Modulate Hedgehog Signaling
  • Humanized Anti-Cxcr5 Antibodies, Derivatives Thereof And Their Use
  • Method For Making Humanized Antibodies
  • Trem2 Cleavage Modulators And Uses Thereof
  • Comprises Purified Imunoglobulin Polypeptide Or Antigen Binding Fragment For Diagnosis Of Disease/Cancer
  • Complex Of Antibody And Radionucleotide; Therapy, Medical Diagnosis
  • Method For Purifying Active Polypeptides Or Immunoconjugates
  • Anti-Glycoprotein Vi Scfv Fragment For Treatment Of Thrombosis
  • Polypeptides And Immunizing Compositions Containing Gram Positive Polypeptides And Methods Of Use
  • Protein Formulation
  • Humanized Chimeric Antibody Directed Against Ganglioside Gd3
  • Used To Modulate P-Rb (Retinoblastoma Susceptibility Gene Product)-Protein Interactions, For Cancer Analysis And Treatment By Controlling Cell Growth And Proliferation
  • Cell Culture Compositions With Antioxidants And Methods For Polypeptide Production
  • Antibody Formulations
  • Cell Engaging Binding Molecules
  • Polynucleotides Encoding Optimized Variants Of Anti-Vegf Antibodies
  • Anti-C-Met Antibody And Anti-C-Met Antibody-Cytotoxic Drug Conjugate And Pharmaceutical Use Thereof
  • Lowered Affinity Antibodies And Methods Of Making The Same
  • Administering Antibodies Or Antigen-Binding Fragments Which Are Specific For Human Tumor Necrosis Factor- Alpha (Tnf Alpha), Used For In Vivo Medical Diagnosis And Therapy; Immunoassay And Immunotherapy
  • Use Of Caprylic Acid Precipitation For Protein Purification
  • Treatment Methods Using C-Met Antibodies
  • Internalizing Anti-Cd74 Antibodies And Methods Of Use
  • Method To Detect Autoantibody Reactivity For Deamidated Insulin Autoantigen In Diabetes
  • Compounds, Compositions, And Methods For Preventing Metastasis Of Cancer Cells
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Dual Fc Antigen Binding Proteins
  • Method For Making Heteromultimeric Molecules
  • Gremlin-1 Antibody
  • Recombinant Anti-Vla4 Antibody Molecules
  • Biological Materials And Uses Thereof
  • Modular Point-Of-Care Devices, Systems, And Uses Thereof
  • Enterically Delivered Bitter Oligopeptides For The Treatment For Type 2 Diabetes
  • Anti-Cea Antibodies
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Methods For Diagnosing And Treating Inflammatory Bowel Disease
  • Polyclonal Immunoglobulin For Use In Diagnosis, Prevention And Treatment Of Infection, Cell Proliferative, Blood, Autoimmune And Nervous System Disorders
  • Comprises Membrane Protein For Use In The Diagnosis, Prevention And Treatment Of Tumor Disorders
  • Binding Domain-Immunoglobulin Fusion Proteins
  • Enhancement Of Antibody-Mediated Immune Responses
  • Prevention, Treatment And Diagnosis Of P. Gingivalis Infection
  • Methods Of Treating Inflammatory Disorders Using High Concentration Natalizumab Compositions
  • Modified Polypeptides, Whereby The Modification Results In A Reduced Number Of Potential Lymphocyte Epitopes That Provides A Reduced Propensity For The Polypeptide To Elicit An Immune Response Upon Administration To A Human, But Retain The Ability To Bind To Cd52 Antigens
  • Antiinflammatory Agents; Anticancer Agents; Antiproliferative Agents
  • Anti-Tnfrsf9 Antibodies And Uses Thereof
  • Tau-Binding Antibodies
  • Compositions And Methods For Treatment Of Cancer
  • Production Of Secreted Therapeutic Antibodies In Microalgae
  • Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use Thereof
  • Anti-Cd47 X Anti-Mesothelin Antibodies And Methods Of Use Thereof
  • Methods For Inducing Or Enhancing An Immune Response By Administering Agonistic Glucocorticoid-Induced Tnfr-Family-Related Receptor (Gitr) Antibodies
  • Treatment For Asthma With Α4-Specific Antibodies
  • Anti Ccr8 Antibody Therapy: Biomarkers & Combination Therapies
  • Detecting Tumor Cells Expressing Tag-72 Using Cc49 In Which Less Than All Six (Three Heavy Chain And Three Light Chain) Complementarity Determining Regions Are Present; Host Cells
  • Serine At Position 228 Of Hinge Region Has Been Replaced By Proline; Side Effect Reduction; Antiinflammatory Agents; Antiarthritic Agents; Treatment Of Psoriasis, Eczema, Cirrhosis, Crohn's Disease; Diagnosis Of Related Diseases
  • Compositions And Methods For Treating And Preventing Macular Degeneration
  • Compositions And Methods For Binding Lysophosphatidic Acid
  • Multispecific Antibodies
  • Dipeptide Analogs For Treating Conditions Associated With Amyloid Fibril Formation
  • Glycan-Interacting Compounds And Methods Of Use
  • Compositions And Methods For Treatment Of Cancer
  • Antibodies To Human Il-1Β
  • Genetically Modified Human Natural Killer Cell Lines
  • Combination Therapy With Anti-Cd74 And Anti-Cd20 Antibodies Provides Enhanced Toxicity To B-Cell Diseases
  • Trivalent, Bispecific Antibodies
  • Anti-Cmet Antibody
  • Microarrays And Uses Therefor
  • Methods For Treating, Diagnosing, And Monitoring Lupus
  • Signature Of Tl1a (Tnfsf15) Signaling Pathway
  • Humanized Anti-Cxcr5 Antibodies, Derivatives Thereof And Their Use
  • Anti-Alphavbeta1 Integrin Inhibitors And Methods Of Use
  • Compositions And Methods For The Therapy And Diagnosis Of Cytomegalovirus Infections
  • Antibody Molecules Having Binding Specificity For Human Il-13
  • Efficient Synthesis Of Protein-Oligonucleotide Conjugates
  • Interferon Receptor 1 Antibodies And Their Uses
  • Treatment Of Asthma With Anti-Tslp Antibody
  • Compositions And Methods For Cancer
  • Cd40 Ligand Adjuvant For Respiratory Syncytial Virus
  • Antibody Fragments Are Selected From Fab Fragments, Fv Fragments, Single Domain Antigen Binding Fragments, Scfv And Aggregates Thereof; For Treatment Of Solid Tumor Carcinomas
  • Humanized Anti-Cxcr5 Antibodies, Derivatives Thereof And Their Use
  • Biological Materials And Uses Thereof
  • Spliceostatin Analogs And Methods For Their Preparation
  • Ilt7 Binding Molecules And Methods Of Using The Same
  • Anti-Il1rap Antibody
  • Method For Producing Polymers Having A Preselected Activity
  • Needle Assembly And Drug Delivery Device Having Such Needle Assembly
  • Endosialin-Binding Antibody
  • Antibodies Against E-Selectin
  • Engineered Anti-Il-23p19 Antibodies
  • Anti-Il31 Antibodies For Veterinary Use
  • Agents, Uses And Methods For The Treatment Of Synucleinopathy
  • Icam-1 Binding Antibodies
  • Apo-2-Receptor
  • Antibodies Reactive With B7-H3 And Users Thereof
  • Automatic Calibration Systems And Methods Of Use
  • Methods For Treating Angelman Syndrome And Related Disorders
  • Reactive Labelling Compounds And Uses Thereof
  • Compounds
  • Il-1 Binding Proteins
  • Reducing The Immunogenicity Of Fusion Proteins
  • Recombinant Antibodies For Human Therapy
  • Method For The Treatment Of Inflammatory Disorders
  • Method For The Production Of A Glycosylated Immunoglobulin
  • Method Of Treating A Solid Tumor With Il1rap Antibodies
  • Method For The Treatment Of Inflammatory Disorders
  • Methods And Kits For Diagnosing Tumorigenicity
  • Iconic Communication
  • Distinguishing Antagonistic And Agonistic Anti B7-H1 Antibodies
  • Humanized Anti-Tau(Ps422) Antibody Brain Shuttles And Use Thereof
  • Production Of Anti-Self Bodies From Antibody Segment Repertories And Displayed On Phage
  • Antibodies Specific For Cd3 And Uses Thereof
  • Neuropilin Antagonists
  • Cells Expressing Anti-Gd2 Antibodies And Methods Related Thereto
  • Extracellular Matrix Metalloproteinase Inducer (Emmprin) Peptides And Binding Antibodies
  • Method And Means For Site Directed Therapy
  • Vibrating Guidewire Torquer And Methods Of Use
  • Methods For Treating Autoimmune And Chronic Inflammatory Conditions Using Antagonists Of Cd30 Or Cd30l
  • Compositions And Methods For Treating Hif-1alpha Over-Expressing Cancers
  • Chemically Modified Binding Protein
  • Modified Polynucleotides Encoding Septin-4
  • Complement Inhibition For Improved Nerve Regeneration
  • Antibody Constructs For Flt3 And Cd3
  • Enhancement Of Natural Killer (Nk) Cell Proliferation And Activity
  • Compositions And Methods For Diagnosing And Treating Cancer
  • Peptides Directed For Diagnosis And Treatment Of Amyloid-Associated Disease
  • Peptide Nanostructures And Methods Of Generating And Using The Same
  • Analysis Of Ubiquitinated Polypeptides
  • Covalent Diabodies And Uses Thereof
  • Antibodies With Immune Effector Activity And That Internalize In Endosialin-Positive Cells
  • Cross-Reactive Staphylococcus Aureus Antibody
  • Human Fibroblast Diffusable Factors
  • Administering The Antibody Concurrently With An Antagonist Of Il-1 Alpha To Treat Psoriatic Arthritis; Arthritis Nodosa; Seronegative Spondylarthropathy, And Ulcerative Colitis
  • Human M2e Peptide Immunogens
  • Tumor-Selective Ctla-4 Antagonists
  • Antibodies To The E1 Extracellular Loop Of Ion Channels
  • Biological Materials And Uses Thereof
  • Diagnosis And Treatments Relating To Th2 Inhibition
  • Anti-Fgfr3 Antibodies And Methods Using Same
  • Antibodies To Apo-2 Receptor Polypeptides
  • Cell Culture Compositions With Antioxidants And Methods For Polypeptide Production
  • Anti-Pd-L1 Antibodies And Uses Therefor
  • Methods For Producing Members Of Specific Binding Pairs
  • Compositions And Methods For Growth Factor Modulation
  • Anti-Her2 Antibody Variants
  • Generation And Profiling Of Fully Human Hucal Gold-Derived Therapeutic Antibodies Specific For Human Cd38
  • Anti-Dll4/Vegf Dual Variable Domain Immunoglobulin And Uses Thereof
  • Glycan-Interacting Compounds And Methods Of Use
  • Neutralizing Monoclonal Antibodies Against The Nogo-66 Receptor (Ngr) And Uses Thereof
  • Cd3 Specific Recombinant Antibody
  • Use Of Anti-Amyloid Beta Antibody In Ocular Diseases
  • Egvi Endoglucanase And Nucleic Acids Encoding The Same
  • Treatment Of Amyloidogenic Diseases
  • Identification And Engineering Of Antibodies With Variant Fc Regions And Methods Of Using Same
  • Antibodies To Tgf-Beta
  • Anti-Lgr5 Antibodies And Immunoconjugates
  • Antibodies That Bind Interleukin-2 And Uses Thereof
  • Antibodies That Bind Il-4 And/Or Il-13 And Their Uses
  • Modified Polynucleotides Encoding Apoptosis Inducing Factor 1
  • Methods And Compositions For Treating Siglec-8 Associated Diseases
  • Fc Region-Containing Polypeptides That Exhibit Improved Effector Function Due To Alterations Of The Extent Of Fucosylation, And Methods For Their Use
  • Glycan Arrays On Ptfe-Like Aluminum Coated Glass Slides And Related Methods
  • Pd-1-Binding Molecules And Methods Of Use Thereof
  • Anti-Factor D Antibody Variant Conjugates And Uses Thereof
  • Combination Of Anti-Ep-Cam Antibody With A Chemotherapeutic Agent
  • Hybrid Proteins
  • Genetically Modified Human Natural Killer Cell Lines
  • Tes7 And Antibodies That Bind Thereto
  • Polypeptides And Immunizing Compositions Containing Gram Positive Polypeptides And Methods Of Use
  • Il-D80 Polypeptides And Il-27
  • Screening Of Conjugated Antibodies
  • Isolated Dna Sequences Encoding, And Methods For Making, Antibody Molecules Having Binding Specificity For Human Il-13
  • Humanized Aβ Antibodies For Use In Improving Cognition
  • Method For The Selection Of Antibodies Against Bcma
  • Bispecific Antibodies Against Human Tweak And Human Il17 And Uses Thereof
  • Methods Of Treating Autoimmune Disease Via Ctla-4ig
  • Pd-1-Binding Molecules And Methods Of Use Thereof
  • Compositions And Methods For Tcr Reprogramming Using Fusion Proteins
  • Anti-Tissue Factor Antibodies And Methods Of Use Thereof
  • Single Linker Fabfv Antibodies And Methods Of Producing Same
  • Method Of Treatment For Leukemia Using An Anti-Il1rap Antibody
  • Variants Of Tnfsf15 And Dcr3 Associated With Crohn's Disease
  • Combination Of An Anti-Ep-Cam Antibody With A Chemotherapeutic Agent
  • Preparing Humanized Immunoglobulin From Complimentarity And Human Framework Region; Obtaining Human And Mammalian Variable Domain Sequences, Detecting, Replacing, And Adjusting Sequences, Detect Binding, Prepare Immunoglobulin
  • Hydrazinyl-Indole Compounds And Methods For Producing A Conjugate
  • Nucleic Acids Encoding Antibodies Against Human Csf-1r And Uses Thereof
  • Heterodimeric Proteins
  • Neutralising Antibodies To The Major Exotoxins Tcda And Tcdb Of Clostridium Difficile
  • Modified Binding Molecules Comprising Connecting Peptides
  • Anti-B7-H4 Antibodies And Immunoconjugates
  • Antibodies Specific For Cd44v6
  • Effective In Inhibiting Tumor Cell Growth; Immunotherapy; Purified Immunoglobulin; Preventing Or Delaying Development Of Metastasis, Treating Metastatic Cancer, Or Inhibiting Proliferation Of Metastatic Cancer Cells
  • Anti-Cd79b Antibodies And Immunoconjugates And Methods Of Use
  • Biological Products
  • Immunoassay Using At Least Two Pegylated Analyte-Specific Binding Agents
  • Bh3 Peptides And Method Of Use Thereof
  • Diagnostics For Pulmonary Arterial Hypertension And Sudden Cardiac Death
  • Human Cytomegalo Virus; Human Growth Hormone Polyadenylation Signal Domains; Dihydrofolate Reductase Genes; Host Cells; Gene Therapy
  • Comprising Regulating The Expression Or Activity Of Cannabinoid Receptors In Bone Cells
  • Modified Polynucleotides For The Production Of Nuclear Proteins
  • Klebsiella Antigens
  • Antibodies To C-Met
  • Antigen Binding Constructs To Cd8
  • Methods Of Making And Using Multispecific Antibody Panels And Antibody Analog Panels
  • Human Cdr-Grafted Antibody And Antibody Fragment Thereof
  • Determining The Capability Of A Test Compound To Affect Solid Tumor Stem Cells
  • Genetically Modified Human Natural Killer Cell Lines
  • Antibody Formulations And Uses Thereof
  • Anti-Jagged1 Antigen Binding Proteins
  • Agents For Influenza Neutralization
  • Use Of Interleukin-4 Antibodies And Compositions Thereof
  • Compositions And Methods For Treating Pigmentary Conditions And Melanoma
  • Anti-B7-H4 Antibodies And Their Uses
  • Humanized Anti-Factor D Antibodies And Uses Thereof
  • Agents For Influenza Neutralization
  • Antibody Constructs For Dll3 And Cd3
  • Specific Binding Agents
  • Enzymatic Conjugation Of Polypeptides
  • Cytotoxicity Mediation Of Cells Evidencing Surface Expression Of Cd44
  • Combination Therapy With Anti-Cd74 Antibodies Provides Enhanced Toxicity To Malignancies, Autoimmune Disease And Other Diseases
  • For Identifying And/Or Using Inhibitors Of The Hgf/C-Met Signaling Pathway; A Mesenchyme-Derived Pleiotrophic Factor With Mitogenic, Motogenic And Morphogenic Activities On A Number Of Different Cell Types
  • Preparing Chimeric Immunoglobulin With Preferential Binding Activity And Reduced Immunogenicity For Use In Human Therapeutics And Diagnostics
  • Polynucleotides Encoding Anti-Gd2 Antibodies
  • Polynucleotides Encoding Humanized Antibodies Against Ceacam1
  • Anti-Ige Antibodies And Methods Of Improving Polypeptides
  • Novel B7-H3 Binding Molecules, Antibody Drug Conjugates Thereof And Methods Of Use Thereof
  • Sulfated Peptides For Chemokine Receptor Antibody Generation
  • Monoclonal Antibodies, Compositions And Methods For Detecting Mucin-Like Protein (Mlp) As A Biomarker For Ovarian And Pancreatic Cancer
  • Nucleic Acid Encoding Anti-Ige Antibodies
  • Anti-Aβ Oligomer Humanized Antibody
  • Monoclonal Antibody Or An Fab Fragment Capable Of Binding To Mouse Vascular Endothelial Cell Growth Factor (Vegf) And Human Vegf; Cancer, Diabetes Related Diseases, Age-Induced Macular Degeneration
  • Apo-2 Ligand
  • Covalent Diabodies And Uses Thereof
  • Nucleotide And Amino Acid Sequences Encoding An Exported Protein 1 Derived From Plasmodium Vivax And Uses Thereof
  • Therapeutic Compositions Comprising Anti-Ige Antibodies And Immunosuppressive Agent
  • Compositions For The Prevention And Treatment Of Smallpox
  • Monoclonal Anti-Alpha-Synuclein Antibodies For Preventing Tau Aggregation
  • Profiling Peptides And Methods For Sensitivity Profiling
  • Phosphopeptide Compositions And Anti-Phosphopeptide Antibody Compositions And Methods Of Detecting Phosphorylated Peptides
  • Hepatocyte Growth Factor Receptor Antagonist Antibodies And Uses Thereof
  • Variant Enzymes
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Fcγriib Specific Antibodies And Methods Of Use Thereof
  • Bgl7 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Human Anti-Pd-1 Antibodies And Uses Therefor
  • Antibody-Mediated Immunocontraception
  • Antibodies Against Human Csf-1r And Uses Thereof
  • Labeled Humanized Anti-Cd18 Antibodies And Fragments And Kits Comprising Same
  • Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor
  • Colony Detection
  • Il-15 And Il-15rα Sushi Domain Based Immunocytokines
  • Used In Cancer Therapy
  • Ccr8 Antibodies For Therapeutic Applications
  • Methods And Compositions For Identifying Epitopes
  • Comprises Apoptosis Membrane Protein (Apo-2) And Monoclonal Antibody Antagonist For Treating Cancer, Cardiovascular And Nervous System Disorders
  • Anti-Htra1 Antibodies And Methods Of Use
  • Antibodies Specific To Glycosylated Btla (B- And T- Lymphocyte Attenuator)
  • Cell Culture Compositions
  • Anti-Sirpα Antibodies
  • Enzymatic Conjugation Of Antibodies
  • Humanized Immunoglobulins
  • Binding Polypeptides With Diversified And Consensus Vh/Vl Hypervariable Sequences
  • Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use Thereof
  • Antibodies With Immune Effector Activity And That Internalize In Endosialin-Positive Cells
  • Chimeric Polypeptides And Uses Thereof
  • Bispecific Anti-Hapten/Anti-Blood Brain Barrier Receptor Antibodies, Complexes Thereof And Their Use As Blood Brain Barrier Shuttles
  • Methods Of Producing Two Chain Proteins In Bacteria
  • Immunoconjugates Targeting Cd46 And Methods Of Use Thereof
  • Methods For Removing A Contaminant Using Indigenous Protein Displacement Ion Exchange Membrane Chromatography
  • Methods For Assessing Responsiveness Of B-Cell Lymphoma To Treatment With Anti-Cd40 Antibodies
  • Polynucleotides Encoding Modified Antibodies With Human Milk Fat Globule Specificity
  • Nuovo Agente Terapeutico Per Il Trattamento Di Un Tumore E/O Metastasi
  • Peptide Ligands For G-Protein Coupled Receptors
  • Modulators For The Prevention Of Nervous System Degradation; Transfect Eukaryotic Cells Expressing Presenilin Proteins, Expose To Modulators And Monitor Transcriprion Factor Induction
  • Dna Encoding Antibody Molecules Having Specificity For Human Il-6
  • Polypeptides And Immunizing Compositions Containing Gram Positive Polypeptides And Methods Of Use
  • Amyloid-Beta Globulomer Antibodies
  • Anti-Fgfr3 Antibodies And Methods Using Same
  • Multivalent And Multiepitopic Antibodies Having Agonistic Activity And Methods Of Use
  • Human Cdr-Grafted Antibody And Antibody Fragment Thereof
  • Anti-Cd19 Antibodies With Reduced Immunogenicity
  • Methods Of Modulating Immune Function
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Il15/Il15rα Heterodimeric Fc-Fusion Proteins
  • Activatable Interleukin-2 Polypeptides And Methods Of Use Thereof
  • Anti-Cancer Antibodies With Reduced Complement Fixation
  • Monoclonal Antibodies Against The Interferon Receptor, With Neutralizing Activity Against Type I Interferon
  • Pseudomonas Exotoxin A With Less Immunogenic B Cell Epitopes
  • A Method For Reducing The Immunogenicity Of Antibody Variable Domains
  • Use Of These Vectors In Gene Therapy
  • Tissue Plasminogen Activator Antibodies And Method Of Use Thereof
  • Compositions And Methods For Production Of Immunoglobulins
  • Targeting Dna-Pkcs And B7-H1 To Treat Cancer
  • Compositions And Methods For Tcr Reprogramming Using Fusion Proteins
  • Antibody Binding Active Alpha-Synuclein
  • Isolated Human Monoclonal Antibodies Or Antigen Binding Portion, That Bind To Ifnar-1, Capable Of Blocking The Action Of Type I Interferons; Use In The Treatment Of Immune Mediated Disorders, Including Autoimmune Disorders, Transplant Rejection And Graft Versus Host Disease (Gvhd)
  • Methods Of Determining Cellular Chemosensitivity
  • Variant Enzymes
  • For Stimulating Release Of Tumor Necrosis Factor And/Or Cellular Prolifefration/Differentiation Of Chondrocytes By Contacting Blood W/Polypeptide; Diagnosis Cancer
  • Combination Therapy For The Treatment Of Cancer
  • Framework Mutated Antibodies And Their Preparation
  • Mhc-Peptide Complex Binding Ligands
  • Administration Of A Bispecific Construct Binding To Cd33 And Cd3 For Use In A Method For The Treatment Of Myeloid Leukemia
  • Humanized Anti-Cxcr5 Antibodies, Derivatives Thereof And Their Use
  • Antibody-Drug Conjugates And Uses Thereof
  • Delivering Functional Nucleic Acids To Mammalian Cells Via Bacterially-Derived, Intact Minicells
  • Antibodies To Lymphotoxin-Alpha
  • Ultra High Affinity Neutralizing Antibodies
  • High Potency Recombinant Antibodies And Method For Producing Them
  • Anticoagulant Antidotes
  • Binding Polypeptides And Uses Thereof
  • Anti-Vla-4 Antibodies
  • Method Of Treating Or Ameliorating Metabolic Disorders Using Binding Proteins For Gastric Inhibitory Peptide Receptor (Gipr) In Combination With Glp-1 Agonists
  • Amyloid Beta(1-42) Oligomers, Derivatives Thereof And Antibodies Thereto, Methods Of Preparation Thereof And Use Thereof
  • Apoptosis Inducing Molecule Ii And Methods Of Use
  • Method For Chromatography Reuse
  • Binding Molecules For The Treatment Of Cancer
  • Methods For Identifying Inhibitors Of Cytokinesis Using Cyk-4 Proteins
  • Hcv Ns3 Recombinant Antigens And Mutants Thereof For Improved Antibody Detection
  • Antibody Comprising A Human Heavy Chain Framework Sequence, Three Heavy Chain Hypervariable Region Sequences And Three Light Chain Hypervariable Region Sequences; Modulating Biological Activity Of Integrins Containing The Beta7 Subunit
  • Nucleic Acid Molecules Encoding Minimally Immunogenic Variants Of Sdr-Grafted Humanized Antibody Cc49
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Use Of Anti-Tissue Factor Antibodies For Treating Thromboses
  • Engineered Anti-Il-23p19 Antibodies
  • Pidilizumab Monoclonal Antibody Therapy Following Stem Cell Transplantation
  • Method For The Treatment Of Amyloidoses
  • Covalent Diabodies And Uses Thereof
  • For Drug Screening Anticancer Agents/Diagnosis/Therapy; Detection Kits
  • Catalytic Antibodies Against Cocaine And Methods Of Using And Producing Same
  • Combination Therapy With Anti-Hla-Dr Antibodies And Kinase Inhibitors In Hematopoietic Cancers
  • Binding Native Human Tissue Factor (Tf) And Does Not Substantially Bind Non-Native Tissue Factor; Superior Anticoagulant Activity By Binding With High Affinity And Specificity; Reducing Cancer Cell Tissue Factor Activity And Detecting Cancer Cells That Express Tf; Factor X Binding Is Inhibited
  • Used For The For The Medical Diagnosis And Treatment Of Alzheimer's Disease
  • Pseudomonas Exotoxin A With Less Immunogenic B Cell Epitopes
  • Anti-Glycoprotein Vi Scfv Fragment For Treatment Of Thrombosis
  • An Antibody Capable Of Inhibiting The Binding Between Parathyroid Hormone Related Protein (Pthrp) And A Receptor; Antagonists; Systemic Disorders Caused By Cancer; Anorexic Agents; Anemia, Electrolyte Imbalance; Immunotherapy
  • Binding Proteins That Bind To Human Fgfr1c, Human Β-Klotho And Both Human Fgfr1c And Human Β-Klotho
  • Methods For Treating Bone Cancer Pain By Administering A Nerve Growth Factor Antagonist Antibody
  • Isolated Nucleic Acids Encoding Anti-Sortilin Antibodies
  • Treatment With Anti-Erbb2 Antibodies
  • Viscosity Reduction Of Highly Concentrated Protein Formulations
  • Glycan-Interacting Compounds And Methods Of Use
  • Microporous Materials, Methods Of Making, Using, And Articles Thereof
  • Methods For Treating Pain By Administering A Nerve Growth Factor Antagonist And An Nsaid And Compositions Containing The Same
  • Anti-Amyloid Beta Antibodies Binding To A Cyclic Amyloid Beta Peptide
  • Anti-B7-H4 Antibodies And Immunoconjugates
  • Comprises Immunoglobulin For Treating And Preventing Inflammation, Thrombocytopenia And/Or Autoimmune Hemolytic Anemia
  • Lag-3-Binding Molecules And Methods Of Use Thereof
  • Nucleic Acid Sequence Encoding Old World Monkey Immunoglobulin-Binding Region And Second Sequence Encoding Human Or Chimpanzee Region
  • Anti-Cd79b Antibodies And Immunoconjugates And Methods Of Use
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Agents, Uses And Methods For Treatment
  • Recombinant Immunoglobulins To Mediate Cytotoxicity And Treat Cell Proliferative Disorders; Immunotherapy
  • Diagnostic, Prognostic, And Monitoring Methods For Multiple Myeloma, Chronic Lymphocytic Leukemia, And B-Cell Non-Hodgkin Lymphoma
  • Adam9-Binding Molecules, And Methods Of Use Thereof
  • Heterodimeric Proteins
  • 88kda Tumorigenic Growth Factor And Antagonists
  • Humanized Immunoglobulin Reactive With Α4Β7 Integrin
  • Cation Exchange Chromatography Methods
  • Fgf21 Mutants Multimers And Uses Thereof
  • Gametes Separation Methods, Compositions And Uses Thereof
  • Anti-Aβ Globulomer 7c6 Antibodies
  • Modified Antibody Variable Domains
  • Structural Isomers Of Sc(Fv)2
  • Cd40-Binding Activating Antibodies
  • Antibodies To Vla-1
  • Prostate Specific Membrane Antigen Binding Protein
  • Recombinant Anti-Vla-4 Antibody Molecules
  • Protein Kinase Ck2 Gene Mutations, Amplifications And Polymorphisms In Human Cancers And Methods Of Use
  • Anticoagulant Antidotes
  • Heterodimeric Antibodies That Bind Fibroblast Activation Protein
  • Modified Polynucleotides For Treating Protein Deficiency
  • Antibodies, Binding Fragments, And Methods Of Use
  • Methods And Compositions For Treatment Of Cancer
  • Egvii Endoglucanase And Nucleic Acids Encoding The Same
  • Human Antigen Binding Proteins That Bind Β-Klotho, Fgf Receptors And Complexes Thereof
  • Humanized Cdr-Grafted Anti-Icam-1 Antibodies, Methods Of Preparation And Usage Thereof
  • Methods For Treating Obesity Using Fibroblast Growth Factor-Like Polypeptides
  • Fcγriib Specific Antibodies And Methods Of Use Thereof
  • Anti Ceacam1 Antibodies And Methods Of Using Same
  • Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Mek Inhibitors
  • Compositions And Methods For Immunotherapy Of Cancer And Infectious Diseases
  • Stable Igg4 Based Binding Agent Formulations
  • Genetically Engineered Antibodies
  • Immunoglobulins Comprise Two Heavy Chains Linked Together By Disulphide Bonds And Two Light Chains, Each Light Chain Being Linked To A Respective Heavy Chain By Disulphide Bonds
  • Rsv-Specific Binding Molecules And Means For Producing Them
  • Polynucleotide Encoding A Monoclonal Antibody
  • Porcine Circovirus Type 2 Vaccines
  • Optimized Variants Of Anti-Vegf Antibodies And Methods Of Treatment Thereof By Reducing Or Inhibiting Angiogenesis
  • Immunoreceptor Tyrosine-Based Activation Motif (Itam); Immunoreceptor Tyrosine-Based Inhibition Motif (Itim); Bispecific Molecule Such As Fusion Protein And Vectors Encoding It; Treating Allergic Diseases
  • Encodes Cytokine Fusion Proteins With An Increased Therapeutic Index; Able To Bind To More Than One Type Of Cytokine Receptor Expressed On Cells; For Treating Tumors; Immunotherapy; Antitumor Agents
  • Hcv Core Lipid Binding Domain Monoclonal Antibodies
  • Compositions For Preventing Or Treating Viral And Other Microbial Infections
  • Antibodies To Madcam
  • Delivery And Formulation Of Engineered Nucleic Acids
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Anti-Alpha V Beta 6 Antibodies And Uses Thereof
  • Modified Antibody Variable Domains
  • Combination Therapy Using Inhibitors Of Human Growth And Differentiation Factor 15 (Gdf-15) And Immune Checkpoint Blockers
  • Human Protein Tyrosine Phosphatase Inhibitors And Methods Of Use
  • Fcγriib-Specific Antibodies And Methods Of Use Thereof
  • Inducing Lysis Of Tumor Cells That Expresses Epidermal Growth Factor Receptor; Antiproliferative Agents
  • Methods And Compositions For Preventing And Treating Conditions Related To Alpha-Synuclein
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Antibodies Against Human Csf-1r And Uses Thereof
  • Bispecific Molecules Comprising An Hiv-1 Envelope Targeting Arm
  • Antibodies Against Human Tweak And Uses Thereof
  • Constant Chain Modified Bispecific, Penta- And Hexavalent Ig-M Antibodies
  • Methods And Compositions For Screening And Detecting Biomarkers
  • Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use Thereof
  • 4-{2-[2-(Tert-Butoxycarbonyl)-3-Phenylpropanamido]-2-(4-Ethylthiazol-2-Yl)Ethyl}Phenylsulfamic Acid; Anticarcinogenic, Antitumor, Antidiabrtic Agent; Angiogenesis Inhibitor; Sarcoid, Syphilis, Paget's Disease, Vein Occlusion, Artery Occlusion, Carotid Obstructive Disease, Chronic Uveitis/Vitritis
  • Anti-Htra1 Antibodies And Methods Of Use Thereof
  • Anti-Vegf Antibodies
  • Monovalent Anti-Cd3 Adjuvants
  • Compositions And Methods For Ex Vivo Expansion Of Human Hematopoietic Stem/Progenitor Cells
  • Peptides Protective Against S. Pneumoniae And Compositions, Methods And Uses Relating Thereto
  • Human Antibodies Specific For Gastrin Materials And Methods
  • Humanized Fcγriib-Specific Antibodies And Methods Of Use Thereof
  • Anti-Ngf Antibodies And Methods Using Same
  • Humanized Anti-Human Cd19 Antibodies And Methods Of Use
  • Peptides, Derivatives And Analogs Thereof, And Methods Of Using Same
  • Antibodies Against Platelet-Derived Growth Factor (Pdgf)
  • Therapeutic Vitamin D Conjugates
  • High Concentration Antibody And Protein Formulations
  • Genetically Engineered Polypeptide For Treatment Of Cardiovascular And Neurodegenerative Disorders; Anticarcinogenic, Antitumor, And Antiproliferative Agents; Non-Insulin Dependent Diabetes; Neuropathic Pain, Dyslipidemia, Obesity, And Retinopathy
  • Anti-Aβ Oligomer Humanized Antibody
  • Microporous Materials, Methods Of Making, Using, And Articles Thereof
  • Ionic Strength-Mediated Ph Gradient Ion Exchange Chromatography
  • Humanized Anti-Tag-72 Cc49 Monoclonal Antibodies; Retain Binding Affinity For Tag-72 And Have Reduced Immunogenicity, As Compared To A Parental Hucc49v10 Antibody; Carcinoma; Antitumor Agent
  • Agent, Uses And Methods For Treatment
  • Method For Purification Of Monoclonal Antibodies
  • Cytokine Derived Treatment With Reduced Vascular Leak Syndrome
  • Methods For Killing Psma-Expressing, Taxane-Resistant Cancer Cells
  • Therapeutic Musk Antibodies
  • Cytotoxicity-Inducing Therapeutic Agent
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Agonistic Trkb Binding Molecules For The Treatment Of Eye Diseases
  • Assay For Detecting Th1 And Th2 Cell Populations
  • Anti-Mpl Antibodies
  • Crystal Structures Of Heterodimeric Fc Domains
  • Prevention And Treatment Of Amyloidogenic Disease
  • Inhibiting Growth Of Cancerous Cells Using An Antibody (Mpa7) Which Binds To Antigen Cd46 Which Is Present On A Variety Of Human Cancers From Ovary, Breast, Lung, Prostate, Colon, Kidney, And Pancreas
  • Synthetic Peptide Constructs For The Diagnosis And Treatment Of Periodontitis Associated With Porphyromonas Gingivalis
  • Substituted Pyrazines As Cadherin-11 Inhibitors
  • Compositions And Methods For The Treatment Of Aberrant Angiogenesis
  • Methods Of Determining Cellular Chemosensitivity
  • Treatment Of High Trop-2 Expressing Triple Negative Breast Cancer (Tnbc) With Sacituzumab Govitecan (Immu-132) Overcomes Homologous Recombination Repair (Hrr) Rescue Mediated By Rad51
  • Il-1 Binding Proteins
  • Methods Of Decreasing Tumor Volume And Reducing Tumor Burden Using Tnf-Receptor-Coupling Agents
  • Therapeutic Use Of Anti-Cd22 Antibodies For Inducing Trogocytosis
  • Time-Resolved Laser-Induced Fluorescence Spectroscopy Systems And Uses Thereof
  • Fgf21 Mutants And Uses Thereof
  • Polynucleotide Sequences Which Code For Reshaped Human Monoclonal Antibody Preferential To Interleukins
  • Method For Selection And Production Of Tailor-Made Highly Selective And Multi-Specific Targeting Entities Containing At Least Two Different Binding Entities And Uses Thereof
  • Il-1 Binding Proteins
  • Antibodies Against Human Csf-1r And Uses Thereof
  • Anti-Cancer Antibodies With Reduced Complement Fixation
  • Cd3-Binding Molecules Capable Of Binding To Human And Non-Human Cd3
  • Aptamer Therapeutics Useful In The Treatment Of Complement-Related Disorders
  • Methods For The Production Of Proteins With A Desired Function
  • Iga Multi-Specific Binding Molecules
  • Methods For Treating Cancer Using Psca Antibodies And Fragments Thereof
  • Humanized Anti-Tag 72 Cc49 For Diagnosis And Therapy Of Human Tumors
  • Therapy For Metastatic Urothelial Cancer With The Antibody-Drug Conjugate, Sacituzumab Govitecan (Immu-132)
  • Human Control Antibodies And Uses Therefor
  • Variant Fc Regions
  • Anti-Siglec-7 Antibodies And Methods Of Use Thereof
  • Modified Polynucleotides Encoding Basic Helix-Loop-Helix Family Member E41
  • Identification Of Class I Mhc Associated Glycopertides As Targets For Cancer Immunotherapy
  • Agent For Treating Disease
  • A Human Polypeptide; Diagnosis And Therapy For Testicular Cancer
  • Increasing Antibody Affinity By Altering Glycosylation Of Immunoglobulin Variable Region
  • Enzymatic Conjugation Of Antibodies
  • Bispecific And Monospecific Antibodies Using Novel Anti-Pd-1 Sequences
  • Monovalent Antigen Binding Proteins
  • Antibodies Binding To Hla-A2/Wt1
  • Prevention, Treatment And Diagnosis Of P. Gingivalis Infection
  • Compositions And Methods For Growth Factor Modulation
  • Bacterially Derived Intact Minicells That Encompass Plasmid Free Functional Nucleic Acid For In Vivo Delivery To Mammalian Cells
  • Altering Affinity Of Antibody For Antigen By Deleting Dna Encoding A Carbohydrate Recognition Site From Variable Domain Of Antibody, Expressing Mutagenized Gene, Measuring Affinity Of Altered Antibody And Comparing To Control
  • Protein Purification Methods
  • Methods And Materials For Treating Cancer
  • Method For Treating Cancer Using An Antibody That Inhibits Notch4 Signaling
  • Have Specificity For Antigens Displayed By Microorganisms, Especially Viruses, As Well As Antigenic Sites Present On Cancer Cells And On Various Types Of Toxins, And Products Of Toxins
  • Anti-Herpes Simplex Virus Antibodies And Methods Of Use Thereof
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Smooth Transition Catheters
  • T Cell Receptor-Like Antibodies Specific For A Prame Peptide
  • Antibodies Against Human Csf-1r And Uses Thereof
  • Anti-Cd33 Antibodies And Methods Of Use Thereof
  • Anti-Aβ Globulomer 5f7 Antibodies
  • Peptides Directed For Diagnosis And Treatment Of Amyloid-Associated Diseases
  • Anti-Ox40 Antibodies And Methods Of Use
  • Bcma And Cd3 Bispecific T Cell Engaging Antibody Constructs
  • Administering Modified Antibody Which Selectively Binds Human Milk Fat Globule (Hmfg) Antigen, And Competes As Well Or Better With Unmodified Unmodified Antibody For Binding The Hfmg For Reducing Tumor Growth Or Reducing Size Of Tumor
  • Hydrazinyl-Pyrrolo Compounds And Methods For Producing A Conjugate
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Antibodies That Bind Human Protein Tyrosine Phosphatase Beta (Hptpβ)
  • Antibodies To Receptor For Advanced Glycation End Products (Rage) And Uses Thereof
  • Anticancer Agents; Diagnosis Using Alternation Of Gene Expression
  • Dock-And-Lock (Dnl) Complexes For Therapeutic And Diagnostic Use
  • Lox And Loxl2 Inhibitors And Uses Thereof
  • For Detecting A Pms2 Protein, Including A Truncated Pms2, For Detecting A Predisposition To Cancer, Monoclonal Antibody
  • Chains With Amino Acid Sequences For Antibodies Or Immunoglobulins
  • Cell Migration Assay
  • Therapeutic Dll4 Binding Proteins
  • Polypeptides And Use Thereof
  • Methods And Compositions For Treating Systemic Mastocytosis
  • Ccr8 Antibodies And Uses Thereof
  • Plasmodium Falciparum-Infected Erythrocytes Binding To Icam-1 And Cd36
  • Trispecific Antibodies
  • Monoclonal Antibodies To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9)
  • Monoclonal Antibodies Specific For Different Epitopes Of Human Gp39 And Methods For Their Use In Diagnosis And Therapy
  • Anti-Nkp46 Antibodies, Toxin Conjugates, And Therapeutic Use Of Same
  • High Affinity Antibodies That Neutralize Staphylococcus Enterotoxin B
  • Bi-Specific Monovalent Diabodies That Are Capable Of Binding To Gpa33 And Cd3, And Uses Thereof
  • Combination Therapy With A Hyaluronan-Degrading Enzyme And An Immune Checkpoint Inhibitor
  • Constructs Specifically Recognizing Glypican 3 And Uses Thereof
  • Three Dimensional Coordinates Of Hptpbeta
  • Cell Detection
  • Platelet-Specific Chimeric 7e3 Immunoglobulin
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Antibodies To Receptor Of Advanced Glycation End Products (Rage) And Uses Thereof
  • Methods And Products For Evaluating An Immune Response To A Therapeutic Protein
  • Hybrid Antibodies
  • Anti-Cmet Antibody
  • Contacting Microporous Material (Ceramic, Carbon, Glass, Metal, Or Metal Oxide) With Tin Compound To Produce Composite, Then Contacting With Pigment Comprising Elemental Metal, Metal Oxide, And/Or Alloy; For Hybridizing Nucleic Acids; Solid Phase Synthesis
  • Intravascular Pressure Sensor Calibration
  • Combination Immune Therapy And Cytokine Control Therapy For Cancer Treatment
  • Anti-Epidermal Growth Factor Receptor (Egfr) Antibodies
  • Nucleotide And Amino Acid Sequences Encoding An Exported Protein 1 Derived From Plasmodium Vivax And Uses Thereof
  • Anti-Hulrrc15 Antibody Drug Conjugates And Methods For Their Use
  • Hemagglutinin Polypeptides, And Reagents And Methods Relating Thereto
  • Humanized Cdr-Grafted Anti-Icam-1 Antibodies, Methods Of Preparation And Usage Thereof
  • Methods Of Producing Two Chain Proteins In Bacteria
  • Pharmaceutical Compositions Containing Sc(Fv)2
  • Humanized Antibodies Targeting Human Tissue Factor
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Method Of Producing Secretable Antibodies By Expression In Saccharomyces Cerevisiae
  • Methods For Inhibiting Angiogenesis In A Subject In Need Thereof
  • Immunoglobulins And Variants Directed Against Pathogenic Microbes
  • Methods For The Treatment Of Disease Using Immunoglobulins Having Fc Regions With Altered Affinities For Fcγractivating And Fcγrinhibiting
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Compositions And Method For Treating Complement-Associated Conditions
  • Humanized Anti-Cxcr5 Antibodies, Derivatives Thereof And Their Use
  • Pharmaceutical Composition For Treatment And/Or Prevention Of Cancer
  • Il-17 Binding Proteins
  • Human-Murine Chimeric Antibodies Against Respiratory Syncytial Virus
  • Gene Expression Markers And Treatment Of Multiple Sclerosis
  • Methods Of Inhibiting Solid Tumor Growth By Administering Gpr49 Antibodies
  • Multi-Specific Fab Fusion Proteins Comprising A Cd3-Binding Fab Fragment With N-Terminal Fusion To Binding Domains And Methods Of Use
  • Anti-Axl Antibodies And Methods Of Use
  • B7-H3l Cell Surface Antigen And Antibodies That Bind Thereto
  • Recombinant Anti-Cd4 Antibodies For Human Therapy
  • Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use Thereof
  • Recombinant Human Anti-Cd18 Antibodies
  • Control Of Rage Fusion Protein Glycosylation And Rage Fusion Protein Compositions
  • At Least One Aromatic Amino Acid (Phenylalanine); Hollow And Fibrillar Peptide; Macroscopic And Microscopic Articles; Self-Assembled; 9-Fluorenylmethyloxycarbonyl (Fmoc) And Benzyloxycarbonyl (Cbz); Slow Release Of Drug, Nucleic Acid Molecule Or A Polypeptide; Antibody
  • Antibodies That Bind To The C35 Polypeptide
  • Assays For Detecting T Cell Immune Subsets And Methods Of Use Thereof
  • Compounds, Compositions, And Methods For Preventing Metastasis Of Cancer Cells
  • Cell Culture Compositions With Antioxidants And Methods For Polypeptide Production
  • Polynucleotides Encoding Notch Receptor Antibodies
  • Polynucleotides Encoding Antibodies Directed Against Amyloid-Beta Peptide
  • Pharmaceutical Compositions And Methods Useful For Modulating Angiogenesis, Inhibiting Metastasis And Tumor Fibrosis, And Assessing The Malignancy Of Colon Cancer Tumors
  • Method For Reducing An Immune Response By Administering An Immune Evading Adeno-Associated Aav8 Or Aavdj Viral Vector
  • Methods And Compositions For Modulating Hepsin Activation Of Macrophage-Stimulating Protein
  • Tnfa-Il-17 Bispecific Antibodies
  • Using Lectin Membrane Protein Specific Immunoglobulin To Treat, Target And Prevent Cell Proliferative Disorders
  • Yersinia Spp. Polypeptides And Methods Of Use
  • Granulocyte-Binding Antibody Constructs, Their Preparation And Use
  • Multispecific Binding Molecules Comprising Connecting Peptides
  • Anti-Glucosaminidase Passive Immunization For Staphylococcus Aureus Infections
  • Tri-Specific Binding Molecules That Specifically Bind To Multiple Cancer Antigens And Methods Of Use Thereof
  • B7-H3l Cell Surface Antigen And Antibodies That Bind Thereto
  • Anti-Cxcr4 Antibodies And Antibody-Drug Conjugates
  • Diagnosis And Treatment Of Viral Diseases
  • Anti Human Immunodeficiency Antibodies And Uses Thereof
  • Method Of Treating Allergic Disorders
  • Therapeutic Canine Immunoglobulins And Methods Of Using Same
  • Pdgf Receptor Beta Binding Polypeptides
  • Anti-Cmet Antibody
  • Method And Apparatus To Identify Vulnerable Plaques With Thermal Wave Imaging Of Heated Nanoparticles
  • Anti-Factor D Antibody Variant Conjugates And Uses Thereof
  • Anti-Ox40l Antibodies
  • Immmunoglobulin Fusion Protein Which Binds Integrin Associated Protein (Iap) For Treating Cancer Of Blood; Antitumor/Anticarcinogenic Agents
  • Rotational Ultrasound Imaging Catheter With Extended Catheter Body Telescope
  • Compositions And Methods For Diagnosing And Treating Cancer
  • Chimeric Antigen Receptors Targeting G-Protein Coupled Receptor And Uses Thereof
  • Degraded Tpo Agonist Antibody
  • Her2/Neu-Specific Antibodies And Methods Of Using Same
  • Expression Vectors Constructed By Inserting Antibody Heavy Chain Variable Region-Encoding Cdna And Antibody Light Chain Variable Region-Encoding Cdna Isolated From Hybridomas Producing Rat Onoclonal Antibody Reacting With Ganglioside Gm2
  • Anti-Ceacam5 Antibodies And Uses Thereof
  • Methods For Inducing Or Enhancing An Immune Response By Administering Agonistic Gitr-Binding Antibodies
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Immunoglobulin Comprising Variable Heavy Chain Domain For Prevention And Treatment Of Age-Related Macular Degeneration Or Diabetic Retinopathy
  • Cys80 Conjugated Immunoglobulins
  • Heterodimeric Antibodies That Bind Enpp3 And Cd3
  • Anti-Ige Antibodies And Method Of Improving Polypeptides
  • Method Of Diagnosing The Presence Of A Tumor In A Mammal By Assessing Cdo Expression Levels
  • Method Of Treatment With Antibodies Having Specificity For Human Ox40
  • Methods Of Improving Vaccine Immunogenicity
  • Therapeutic Peptides
  • Modified Antibodies
  • Hybrid Amyloid-Beta Antibodies
  • Peptides And Methods Using Same For Diagnosis And Treatment Of Amyloid-Associated Disease
  • Isolation And Use Of Solid Tumor Stem Cells
  • Decreasing Lactate Level And Increasing Polypeptide Production By Downregulating The Expression Of Lactate Dehydrogenase And Pyruvate Dehydrogenase Kinase
  • Isolating Polypeptide Genes Coding For A Receptor Having Catalytic Acitivity That Is Capable Of Binding Ligands Having Immunological Activity
  • Methods Of Reducing Trail-Induced Apoptosis By Trail Isoforms
  • Antibodies To Gm-Csf
  • Pharmaceutical Composition For Treatment And/Or Prophylaxis Of Cancer
  • Method For Detecting Cancer Using Caprin-1 As A Marker
  • Antibodies Inhibiting C-Met Dimerization And Uses Thereof
  • Psma And Cd3 Bispecific T Cell Engaging Antibody Constructs
  • Enrichment Method For Variant Proteins With Altered Binding Properties
  • Glycan Conjugates And Methods Of Use Thereof
  • Compositions And Methods To Inhibit Stem Cell And Progenitor Cell Binding To Lymphoid Tissue And For Regenerating Germinal Centers In Lymphatic Tissues
  • Endosialin-Binding Antibody
  • Ror1-Binding Molecules, And Methods Of Use Thereof
  • Antibodies For The Treatment Of Hiv
  • Single Domain Antibodies Directed Against Tumor Necrosis Factor-Alpha And Uses Therefor
  • Method Of Treating Cancer By Administering An Anti-Lgr5 Monoclonal Antibody
  • Anti-Her3 Antibodies And Compositions
  • Therapeutic Use Of Anti-Cd22 Antibodies For Inducing Trogocytosis
  • Liquid Protein Formulations Containing Cimetidine
  • Signal Biomarkers
  • Microarrays And Uses Therefor
  • Method For Treating Joint Damage
  • Anti-Cmet Antibody
  • Monoclonal Antibody
  • Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells Activity
  • Monoclonal Antibody To Pd-L1
  • Epitope Which Binds To Monoclonal Antibody
  • Methods For The Treatment Of Cancer Using Anti-Cd40 Antibodies
  • Methods For Producing Recombinant Proteins
  • Spliceostatin Analogs And Methods For Their Preparation
  • Anti-Cxcr4 Antibodies And Antibody-Drug Conjugates
  • Recognition Tags For Tgase-Mediated Conjugation
  • Treatment With Anti-Alpha2 Integrin Antibodies
  • Humanized Antibodies To Tnf-Like Ligand 1a (Tl1a) And Uses Thereof
  • Anti-Pd-1 Antibodies And Uses Thereof
  • Bispecific Molecules Having Immunoreactivity With Pd-1 And Ctla-4, And Methods Of Use Thereof
  • Method For Treating Glioblastoma Or Glioma With Antibody Constructs For Egfrviii And Cd3
  • Cancer Treatment With C-Met Antagonists And Correlation Of The Latter With Hgf Expression
  • Antibodies That Bind To Repulsive Guidance Molecule A (Rgma)
  • Cancer Associated Polynucleotides, Genes And Antibodies Specific For The Gene Products, Used In The Detection, Diagnosis, Prevention And/Or Treatment Of Associated Cancers
  • Modified Polynucleotides For The Production Of Proteins
  • Identification And Engineering Of Antibodies With Variant Fc Regions And Methods Of Using Same
  • Deimmunized Serum-Binding Domains And Their Use In Extending Serum Half-Life
  • Antibodies, Pharmaceutical Compositions And Methods
  • Methods For Treating Progressive Multiple Sclerosis
  • Anti-Ox40 Antibodies And Methods Of Use
  • Notch1 Receptor Antibodies And Methods Of Treatment
  • Vaccine Compositions And Methods For Restoring Nkg2d Pathway Function Against Cancers
  • Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes
  • For The Identification And Isolation Of Chondrocytes, Mesenchymal Progenitor Cells And Embryonic Stem Cells For Tissue Engineering Of Cartilage; Diseases Related To Joints, Cartilage And Atherosclerosis
  • A Highly Sensitive And Specific Luciferase Based Reporter Assay For Antigen Detection
  • Antibodies To Alpha-Synuclein And Uses Thereof
  • Coiled Coil And/Or Tether Containing Protein Complexes And Uses Thereof
  • Method Of Overcoming Therapeutic Limitations Of Nonuniform Distribution Of Radiopharmaceuticals And Chemotherapy Drugs
  • Binding Constructs And Methods For Use Thereof
  • Comprises A Filamentous Bacteriophage Particle Displaying On Its Surface A Binding Molecule Which Has A Binding Domain Able To Bind Target Epitope Or Antigen; Genetic Engineering
  • Humanized Anti-Tag 72 Cc49 For Diagnosis And Therapy Of Human Tumors
  • Variants Of Tnfsf15 And Dcr3 Associated With Crohn's Disease
  • Binding Molecules For The Treatment Of Cancer
  • Antibodies Directed To Angiopoietin-1 And Angiopoietin-2 And Uses Thereof
  • Methods And Materials For Detecting C9orf72 Hexanucleotide Repeat Expansion Positive Frontotemporal Lobar Degeneration Or C9orf72 Hexanucleotide Repeat Expansion Positive Amyotrophic Lateral Sclerosis
  • Immunoglobulins, Binding, Antibodies And Sequences
  • Methods For Inhibiting Cell Proliferation
  • Human Inkt Cell Activation Using Glycolipids
  • Carbonic Anhydrase Ix-Specific Antibodies And Uses Thereof
  • Binding Moieties Based On Shark Ignar Domains
  • Modified Pseudomonas Exotoxin A
  • Pax 5 Monoclonal Antibody
  • Antibodies Specifically Binding To Her3
  • Albumin Binding Antibodies And Binding Fragments Thereof
  • Biofilm Treatment
  • Anti-Cd79b Antibodies And Immunoconjugates And Methods Of Use
  • Single-Chain Multiple Antigen-Binding Molecule, Its Preparation And Use
  • Amino Acid Sequence Of Native Polypeptide Which Interacts With Hedgehog And Patched Signaling Molecules Involved In Cell Proliferation And Differentiation; For Therapy And Diagnosis
  • Cd16a Binding Proteins And Use For The Treatment Of Immune Disorders
  • Use Of Dr6 And P75 Antagonists To Promote Survival Of Cells Of The Nervous System
  • Polynucleotides Encoding An Anti-Beta-Amyloid Monoclonal Antibody
  • Delivery And Formulation Of Engineered Nucleic Acids
  • Fusion Antibodies For Hiv Therapy
  • Bgl3 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Cancer, Autoimmune And Inflammatory Disease, Vaccines; Binds To The Extracellular Domain Of Native Human Fc Gamma Riib With Greater Affinity Than To The Extracellular Domain Of Native Human Fc Gamma Riia
  • Anti-Cdh3 Humanized Antibody, Drug Conjugate Thereof, And Use Thereof
  • Porphyromonas Gingivalis Polypeptides And Nucleotides
  • Antibody-Drug Conjugates And Uses Thereof
  • Monoclonal Antibodies Reactive With Tumor Proliferating Cells
  • Anti-Ox40 Antibodies And Uses Thereof
  • Compositions And Methods Of Altering Cholesterol Levels
  • A Novel And Efficient Method For Reprogramming Immortalized Lymphoblastoid Cell Lines To Induced Pluripotent Stem Cells
  • Humanized C-Erbb-2 Specific Antibodies
  • Method Of Determining Virus Removal From A Sample Containing A Target Protein Using Activated Carbon
  • Humanized Antibodies
  • Method For Making Monoclonal Antibodies And Cross-Reactive Antibodies Obtainable By The Method
  • Humanized Interleukin-2 Receptors Antibodies
  • Non-Cross-Reactive Anti Igg Antibodies
  • Hybridoma And Anti-Kc-4 Humanized Monoclonal Antibody
  • Methods And Compositions For The Treatment Of Proliferative And Pathogenic Diseases
  • Covalent Diabodies And Uses Thereof
  • Novel Antibodies For Conferring Passive Immunity Against Infection By A Pathogen In Humans
  • Carrier Molecules
  • Antibodies Reactive With B7-H3 And Uses Thereof
  • M-Csf-Specific Monoclonal Antibody And Uses Thereof
  • Cadherin-11 Inhibitors And Methods Of Use Thereof
  • Anti-Htra1 Antibodies And Methods Of Use Thereof
  • Tumor Necrosis Factor-Gamma
  • Multispecific Fab Fusion Proteins And Use Thereof
  • Antibody Produced By A Host Cell With A Deposit Number Of Atcc No. Pta-6516 Or Progeny Thereof, Or An Antigen-Binding Fragment Thereof, Said Antibody Specifically Binds To Carboxypeptidase M; Use In Diagnosing And Treating Various Human Cancers And Diseases That Express Kid31(Carboxypeptidase M)
  • Engineered Anti-Il-23 Antibodies
  • Anti Human Interleukin-1 Receptor Accessory Protein (Il1 Rap) Antibodies And Uses Thereof
  • Antibodies, Pharmaceutical Compositions And Methods
  • Ultrapurified Dsba And Dsbc And Methods Of Making And Using The Same
  • Antibodies Specifically Binding To Masp-3 For The Treatment Of Various Diseases And Disorders
  • Compositions And Methods For Growth Factor Modulation
  • Polypeptides And Immunizing Compositions Containing Gram Positive Polypeptides And Methods Of Use
  • Immunoglobulin Variable Region Cassette Exchange
  • Anti-Alphavbeta1 Integrin Compounds And Methods
  • Antibody Molecules Having Specificity For Human Ox40
  • Combination Of Fcγriib-Specific Antibodies And Cd20-Specific Antibodies And Methods Of Use Thereof
  • Antibodies Directed To Angiopoietin-1 And Angiopoietin-2 And Uses Thereof
  • Antibodies Against Human Csf-1r And Uses Thereof
  • Anti-Il-12/Il-23 Antibodies
  • Calcium Binding Recombinant Antibody Against Protein C
  • Cdr-Repaired Antibodies
  • Use Of Signal Enhancing Compounds In Electrochemiluminescence Detection
  • Antibodies To Receptor Of Advanced Glycation End Products (Rage) And Uses Thereof
  • System And Method For Catheter Steering And Operation
  • Immuno-Pet Imaging Of Antibodies And Immunoconjugates And Uses Therefor
  • Her2/Neu-Specific Antibodies And Methods Of Using Same
  • Human Protein Tyrosine Phosphatase Inhibitors And Methods Of Use
  • First Antigen Recognition Portion That Binds A C3b-Like Receptor And A Second That Binds An Antigenic Molecule Present In The Circulatory System
  • Antibodies Against Tim3 And Uses Thereof
  • Anti-Cd303 Monoclonal Antibodies
  • Saccharide-Based Biomarkers And Therapeutics
  • Covalent Diabodies And Uses Thereof
  • Antibodies With Immune Effector Activity And That Internalize In Folate Receptor Alpha-Positive Cells
  • Anti-Bv8 Antibodies And Uses Thereof
  • Treatment And Reversal Of Fibrosis And Inflammation By Inhibition Of The Tl1a-Dr3 Signaling Pathway
  • Chimeric Ospa Genes, Proteins, And Methods Of Use Thereof
  • Compositions And Methods Useful For Stabilizing Protein-Containing Formulations
  • Anti-Glucosaminidase Passive Immunization For Staphylococcus Aureus Infections
  • Interferon Alpha Receptor I Antibodies And Their Use
  • Anti-Alpha V Beta 6 Antibodies And Uses Thereof
  • Diagnosis And Treatment Of Viral Diseases
  • Humanized Anti-Il-1r3 Antibodies
  • Methods Of Diagnosing Inflammatory Bowel Disease Through Rnaset2
  • Antibodies Specific For Cd44v6
  • Neuritogenic Peptides
  • Systems And Methods For Recording Simultaneously Visible Light Image And Infrared Light Image From Fluorophores
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Cytotoxic Peptides And Antibody Drug Conjugates Thereof
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Anti-Pmel17 Antibodies And Immunoconjugates
  • Humanized Anti-Beta7 Antagonists And Uses Therefor
  • Fcγriib Specific Antibodies And Methods Of Use Thereof
  • Compositions Comprising Purified Recombinant Il-13 Antibody
  • Methods Of Reducing Level Of One Or More Impurities In A Sample During Protein Purification
  • High Throughput Generation And Affinity Maturation Of Humanized Antibody
  • Methods Of Preparing P. Gingivalis Antibodies
  • High Throughput Generation And Affinity Maturation Of Humanized Antibody
  • Anti-Notch3 Antibodies And Antibody-Drug Conjugates
  • Anti-Vegf Antibodies
  • Method Of Enhancing Proliferation Or Differentiation Of Hematopoietic Stem Cells Using Wnt Polypeptides
  • Cdk9 Inhibitors And Polymorphs Thereof For Use As Agents For Treatment Of Cancer
  • Methods And Compositions Relating To Islet Cell Neogenesis
  • Compositions And Methods For Treating Subjects With Immune-Mediated Diseases
  • Production Of Motif-Specific And Context-Independent Antibodies Using Peptide Libraries As Antigens
  • Anti-Factor B Antibodies And Their Uses
  • Antibody Formulations
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Psca: Prostate Stem Cell Antigen And Uses Thereof
  • Pd-1 Specific Antibodies And Uses Thereof
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Methods Of Determining Patient Response By Measurement Of Her-3
  • Methods Of Culturing And Expanding Mesenchymal Stem Cells
  • Methods For Producing Members Of Specific Binding Pairs
  • Methods For Identifying Safe And Functional Humanized Antibodies
  • Antibodies Against Human Csf-1r And Uses Thereof
  • Method Of Using Humanized Antibody Against Cd18
  • Efficacy Of Anti-Hla-Dr Antiboddy Drug Conjugate Immu-140 (Hl243-Cl2a-Sn-38) In Hla-Dr Positive Cancers
  • Beta Secretase Polypeptides
  • Antibodies Against Human Csf-1r And Uses Thereof
  • Amyloid Β(1-42) Oligomers, Derivatives Thereof And Antibodies Thereto, Methods Of Preparation Thereof And Use Thereof
  • Oncogene- Or Virus-Controlled Expression Systems
  • Fusion Proteins And Polynucleotides Encoding Gelonin Sequences
  • Notch1 Receptor Binding Agents And Methods Of Use Thereof
  • Biomarkers For Detecting Cancer
  • Modified Polynucleotides Encoding Copper Metabolism (Murr1) Domain Containing 1
  • Anti-C10orf54 Antibodies And Uses Thereof
  • Methods And Compositions For Treatment And Diagnosis Of Fibrosis, Tumor Invasion, Angiogenesis, And Metastasis
  • Anti-Hepcidin Antibodies And Uses Thereof
  • High Affinity Antibodies That Neutralize Staphylococcus Enterotoxin B
  • In Vitro Methods Of Producing And Identifying Immunoglobulin Molecules In Eukaryotic Cells
  • Cell Engaging Binding Molecules
  • Composition And Method For Diversification Of Target Sequences
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Humanized Anti-Amyloid Antibody
  • Production Of Tnfr-Ig
  • Bgl6 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Method For Making Heteromultimeric Molecules
  • Antibody Constructs For Cd70 And Cd3
  • Methods For Detecting Cancer Metastasis
  • Antibodies Against Human Csf-1r And Uses Thereof
  • Compositions And Methods For Treatment And Detection Of Cancers
  • Chimeric Ospa Genes, Proteins, And Methods Of Use Thereof
  • Compositions And Methods For Recombinant Biosynthesis Of Propane
  • Site Directed Mutagenesis Of Trem-1 Antibodies For Decreasing Viscosity
  • Humanized Chimeric Antibody Directed Against Ganglioside Gd3
  • Granulocyte-Macrophage Colony-Stimulating Factor (Gm-Csf) Neutralizing Antibodies
  • Polynucleotides Which Encode Reshaped Il-8-Specific Antibodies And Methods To Produce The Same
  • Polynucleotides Encoding Immune Modulating Polypeptides
  • Cytolethal Distending Toxin Subunit B Conjugated Or Fused To Bacillus Anthracis Toxin Lethal Factor
  • Human Antigen Binding Proteins That Bind Β-Klotho, Fgf Receptors And Complexes Thereof
  • Method For Detecting Cancer Via Measurement Of Caprin-1 Expression Level
  • Evaluating Tumor Propagation In Humans; Obtain Tissue Sample, Detect Presence Of Preferential Glycoprotein In Cells, Count Cells, Determine Senstivity To Tumor Propagation
  • Anti-Cd79b Antibodies And Immunoconjugates And Methods Of Use
  • Il-17 Binding Proteins
  • Humanized Anti-Cd40 Antibodies And Their Methods Of Use
  • Hybrid Antibodies
  • Having Specificity For The Epitope Recognized By The Murine Monoclonal Antibody A33, Wherein Said Human Antibody Molecule Is Optionally Conjugated To An Effector Or Reporter Molecule; Colorectal Cancer Diagnosis, Therapy
  • Human Monoclonal Antibodies Against Cd25
  • Alpha-Synuclein Antibodies
  • Anti-Cd40 Antibodies And Uses Thereof
  • Bacterially Derived, Intact Minicells Encompassing Regulatory Rna
  • Bcma And Cd3 Bispecific T Cell Engaging Antibody Constructs
  • Anticancer Agent
  • Ephb3-Specific Antibody And Uses Thereof
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Compositions Comprising Polyglutamic Acid Nanoparticles And Cd40 Agonists
  • Human Protein Tyrosine Phosphatase Inhibitors And Methods Of Use
  • Heterodimeric Proteins
  • Humanized Anti-Fgf19 Antagonists And Methods Using Same
  • Compositions And Methods For The Therapy And Diagnosis Of Cytomegalovirus
  • Hcv Antigen-Antibody Combination Assay And Methods And Compositions For Use Therein
  • Multimeric Proteins And Methods Of Making And Using Same
  • Fgf21 Mutants Comprising A Mutation At Position 98, 171 And/Or 180
  • Anti-Siglec-5 Antibodies And Methods Of Use Thereof
  • Anti-Ανβ6 Antibodies And Uses Thereof
  • Using A Hapten Comprising Tetracarboxy Phenyl Porphyrin Zinc Or Cobalt Complexes, To Generate Monoclonal Or Polyclonal Antibodies And Testing For Inhibitory Effects Of The Antibodies On The Gelatinase B; Metalloenzyme Inhibitors
  • Yersinia Spp. Polypeptides And Methods Of Use
  • Signature Of Tl1a (Tnfsf15) Signaling Pathway
  • Compound Bearing Beta-Galactoside-Introduced Self-Immolative Linker
  • Administering Antibodies Capable Of Neutralizing Rabies Virus Infection In An Exposed Individual
  • Il-18 Binding Protein (Il-18bp) In Inflammatory Diseases
  • High Affinity Antibodies That Neutralize Staphylococcus Enterotoxin B
  • Monoclonal Antibody Capable Of Binding Integrin Alpha 10 Beta 1
  • Polypeptides And Immunizing Compositions Containing Gram Positive Polypeptides And Methods Of Use
  • Method For Treating Coronary Artery Disease Using Antibody Binding Human Protein Tyrosine Phosphatase Beta(Hptpbeta)
  • Method To Generate Antibodies To Ion Channels
  • Efficacy Of Anti-Hla-Dr Antibody Drug Conjugate Immu-140 (Hl243-Cl2a-Sn-38) In Hla-Dr Positive Cancers
  • Garp-Tgf-Β 1 Igg Antibodies
  • Xbp1, Cd138, And Cs1 Peptides
  • Identification Of Cytolytic T Cell (Ctl) Epitopes Of Hpv Proteins; Immunization Comprising An Hpv Virus Like Particle Comprising A First Hpv E2 Polypeptide, Cd40 Agonist And Granulocyte/Macrophage Colony Stimulating Factor (Gm-Csf) Agent
  • Antibodies To Vla-1
  • Inhibiting C-Met Activation In Subject By Administering An Hgf/C-Met Antagonist Molecule, Wherein The Hgf/C-Met Antagonist Molecule Comprises An Hgf Mutant Comprising A Mutation In Hgf Beta Chain N Terminal Region, Wherein Mutation Is G498i, G498p, G498v, R502del Plus T503del, Or D672n
  • Thrombin/Plasmin-Regulated Antibodies That Bind Tfpi
  • Multispecific Antibody Constructs
  • Methods For Producing Antibodies
  • Anticancer Agents; Removal Bone Marrow, Contactor With Protein; Reinsertion
  • Anti-Sortilin Antibodies, Uses And Methods For Treatment
  • Glycan-Interacting Compounds And Methods Of Use
  • Combination Therapies Employing Gitr Binding Molecules
  • Anti-Cd79b Antibodies And Immunoconjugates And Methods Of Use
  • Chimeric Cytokine Formulations For Ocular Delivery
  • Agents, Uses And Methods For The Treatment Of Synucleinopathy
  • Bgl7 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Antibodies Specific To Human Poliovirus Receptor (Pvr)
  • Systems For Indicating Parameters In An Imaging Data Set And Methods Of Use
  • Anti-Fgfr3 Antibodies And Methods Using Same
  • Novel Blood Cell Biomarker For Late Onset Alzheimer's Disease
  • Formulation And Delivery Of Plga Microspheres
  • Antibodies Targeting B-Cell Maturation Antigen And Methods Of Use
  • Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9)
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Method For Selection And Production Of Tailor-Made Highly Selective And Multi-Specific Targeting Entities Containing At Least Two Different Binding Entities And Uses Thereof
  • Compositions And Methods For Growth Factor Modulation
  • Modified Immunoglobulin Molecules That Specifically Bind Human Vegf And Dll4
  • Antibody Capable Of Binding A Transition State Analog For The Hydrolysis Of Cocaine Benzoyl Ester Group; Treatment Of Drug Abuse, Drug Dependence, Overdoses
  • Antibodies Specific For Tgf-Beta And Methods For Treating Thereof
  • Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes
  • Site Directed Mutagenesis Of Trem-1 Antibodies For Decreasing Viscosity
  • Binding Molecules With Modified J-Chain
  • Selective Exosite Inhibition Of Papp-A Activity Against Igfbp-4
  • Methods For Treating Cancer In Patients With Elevated Levels Of Bim
  • Methods Of Inducing Or Enhancing An Immune Response In A Subject Having Cancer By Administering Gitr Antibodies
  • Bispecific Heterodimeric Fusion Proteins Containing Il-15-Il-15rα Fc-Fusion Proteins And Pd-1 Antibody Fragments
  • Bispecific Molecules That Are Immunoreactive With Immune Effector Cells Of A Companion Animal That Express An Activating Receptor And Cells That Express B7-H3 And Uses Thereof
  • Anti-Cd26 Antibodies And Methods Of Use Thereof
  • Antibodies Against Signal-Regulatory Protein Α And Methods Of Use
  • Humanized Anti-Beta7 Antagonists And Uses Therefor
  • Therapeutic Use Of Anti-Cd22 Antibodies For Inducing Trogocytosis
  • Anti-B7-H4 Antibodies And Immunoconjugates
  • Nucleic Acids Encoding Antibodies To Matrix Metalloproteinase 9
  • Antibodies To Vla-1
  • Fgf-21 Mutants Comprising Polyethylene Glycol And Uses Thereof
  • Using Estrogen Receptor Specific Immunoglobulins To Treat Cell Proliferative Disorders Of Mammary Glands
  • Time-Resolved Laser-Induced Fluorescence Spectroscopy Systems And Uses Thereof
  • Antibody Peg Positional Isomers, Compositions Comprising Same, And Use Thereof
  • Antibodies Against The Rgm A Protein And Uses Thereof
  • Nucleotide And Amino Acid Sequences Encoding An Exported Protein 1 Derived From Plasmodium Vivax And Uses Thereof
  • Methods Of Ex Vivo Hematopoietic Stem Cell Expansion By Co-Culture With Mesenchymal Cells
  • Human Monoclonal Antibodies Against Cd25
  • Signaling And Mediator Molecules In The Hedgehog (Hh) Cascade Which Are Involved In Cell Proliferation And Differentiation
  • Anti-Glucosaminidase Passive Immunization For Staphylococcus Aureus Infections
  • Methods Of Controlling Proliferation And Differentiation Of Stem And Progenitor Cells
  • Antibodies That Bind Il-4 And/Or Il-13 And Their Uses
  • Virtual Neonatal Echocardiographic Training System
  • Optimized Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor (Tfpi)
  • Methods For Inhibiting The Binding Of Endosialin To Ligands
  • Genetically Engineered T. Cruzi Wherein The Amastigote Stage-Regulated Protein Is Expressed From A Gene Involved In Energy Metabolism; Suitable For Use In Diagnosis Of Chagas Disease, In Drug Development, In Antibody Production, And In The Production Of Vaccines, Including Live Vaccines
  • Assay For Measurement Of Antibodies Binding To A Therapeutic Monoclonal Antibody
  • Antibodies Against And Methods For Producing Vaccines For Respiratory Syncytial Virus
  • Agents, Uses And Methods For The Treatment Of Synucleinopathy
  • Anti-Mesothelin Antibodies
  • Covalent Diabodies And Uses Thereof
  • Multiple Signaling Pathways Induced By Hexvalent, Monospecific And Bispecific Antibodies For Enhanced Toxicity To B-Cell Lymphomas And Other Diseases
  • Human Anti-Pd-1, Pd-L1, And Pd-L2 Antibodies And Uses Therefor
  • Antibody Molecules Specific To Human Tumour Necrosis Factor Alpha
  • Humanized Anti-Lymphotoxin Beta Receptor Antibodies
  • Msln Targeting Trispecific Proteins And Methods Of Use
  • Polypeptide (Suv39h2) Having Histone Methyltransferase Activity; Antitumor Agents; Meiotic Chromatin; Contraceptives
  • Monoclonal Antibody Capable Of Binding Integrin Alpha 10 Beta 1
  • Anti-Sclerostin Antibody, Antigen Binding Fragment And Medical Use Thereof
  • Anti-Mesothelin Antibodies
  • Antigen Binding Molecules With Increased Fc Receptor Binding Affinity And Effector Function
  • Treatment For Inflammatory Bowel Disease With A Fibronectin Polypeptide
  • Peptide Nanostructure-Coated Electrodes
  • Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use Thereof
  • Antibodies With Immune Effector Activity And That Internalize In Folate Receptor Alpha-Positive Cells
  • Single Cell Bar-Coding For Antibody Discovery
  • Antibodies To A Non-Ligand Binding Region Of At Least Two Notch Receptors
  • Nucleic Acid Comprising Dicistronic Message For Producing Antibody Where Cistron Contains Dna Coding Heavy And Light Chains
  • Method To Improve Virus Filtration Capacity
  • Three-Dimensional Differentiation Of Epiblast Spheroids To Kidney Organoids Models Stage-Specific Epithelial Physiology, Morphogenesis, And Disease
  • Novel Anti-Hiv Antibodies
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Tetranectin-Apolipoprotein A-I, Lipid Particles Containing It And Its Use
  • Ion Exchange Membrane Chromatography
  • Bispecific Anti-Vegf And Anti-Trkb Binding Molecules For The Treatment Of Eye Diseases
  • Protective Antigen Of Group A Streptococci
  • Capable Of Binding To Mouse Vascular Endothelial Cell Growth Factor (Vegf) And Human Vegf; Cancer, Diabetes Related Diseases, Edema, Inflammation
  • System And Method For Oct Depth Calibration
  • Humanized Anti-Tau(Ps422) Antibodies And Methods Of Use
  • Compositions Capable Of Specifically Binding Particular Human Antigen Presenting Molecule/Pathogen-Derived Antigen Complexes And Uses Thereof
  • Genetically Modified Human Natural Killer Cell Lines
  • Bispecific Antibodies Comprising A Disulfide Stabilized-Fv Fragment
  • Cbh1 Homologs And Variant Cbh1 Cellulases
  • Methods Of Treating Autoimmune Disease Or Chronic Inflammation With Antibodies That Bind And Block Triggering Receptor Expressed On Myeloid Cells-1 (Trem-1)
  • Calcium Channel Inhibitors
  • Antibodies, Fragments Or Derivatives Specifically Binding To A Protein Antigen Capable Of Binding To Nucleic Acids, And Uses Of Same
  • Methods And Compositions For Inhibiting The Growth Of Hematopoietic Malignant Cells
  • Peptide Vaccines Against Interleukin-31
  • Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation
  • Immunoglobulins For Use As Tool In Treatment And Prevention Of Cell Proliferative Disorders Through Enhancement Of Antibody-Dependent Cell Mediated Cytotoxicity (Adcc) Or Complement Dependent Cytotoxicity (Cdc); Immunotherapy
  • Anti-Ngf Antibodies And Methods Using Same
  • Therapeutic Peptides
  • Modified Polynucleotides For The Production Of Proteins Associated With Human Disease
  • Alvocidib Prodrugs Having Increased Bioavailability
  • Method Of Treating Or Ameliorating Metabolic Disorders Using Binding Proteins For Gastric Inhibitory Peptide Receptor (Gipr) In Combination With Glp-1 Agonists
  • Antibodies Targeting B-Cell Maturation Antigen And Methods Of Use
  • Fgf Mutants With Reduced Proteolysis And Aggregation
  • Fcγriib Specific Antibodies And Methods Of Use Thereof
  • Anti-Cd33 Antibodies And Methods Of Use Thereof
  • Dipeptide Analogs For Treating Conditions Associated With Amyloid Fibril Formation
  • Method For Detecting Caprin-1 In A Biological Sample
  • Methods And Compositions For Assessing Responsiveness Of B-Cell Lymphoma To Treatment With Anti-Cd40 Antibodies
  • Inhibitors Of Il-11 Or Il-11ra For Use In The Treatment Of Abnormal Uterine Bleeding
  • Methods Of Screening For Agonists And Antagonists Of Patched-2
  • Masked Cytokine Polypeptides
  • Method For Non Surgical Repair Of Vertebral Compression Fractures
  • Egvii Endoglucanase And Nucleic Acids Encoding The Same
  • Gitr Antigen Binding Proteins And Methods Of Use Thereof
  • Methods Of Treating Autoimmune Disease Or Chronic Inflammation Wtih Antibodies That Bind Peptidoglycan Recognition Protein 1
  • Apo-2 Receptor Polynucleotides
  • Modified Antibody Constant Region
  • Targeted Delivery Of Drugs, Therapeutic Nucleic Acids And Functional Nucleic Acids To Mammalian Cells Via Intact Killed Bacterial Cells
  • Nucleic Acids Encoding B7rp1
  • Antigen Binding Protein And Its Use As Addressing Product For The Treatment Of Cancer
  • Biological Products
  • Nanoparticles Containing Polymeric Nucleic Acid Homologs
  • Antagonizing Cd73 Antibody
  • Gel Microdrop Composition And Method Of Using The Same
  • Chimeric Antibody Specific To Human Cd4 Which Comprises The Variable Heavy And Light Chain Sequences Of An Old World Monkey Monoclonal Antibody Produced Against Human Cd4 And Human Constant Heavy And Light Domain Sequences
  • Methods And Compositions For Immunizing Against Chlamydia Infection
  • Polypeptides And Immunizing Compositions Containing Gram Positive Polypeptides And Methods Of Use
  • Methods Of Using Anti-Cd79b Immunoconjugates
  • In Vivo Production Of Proteins
  • Methods For Modifying Human Antibodies By Glycan Engineering
  • Apo-3 Polypeptide
  • Methods Of Inhibiting Growth Of A Colon Cancer Tumor In A Subject By Administering Monoclonal Antibodies To G Protein-Coupled Receptor 49 (Gpr49)
  • Genetically Modified Human Natural Killer Cell Lines
  • Methods Of Reducing Level Of One Or More Impurities In A Sample During Protein Purification
  • Culturing Of Mesenchymal Stem Cells With Fgf4 And Nicotinamide
  • Fcγriib Specific Antibodies And Methods Of Use Thereof
  • Methods Of Treating Cancer With Human Monoclonal Antibodies To Ctla-4
  • Fgf21 Mutant Fusion Polypeptides And Uses Thereof
  • Recombinant Immunotoxin Targeting Mesothelin
  • Bi-Specific Monovalent Diabodies That Are Capable Of Binding To Gpa33 And Cd3, And Uses Thereof
  • Antigen Pipa And Antibodies That Bind Thereto
  • Biofilm Treatment
  • Engineered Anti-Il-23 Antibodies
  • Insulin Vitamin D Conjugates
  • Extension Sequences For Diabodies
  • Antibodies To Tgf-Β
  • Proteins Comprising An Igg2 Domain
  • Anti-Il31 Antibodies For Veterinary Use
  • Endoglin Antibodies
  • Antibodies To Madcam
  • Catecholic Butanes And Use Thereof For Cancer Therapy
  • Rationally Designed, Synthetic Antibody Libraries And Uses Therefor
  • Met-Binding Agents And Uses Thereof
  • Treatment Of Specific And Non-Specific Inflammation, Including Asthma; Useful In Diagnosing And Localizing Sites Of Inflammation.
  • Method Of Treating Or Ameliorating Metabolic Disorders Using Glp-1 Receptor Agonists Conjugated To Antagonists For Gastric Inhibitory Peptide Receptor (Gipr)
  • Carriers For Improved Drug Delivery
  • Glycopeptide And Uses Thereof
  • Compositions And Methods For Tcr Reprogramming Using Fusion Proteins
  • Nucleic Acids Encoding Hepatocyte Growth Factor Receptor Antagonist Antibodies
  • Anti-Alphabeta3 Humanized Monoclonal Antibodies
  • Methods For Viral Inactivation And Other Adventitious Agents
  • Intravascular Forward Imaging Device
  • High Affinity Antibodies That Neutralize Staphylococcus Enterotoxin B
  • Lowered Affinity Antibodies And Uses Therefor
  • Treating Cancer
  • Anti-Notch1 Antibodies
  • Human Protein Tyrosine Phosphatase Inhibitors And Methods Of Use
  • Humanized Antibodies
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Diagnostic Antibody Assay
  • Optimized Gene Editing Utilizing A Recombinant Endonuclease System
  • Humanized Antibody Specific For Tumor Necrosis Factor-Alpha
  • Humanized Antibody Or Fragment Thereof Specific For Cd45r0
  • Antibodies Targeting B-Cell Maturation Antigen And Methods Of Use
  • Humanized Immunoglobulins And Their Production And Use
  • Cancer Treatment And Monitoring Methods Using Ox40 Agonists
  • Anti-Cd38 Human Antibodies And Uses Thereof
  • Anti-Her2 Glycoantibodies And Uses Thereof
  • Proteins And Immunizing Compositions Containing Pasteurella Proteins And Methods Of Use
  • High Affinity Nucleic Acid Ligands Of Complement System Proteins
  • Labeled Peptides, Proteins And Antibodies And Processes And Intermediates Useful For Their Preparation
  • Combination Therapy With An Anti-Her2 Antibody-Drug Conjugate And A Bcl-2 Inhibitor
  • Methods Of Inducing Or Enhancing An Immune Response In A Subject By Administering Agonistic Gitr Binding Antibodies
  • Antibody Therapy
  • Anti-Mesothelin Immunoconjugates And Uses Therefor
  • Medicament For Treating And/Or Preventing Cancer
  • Yersinia Spp. Polypeptides And Methods Of Use
  • And Stimulate Erythropoiesis; Teatment Of Anemia
  • Antigen-Binding Sites Of Antibody Molecules Specific For Cancer Antigens
  • Antimicrobial Compositions And Methods Of Use
  • Methods And Reagents For Detecting Bioactive Lipids
  • Engineering Fc Antibody Regions To Confer Effector Function
  • Monoclonal Antibodies To Growth And Differentiation Factor 15 (Gdf-15)
  • Peptides Derived From Cytotoxicity Receptor Natural Killer Protein 44 Nkp44
  • Anti-Her2 Antibody Variants
  • Antibodies Against Signal-Regulatory Protein Alpha And Methods Of Use
  • For Diagnosis, Treatment Of Nervous System Disorders, Infections, Crop Protection, Veterinary Applications, And Identifying Binding Agents And Modulators
  • Method For Treating Psoriasis
  • Staphylococcus Aureus Materials And Methods
  • Treatment Of Autoimmune Diseases, Cancer, Graft-Versus-Host Disease
  • Anti-Human Igg1 Antibody
  • Production Of Proteins In Glutamine-Free Cell Culture Media
  • Targeting Regulatory T Cells With Heterodimeric Proteins
  • Monoclonal Antibodies Against The Interferon Receptor, With Neutralizing Activity Against Type 1 Interferon
  • Variant Enzymes
  • Antibodies That Bind To Cancer-Associated Antigen Cd46 And Methods Of Use Thereof
  • Providing A Cell Culture; Maintaining Culture In An Initial Growth Phase Under A First Set Of Culture Conditions To Allow Cells To Reproduce To A Viable Cell Density; Changing Culture Conditions, Maintaining Culture So That The Polypeptide Accumulates In The Cell Culture
  • Bispecific Anti-Vegf/Anti-Ang-2 Antibodies
  • Purified Immunoglobulin
  • Assays For Timp2 Having Improved Performance In Biological Samples
  • Dock-And-Lock (Dnl) Complexes For Therapeutic And Diagnostic Use
  • Macrophage Derived Chemokine (Mdc) And Chemokine Analogs And Assay To Identify Modulators Of Mdc Activity, And Therapeutic Uses For Same
  • Tau-Binding Antibodies
  • Her-3 Antibodies And Methods Of Use
  • Modified Antibody Variable Domains
  • Anti-Tissue Factor Antibodies And Compositions
  • Enhancing Activity Of Car T Cells By Co-Introducing A Bispecific Antibody
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Production Of Anti-Abeta
  • Methods Of Treating Ulcerative Colitis
  • Compositions And Methods For Tcr Reprogramming Using Fusion Proteins
  • Influenza Treatment And/Or Characterization, Human-Adapted Ha Polypeptides; Vaccines
  • Interleukin-13 Binding Proteins
  • Methods To Increase Or Decrease Bone Density
  • Anti-Αvβ3 Humanized Monoclonal Antibodies
  • Glycosyl-Etoposide Prodrugs, A Process For Preparation Thereof And The Use Thereof In Combination With Functionalized Tumor-Specific Enzyme Conjugates
  • Novel Alk2 Inhibitors And Methods For Inhibiting Bmp Signaling
  • Recombinant Humanized Anti-Fb5 Antibodies
  • Production Of Motif-Specific And Context-Independent Antibodies Using Peptide Libraries As Antigens
  • Recombinant Swine Influenza Virus And Uses Thereof
  • Genetic Engineering; Monoclonal Antibody Grafted To Tumor Necrosis Factor
  • Bivalent, Bispecific Antibodies
  • Anti-Tnf-Alpha Glycoantibodies And Uses Thereof
  • Nucleic Acid Encoding Dual Fc Antigen Binding Proteins
  • Yersinia Spp. Polypeptides And Methods Of Use
  • Anti-Factor D Antibodies
  • Combination Therapy With Anti-Cd74 Antibodies Provides Enhanced Toxicity To Malignancies, Autoimmune Disease And Other Diseases
  • Profiling Peptides And Methods For Sensitivity Profiling
  • Bivalent, Bispecific Antibodies
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Methods Of Detecting Factor D With Anti-Factor D Antibodies
  • Antibodies Against Human Epo Receptor
  • Terminally Modified Rna
  • Immunoconjugates Targeting Adam9 And Methods Of Use Thereof
  • Monoclonal Antibody Capable Of Binding To Specific Discontinuous Epitope Occurring In Ad1 Region Of Human Cytomegalovirus Gb Glycoprotein, And Antigen-Binding Fragment Thereof
  • Reducing The Immunogenicity Of Fusion Proteins
  • Anti-Angiogenic Compounds
  • Anti Notch-1 Antibodies
  • Biomarkers
  • Tumor Stem Cell Profile For Diagnosis, Characterization, Prognosis And Treatment Of Cell Proliferative Disodrers; Tissue Targeted Therapy
  • Isolate Nucleic Acids Containing Immunolgical Portions, Prepare Primers For Cloning Polynucleotides Segments Having The Variable Heavy And Light Chain Regions; Prepare And Express The Gene Libraries, Screening For Target Sequences
  • Compositions And Methods Relating To Universal Glycoforms For Enhanced Antibody Efficacy
  • Trimeric Collagen Scaffold Antibodies
  • Il-18 Binding Protein (Il-18bp) And Antibodies In Inflammatory Diseases
  • Methods Of Controlling The Formation Of Disulfide Bonds In Protein Solutions
  • Biomarkers
  • Identification And Engineering Of Antibodies With Variant Fc Regions And Methods Of Using Same
  • Multispecific Antibodies
  • Optimized Anti-Tl1a Antibodies
  • System For Antibody Expression And Assembly
  • Methods For Administering Peptides For The Generation Of Effective C/S Conformation-Specific Antibodies To A Human Subject In Need Thereof
  • Antibodies To Matrix Metalloproteinase 9
  • Bispecific Antibodies That Bind To Cd38 And Cd3
  • Methods For Augmenting An Immune Response Using Anti-Cd40 Antibodies
  • Antibodies With Modified Isoelectric Points
  • Alpha-Fetoprotein Immu31 Antibodies And Fusion Proteins And Methods Of Use Thereof
  • Isolation And Use Of Solid Tumor Stem Cells
  • Il-15/Il-15ralpha Based Conjugates Purification Method
  • Monoclonal Antibodies Against Amyloid Beta Protein And Uses Thereof
  • Recombinant Antibodies For Human Therapy
  • Compositions For Detecting Complement Factor H (Cfh) And Complement Factor I (Cfi) Polymorphisms
  • Ph Adjustment To Improve Thaw Recovery Of Cell Banks
  • Direct Selection Of Cells Expressing High Levels Of Heteromeric Proteins Using Glutamine Synthetase Intragenic Complementation Vectors
  • Antibodies Targeting B-Cell Maturation Antigen And Methods Of Use
  • Endoglin Antibodies
  • Administering An Effective Amount Of Hepatocyte Growth Factor Receptor Antagonist To A Mammal Diagnosed As Having Cancer, Wherein Said Hepatocyte Growth Factor Receptor Antagonist Is An Antibody
  • Anti Human Interleukin-1 Receptor Accessory Protein (Il1 Rap) Antibodies And Uses Thereof
  • Multi-Chain Polypeptide-Containing Tri-Specific Binding Molecules That Specifically Bind To Multiple Cancer Antigens
  • Immunological Targeting Of Pathological Tau Proteins
  • Antibodies Specific To Human T-Cell Immunoglobulin And Itim Domain (Tigit)
  • Formulation For Anti-Α4Β7 Antibody
  • Neuropilin Antagonists
  • Using Interleukin-1 Specfic Immunoglobulin Fusion And Tumor Necrosis Factor Inhibitors To Treat Inflammatory And/Or Autoimmune Disorders
  • Compositions And Methods For The Treatment Of Tumor Of Hematopoietic Origin
  • Hybridoma And Anti-Kc-4 Humanized Monoclonal Antibody, Dna And Rna Encoding It, Kit, Diagnostic And Therapeutic Methods
  • Therapeutic Uses Of The Hypervariable Region Of Monoclonal Antibody M195 And Constructs Thereof
  • Methods And Compositions Comprising Purified Recombinant Polypeptides
  • Bacterially Derived Intact Minicells That Encompass Plasmid Free Functional Nucleic Acid For In Vivo Delivery To Mammalian Cells
  • Methods And Compositions For Making Antibodies And Antibody Derivatives With Reduced Core Fucosylation
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Anti-Jam-A Antibodies
  • Methods Of Making Antibody Heavy And Light Chains Having Specificity For A Desired Antigen
  • Identification And Expression Of A Novel Kinesin Motor Protein
  • Antiidiotypic Antibodies For High Molecular Weight-Melanoma Associated Antigen
  • Antibodies To Ubiquitin C-Terminal Hydrolase L1 (Uch-L1) And Glial Fibrillary Acidic Protein (Gfap) And Related Methods
  • Method For Producing Polymers Having A Preselected Activity
  • Fusion Protein
  • Neuritogenic Peptides
  • Flt3 Binding Proteins And Methods Of Use
  • Multiple Signaling Pathways Induced By Hexavalent, Monospecific And Bispecific Antibodies For Enhanced Toxicity To B-Cell Lymphomas And Other Diseases
  • Immunotoxins Comprising Ribosome-Inactivating Proteins
  • Peptides And Methods Using Same For Diagnosis And Treatment Of Amyloid-Associated Disease
  • Gitr Antibodies And Methods Of Inducing Or Enhancing An Immune Response
  • System And Method For Multipath Processing Of Image Signals
  • Antibody Molecules Having Specificity For Human Ox40
  • Hepatocyte Growth Factor Receptor Agonists And Uses Thereof
  • Methods Of Treating Retinal Nerve Fiber Layer Degeneration With Monoclonal Antibodies Against A Retinal Guidance Molecule (Rgm) Protein
  • Use Of A Decoy Protein That Interferes With The Hedgehog Signalling Pathway For The Manufacture Of A Medicament For Preventing, Inhibiting, And/Or Reversing Ocular Diseases Related With Ocular Neovascularization
  • Apaf-1 An Activator Of Caspase-3
  • O-Fucosyltransferase
  • Pharmaceutical Composition For Treatment And/Or Prevention Of Liver Cancer
  • Induction Of Cytotoxic T Lymphocyte Responses Using Anti-Cd40 Antibodies
  • Bacterially Derived Intact Minicells That Encompass Plasmid Free Dna And Methods Of Using The Same
  • Spliceostatin Analogs And Methods For Their Preparation
  • Neurite Outgrowth Inhibitor -66 Receptor (Nogo-66) Specific Monoclonal Antibody For Treatment And Prevention Of Nervous System, Muscular, Tumor And Vision Disorders
  • Humanized Anti-Factor D Antibodies And Uses Thereof
  • Pd-1 Specific Antibodies And Uses Thereof
  • Combination Therapies For Treatment Of Cancer
  • Targeted Delivery Of Drugs, Therapeutic Nucleic Acids And Functional Nucleic Acids To Mammalian Cells Via Intact Killed Bacterial Cells
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Anti-Fc-Gamma Riib Receptor Antibody And Uses Therefor
  • Methods To Determine Immunogenicity Of Humanized Anti-Tag 72 Cc49 Antibodies
  • Il-15 And Il-15r\Alpha Sushi Domain Based Immunocytokines
  • Anti-4-1bb Antibodies And Their Uses
  • Anti-Axl Antibodies And Methods Of Use
  • Human Monoclonal Antibodies To Ctla-4
  • Pseudomonas Exotoxin A With Reduced Immunogenicity
  • Haemorrhagic Disorder Due To Ventricular Assist Device
  • For Antagonizing The Function Of Vascular Endothelial Growth Factor Receptors, Platelet Derived Growth Factor Receptors And Other Receptors; For Inhibition Of Aberrant Angiogenesis And Lymphangiogenesis, And Inhibition Of Other Effects Of Members Of The Pdgf/Vegf Family Of Growth Factors
  • Optical-Electrical Rotary Joint And Methods Of Use
  • Polypeptides And Nucleic Acid Molecules Encoding The Polypeptide; Such Molecules Have Use As Probes For Diagnosis Of Alzheimer's Disease, And For Identification Of Compounds That Modulate The Activity Of Beta Secretase
  • Anti-B7-H5 Antibodies And Their Uses
  • Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens
  • Method And Apparatus To Identify Vulnerable Plaques With Thermal Wave Imaging Of Heated Nanoparticles
  • Compositions And Methods For The Therapy And Diagnosis Of Cytomegalovirus
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Antibodies To C-Met
  • Agents For Treating Disease
  • Synergistic Effect Of Anti-Trop-2 Antibody-Drug Conjugate In Combination Therapy For Triple-Negative Breast Cancer When Used With Microtubule Inhibitors Or Parp Inhibitors
  • Anti-Cd74 Immunoconjugates And Methods Of Use
  • Cellulase Compositions For Use In Household Detergents, Stonewashing Compositions Or Laundry Detergents; Surfactant Resistance, Heat Resistance, Increased Or Decreased Cellulolytic Capacity, And/Or High Level Expression In Vivo
  • Assay For Detecting Th1 And Th2 Cell Populations
  • Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens
  • Entropic Bristle Domain Sequences And Their Use In Recombinant Protein Production
  • Optimized Antibody Variable Regions
  • Making Antibody Polypeptide Dimers Specific For Antigen Of Interest
  • Safe And Functional Humanized Antibodies
  • Anti-Neuropilin Antibodies And Methods Of Use
  • Modulators Of Hepatocyte Growth Factor Activator
  • Generating Targeted Sequence Diversity In Fusion Proteins
  • Human Inkt Cell Activation Using Glycolipids With Altered Glycosyl Groups
  • Genetically Modified Human Natural Killer Cell Lines
  • Antibody Constructs For Egfrviii And Cd3
  • Compositions And Methods For Detecting And Quantifying Host Cells Protein In Cell Lines And Recombinant Polypeptide Products
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Amino Acid Sequence; For Immunotoxins And Fusion Proteins; Anticarcinogenic Agents And Treatment Of Autoimmune Disorders
  • Humanized Anti-Cd4 Antibody With Immunosuppressive Properties
  • Methods Of Use Of Anti-Cd19 Antibodies With Reduced Immunogenicity
  • Methods And Compositions Comprising Purified Recombinant Polypeptides
  • Guidewire With Centering Mechanism
  • Modified J-Chain
  • Shortened Tetranectin-Apolipoprotein A-1 Fusion Protein, A Lipid Particle Containing It, And Uses Thereof
  • Glycosyl-Etoposide Prodrugs, A Process For Preparation Thereof And The Use Thereof In Combination With Functionalized Tumor-Specific Enzyme Conjugates
  • Immunoglobulin Variants And Uses Thereof
  • Nucleic Acids Encoding Antigen-Binding Sites Specific For Cancer Antigens
  • Dnas Encoding Chimeric Immunoglobulin Light Or Heavy Chains And Fragments Thereof Having Variable Regions Derived From Monoclonal Antibody 7e3, And Vectors And Host Cells Comprising Same
  • Cell-Permeable Probes For Identification And Imaging Of Sialidases
  • Alvocidib Prodrugs And Their Use As Protein Kinase Inhibitors
  • Compositions And Methods For Diagnosing And Treating Cancer
  • Anti-Vegf Antibodies
  • Pharmaceutical Composition For Treating Cancer Using A Monoclonal Antibody Having Immunological Reactivity With Caprin-1
  • Anti-Fgfr3 Antibodies And Methods Using Same
  • Method Of Treating Cancer By Administering An Antibody That Binds Transforming Growth Factor Beta (Tgf-Beta) 1, Tgf-Beta 2 And Tgf-Beta 3
  • Rsv-Specific Binding Molecules And Means For Producing Them
  • Uses Of Wnt Polypeptides
  • Methods Of Modulating Immune Function
  • Ilt3 Binding Molecules And Uses Therefor
  • Targeting Regulatory T Cells With Heterodimeric Proteins
  • Methods For The Treatment Of Disease Using Immunoglobulins Having Fc Regions With Altered Affinities For Fcγractivating And Fcγrinhibiting
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Methods For Purifying A Target Protein From One Or More Impurities In A Sample
  • Antibodies Against Her3
  • Hydrazinyl-Pyrrolo Compounds And Methods For Producing A Conjugate
  • Liquid Protein Formulations Containing 4-(3-Butyl-1-Imidazolio)-1-Butane Sulfonate (Bim)
  • Antibodies Against Ccr5 And Uses Thereof
  • Humanized Anti-Fgf19 Antagonists And Methods Using Same
  • Protein Purification Methods To Remove Impurities
  • Psma Targeting Trispecific Proteins And Methods Of Use
  • Alvocidib Prodrugs Having Increased Bioavailability
  • Notch Receptor (Dll-4) Specific Monclonal Antibody For Use In Diagnosis, Prevention And Treatment Of Cell Proliferative Disorders
  • Monoclonal Antibodies Against Tumor-Associated Antigens
  • Calicheamicin Derivative-Carrier Conjugates
  • Combining Anti-Hla-Dr Or Anti-Trop-2 Antibodies With Microtubule Inhibitors, Parp Inhibitors, Bruton Kinase Inhibitors Or Phosphoinositide 3-Kinase Inhibitors Significantly Improves Therapeutic Outcome In Cancer
  • Cd3-Binding Molecules Capable Of Binding To Human And Non-Human Cd3
  • Fusion Proteins For Prodrug Activation
  • Production Of Heteromultimeric Proteins
  • Bgl3 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Includes An Old World Monkey Portion And A Human Portion, Nucleic Acid Encoding Such Antibodies
  • Determining The Capability Of A Test Compound To Affect Solid Tumor Stem Cells
  • Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target
  • Anti-Mpl Antibodies
  • Methods Of Using Anti-Lap Antibodies
  • Antibodies For The Treatment Of Synucleinopathy
  • Anti-Cd79b Antibodies And Immunoconjugates And Methods Of Use
  • Efficacy Of Anti-Trop-2-Sn-38 Antibody Drug Conjugates For Therapy Of Tumors Relapsed/Refractory To Checkpoint Inhibitors
  • Kits For Multiparametric Phospho Analysis
  • Heterodimeric Antibodies That Bind Somatostatin Receptor 2
  • Administering Agents That Hinder Cd30/Cd30l (Cd30l=Ligand Of Cd30) Binding; Animal Model Of Arthritis For Drug Screening
  • Complementary Determining Region Grafted Antibody Heavy Chain With A Variable Region Domain Of Acceptor Framework And Donor Antigen Binding Regions
  • Predicting Response To Alvocidib By Mitochondrial Profiling
  • Immunology Response; Administering Vaccine
  • Bacterially Derived, Intact Minicells Encompassing Regulatory Rna
  • Multivalent Streptococcal Vaccine Compositions And Methods For Use
  • Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor And An Antigen Expressed By A Cell Infected By A Virus And Uses Thereof
  • Amyloid-Beta Binding Antibodies
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Antigen Binding Protein And Its Use As Addressing Product For The Treatment Of Cancer
  • Use Of Endoglucanase 6 In Saccharification Of Biomass; Fermenation To Bioethanol; Biofuels
  • Aspirating And Removing Biological Material
  • Compositions And Methods For Inhibiting Growth Of Smad4-Deficient Cancers
  • Detecting Variations In Mammalian Immunoglobulins; Obtain Immunoglobulins, Compare Variable Domains Of Immunoglobulins, Detect Homogeneity, Detect Variability In Sequence Complementarity Determining Region Of Immunoglobulins
  • Β-Glucosidase 5 (Bgl5) Compositions
  • Trimeric Collagen Scaffold Antibodies
  • Inhibition And Treatment Of Prostate Cancer Metastasis
  • 5-Hydroxymethylcytosine In Human Cancer
  • Communications Network System And Methods For Using Same
  • Bifunctional Cytotoxic Agents
  • Enzymatic Conjugation Of Polypeptides
  • Antibodies To Tgf-Β
  • Hepatocyte Growth Factor Receptor Antagonists And Uses Thereof
  • Purification Of Biological Molecules
  • Ionic Strength-Mediated Ph Gradient Ion Exchange Chromatography
  • Isolated Monoclonal Anti-Repulsive Guidance Molecule A Antibodies And Uses Thereof
  • Kid3 And Kid3 Antibodies That Bind Thereto
  • Methods Of Producing An Il-1 Rap Antibodies
  • Bgl6 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Conjugated Biological Molecules, Pharmaceutical Compositions And Methods
  • Anti-Theophylline Antibodies And Methods Of Use
  • Genetically Engineered Immunoglobulin; For Use In Treatment Of Asthma
  • 88kda Tumorigenic Growth Factor And Antagonists
  • Trispecific Binding Proteins And Methods Of Use
  • Antibodies With Immune Effector Activity And That Internalize In Folate Receptor Alpha-Positive Cells
  • Therapeutic Composition For Treatment Of Glioblastoma
  • Ctla4-Binding Protein Peptide-Linker Masks
  • Methods And Monitoring Of Treatment With A Dll4 Antagonist
  • Antibodies Specific For Tgf-Β And Methods Of Treatment Thereof
  • Antagonizing Cd73 Antibody
  • A Blocking Monoclonal Antibody To Vla-1 And Its Use For The Treatment Of Vascular Disorders
  • Aav Mediated Influenza Vaccines
  • Alkynyl Sugar Analogs For Labeling And Visualization Of Glycoconjugates In Cells
  • Optical Coherence Tomography System That Is Reconfigurable Between Different Imaging Modes
  • Selecting Variable Region Framework Sequences From Human Antibody Genes By Comparing Canonical Cdr Structure Types For Corresponding Cdrs From A Library Of Human Germline Antibody Sequences
  • Adjusting Nucleic Acids To Increase Binding Of Encoded Antibody By Randomly Incorporating Complementarity Determining Regions; Enhancing Immune Response
  • Lrp-8 Binding Dual Variable Domain Immunoglobulin Proteins
  • Human Cdr-Grafted Antibody And Antibody Fragment Thereof
  • Modified Polynucleotides For The Production Of Secreted Proteins
  • Monoclonal Antibodies To Growth And Differentiation Factor 15 (Gdf-15), And Uses Thereof For Treating Cancer Cachexia And Cancer
  • Treatment Of Allergic Diseases With Chimeric Protein
  • Methods And Compositions For Modulating Angiogenesis
  • Prlr-Specific Antibody And Uses Thereof
  • Nucleotide Sequences Coding Enzymatic Polypeptide For Use In The Preparation Of Bread Doughs
  • Methods Of Treating Ulcerative Colitis
  • Passive Immunization For Staphylococcus Infections
  • Pharmaceutical Composition For Treatment And/Or Prevention Of Cancer
  • Human Il-23 Antigen Binding Proteins
  • Stabilized Liquid Anti-Rsv Antibody Formulations
  • Il-17 Binding Proteins
  • Modified Polynucleotides Encoding Hepatitis A Virus Cellular Receptor 2
  • Guidewire Artifact Removal In Images
  • Polynucleotides Encoding Notch1 Receptor Antibodies
  • Pulmonary Administration Of Immunoglobulin Single Variable Domains And Constructs Thereof
  • Pharmaceutical Composition For Treatment And/Or Prophylaxis Of Cancer
  • Self-Assembled Fmoc-Ff Hydrogels
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Altered Antibodies And Their Preparation
  • Compositions And Methods For Restoring Sensitivity Of Tumor Cells To Antitumor Therapy And Inducing Apoptosis
  • Systems, Devices, And Methods For Time-Resolved Fluorescent Spectroscopy
  • Methods Of Expanding Stem And Progenitor Cells And Expanded Cell Populations Obtained Thereby
  • Egviii Endoglucanase And Nucleic Acids Encoding The Same
  • Anti-Cmet Antibody
  • Targeted Forms Of Methyltrithio Antitumor Agents
  • Cancer Diagnosis And Imaging
  • Antibodies And Their Use In The Treatment, Prevention And Diagnosis Of A Disease Associated With Sod1 Abnormalities
  • Formulation For Anti-Α4Β7 Antibody
  • Method For Inhibiting The Immune Suppressive Function Of Human T Regulatory Cells By Administering An Anti-Garp Monoclonal Antibody
  • Methods Of Increasing Progranulin Levels Using Anti-Sortilin Antibodies
  • Anti-Pcsk9 Antibodies, Formulations, Dosing, And Methods Of Use
  • Method Of Endogenous Stem Cell Activation For Tendon/Ligament Osseointegration
  • Chimeric Antigen Receptor Specific For Folate Receptor Β
  • Trailshort Antibody And Methods Of Use
  • Glycan-Interacting Compounds And Methods Of Use
  • Immunotherapy Regimes Dependent On Apoe Status
  • Humanised Antibodies
  • Decreasing Lactate Level And Increasing Polypeptide Production By Down Regulating The Expression Of Lactate Dehydrogenase And Pyruvate Dehydrogenase Kinase
  • Single Cell Bar-Coding For Antibody Discovery
  • Anti-Gd2 Antibodies
  • Antibodies Which Induces The Death Of A Cell That Expresses Stra6 Polypeptide; Used To Prevent Or Slow Down (Lessen) The Development, Growth, Or Spread Of Tumor Characterized By The Overexpression Of A Pro10282 Polypeptide; Chemotherapy
  • Medical Methods And Agents For Use Therein
  • Polyethylenimine (Pei)-Polypeptide Conjugates And Methods Of Use Thereof
  • Multiplex Protein Fractionation
  • Anti-Cd33 Antibodies And Methods Of Use Thereof
  • Endoglin Antibodies
  • Inhibition And Treatment Of Prostate Cancer Metastasis
  • Psca: Prostate Stem Cell Antigen And Uses Thereof
  • Humanized Anti-Tgf-Beta Antibodies
  • Crosslinking Of Cd22 By Epratuzumab Triggers Bcr Signaling And Caspase-Dependent Apoptosis In Hematopoietic Cancer Cells
  • Genetic Engineering
  • Antibodies To Plasminogen Activator Inhibitor-1 (Pai-1) And Uses Thereof
  • Human Protein Tyrosine Phosphatase Inhibitors And Methods Of Use
  • Assembly Of Bispecific Antibodies
  • Chemokine Receptor Able To Bind To Mcp-1, Mip-1 Α And/Or Rantes And Its Uses
  • Biological Products
  • Anti-Cancer Antibodies, Combination Therapies, And Uses Thereof
  • Solid Phase Tgase-Mediated Conjugation Of Antibodies
  • Bgl3 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Genetically Modified Human Natural Killer Cell Lines
  • Anti-Glucosaminidase Passive Immunization For Staphylococcus Aureus Infections
  • Neutralizing Monoclonal Antibodies Against The Nogo-66 Receptor (Ngr) And Uses Thereof
  • Antibodies With Immune Effector Activity And That Internalize In Endosialin-Positive Cells
  • Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation
  • Tri-Specific Binding Molecules And Methods Of Use Thereof
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Anti-Fgfr3 Antibodies And Methods Using Same
  • Methods Of Producing Antibodies Specific For P95
  • Polynucleotides Encoding Low Density Lipoprotein Receptor
  • Decreasing Lactate Level And Increasing Polypeptide Production By Downregulating The Expression Of Lactate Dehydrogenase And Pyruvate Dehydrogenase Kinase
  • Method Of Preventing The Onset Of Allergic Disorders
  • Anti-Gd2 Antibodies
  • Antibodies To Lymphotoxin-Α
  • Pdgf Receptor Beta Binding Polypeptides
  • Ultrasound Imaging With Variable Line Density
  • Methods And Compositions For Treating Fibrotic Diseases
  • Humanized Anti-Cxcr5 Antibodies, Derivatives Thereof And Their Uses
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Treating Allergic Disorder By Administering Cytokine Receptor Agonist Antibody Or Binding Fragment; Administered With An Anticarcinogen Or Growth Inhibitory Agent
  • Decreasing Lactate Level And Increasing Polypeptide Production By Downregulating The Expression Of Lactate Dehydrogenase And Pyruvate Dehydrogenase Kinase
  • Used To Diagnose And Treat Various Diseases, Including Human Cancers Associated With Expression And/Or Over-Expression Of Kid3
  • Method For Treating Il-8-Related Diseases
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Immunoconjugates And Humanized Antibodies Specific For B-Cell Lymphoma And Leukemia Cells
  • Dll3 Binding Proteins And Methods Of Use
  • Blocking Il-9 Signaling In Conjunction With Chemotherapy To Treat Cancer
  • Zanamivir Phosphonate Congeners With Anti-Influenza Activity And Determining Oseltamivir Susceptibility Of Influenza Viruses
  • Anti-Amyloid Antibodies And Uses Thereof
  • Side Effect Reduction
  • Bispecific Anti-Vegf/Anti-Ang-2 Antibodies And Their Use In The Treatment Of Ocular Vascular Diseases
  • Alkynyl Sugar Analogs For Labeling And Visualization Of Glycoconjugates In Cells
  • Bacterially-Derived, Intact Minicells That Encompass Plasmid-Free Functional Nucleic Acid For In Vivo Delivery To Mammalian Cells
  • Antigen Binding Proteins
  • Specifically Binds To A Human Interleukin-2 Receptor
  • Porphyromonas Gingivalis Polypeptides And Nucleotides
  • Genetically Modified Non-Human Animals And Methods For Producing Heavy Chain-Only Antibodies
  • Humanized Anti-Tag-72 Monoclonal Antibodies
  • Identification And Engineering Of Antibodies With Variant Fc Regions And Methods Of Using Same
  • Rnai Vitamin D Conjugates
  • Anti-C10orf54 Antibodies And Uses Thereof
  • Monoclonal Antibody That Binds Human Notch2 And Notch3
  • Homeobox Gene
  • Anti-Human Trem2 Antibodies And Uses Thereof
  • Modified Polynucleotides For The Production Of Cosmetic Proteins And Peptides
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Anti-Mesothelin Antibodies
  • Stable Igg4 Based Binding Agent Formulations
  • Methods Of Bh3 Profiling
  • Method For The Production Of A Glycosylated Immunoglobulin
  • Antibodies Specifically Binding To Masp-3 For The Treatment Of Various Diseases And Disorders
  • Fucosidase From Bacteroides And Methods Using The Same
  • Antibodies Against Claudin 18.2 Useful In Cancer Diagnosis
  • Anti-Sortilin Antibodies And Methods Of Use Thereof
  • Anti-Kc4 Humanized Monoclonal Antibody And Cells That Express The Antibody
  • Genetically Modified Non-Human Mammals And Cells
  • Antibodies Which Bind B7rp1
  • Antibodies Against Human Csf-1r
  • Combination Of Abcg2 Inhibitors With Sacituzumab Govitecan (Immu-132) Overcomes Resistance To Sn-38 In Trop-2 Expressing Cancers
  • Signal Biomarkers
  • Cd37 Immunotherapeutics And Uses Thereof
  • Modified Hepatitis C Virus Proteins
  • Pd-L1 Promoter Methylation In Cancer
  • Comprises Interleukin Fusion Protein For Treating Tumors; Immunotherapy; Antitumor Agents
  • Humanized Anti-Cd79b Antibodies And Immunoconjugates And Methods Of Use
  • Humanized Anti-Emap Ii Antibody And Use Thereof
  • Anti-Mesothelin Antibodies
  • Therapeutic Vitamin D Conjugates
  • Compositions And Methods For Treating Malignancies
  • Isoforms Of Human Pregnancy-Associated Protein-E
  • Anti-Garp Protein
  • Anti-Cd74 Immunoconjugates And Methods Of Use
  • Selective Histone Deacetylase Inhibitors For The Treatment Of Human Disease
  • Intranasal Administration Of Active Agents To The Central Nervous System
  • Small Streptococcus Pyogenes Antigens And Their Use
  • Anti-Cd74 Immunoconjugates And Methods Of Use
  • Immunoglobulins And Variants Directed Against Pathogenic Microbes
  • Isolation, Detection, Diagnosis And/Or Characterization Of Circulating Trop-2-Positive Cancer Cells
  • B7rp-1 Antagonists
  • Therapeutic Dll4 Binding Proteins
  • Synthetic Peptide Constructs For The Diagnosis And Treatment Of Periodontis Associated With Porphyromonas Gingivalis
  • Analysis Of Ubiquitinated Polypeptides
  • Bacterially-Derived, Intact Minicells That Encompass Plasmid-Free Functional Nucleic Acid For In Vivo Delivery To Mammalian Cells
  • Chimeric Ospa Genes, Proteins And Methods Of Use Thereof
  • Antibody Constructs For Cdh19 And Cd3
  • Antibody Formulations
  • Systems And Methods For Amplifying Light
  • Covalent Diabodies And Uses Thereof
  • Cytotoxic Peptides And Antibody Drug Conjugates Thereof
  • Cytotoxic Drug Therapy
  • Immunology Treatment For Biofilms
  • Production Of Anti-Self Antibodies From Antibody Segment Repertoires And Displayed On Phage
  • Antibodies To The C3d Fragment Of Complement Component 3
  • Antibodies To Carcinoembryonic Antigen (Cea), Methods Of Making Same, And Uses Thereof
  • Antibody Against Human Parathormone Related Peptides
  • Glypican-3-Specific Antibody And Uses Thereof
  • Angiogenesis Inhibiting Molecules, Their Selection, Production And Their Use In The Treatment Of Cancer
  • O-Fucosyltransferase
  • Anti-Nucleolin Antibodies
  • Enhanced Anti-Influenza Agents Conjugated With Anti-Inflammatory Activity
  • High Affinity Antibodies That Neutralize Staphylococcus Enterotoxin B
  • Modulation Of T Cells With Bispecific Antibodies And Fc Fusions
  • Methods For Modular Synthesis Of N-Glycans And Arrays Thereof
  • Modified Polynucleotides Encoding Siah E3 Ubiquitin Protein Ligase 1
  • Compositions And Methods For Treating And Diagnosing Pancreatic Cancer
  • Heterodimeric Antibodies To Cd3 X Cd20
  • Binding Moieties Based On Shark Ignar Domains
  • Pharmaceutical Composition For Treatment And/Or Prevention Of Cancer
  • Calicheamicin Derivative-Carrier Conjugates
  • Glomerulonephritis,Antibodies At Low Dosage
  • Binding Moieties Based On Shark Ignar Domains
  • Monoclonal, Polyclonal, Chimeric, Humanize, Fv, And Or Fab Antibodies; Hybridomas; Vaccines; Genetic Engineering; Isolated Nucleic Acids Encoding A Human Tr2 Receptor And Two Splice Variants; Medical Diagnosis
  • Multi-Chain Polypeptide-Containing Tri-Specific Binding Molecules
  • Conferring Donor Complementary Determining Region Binding Affinity Onto An Antibody Acceptor Variable Region Framework
  • Antibodies To Lymphotoxin-Α
  • Protein Formulation
  • Antibodies Against Tim3 And Uses Thereof
  • Il-18 Binding Proteins
  • Methods For Treating Osteoarthritis Pain By Administering A Nerve Growth Factor Antagonist And Compositions Containing The Same
  • Liquid Protein Formulations Containing Thiamine
  • Covalently Linked Antigen-Antibody Conjugates
  • Humanized Antibody Against Human Tissue Factor (Tf) And Process Of Production Of The Humanized Antibody
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Methods And Compositions For Spinal Cord Cells
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Antigen Binding Protein And Its Use As Addressing Product For The Treatment Of Cancer
  • Modified Anti-Cd52 Antibody
  • Variants Of Humanized Anti-Carcinoma Monoclonal Antibody Cc49
  • Adjusting Affinity Of Polypeptide To Target Molecule By Identifying Aspartyl Residues Which Are Prone To Isomerization, Substituting Alternative Residues And Screening Resulting Mutants For Affinity Against Target Molecule
  • Locating Intravascular Images
  • Hepatitis C Antibodies And Uses Thereof
  • Apo-2 Ligand
  • Using Staphylococcal Protein For Use In Preparing Vaccines And/Or Immunogenic Compositions For Preventing Microorganismal Infection
  • Antibodies That Bind Il-18 And Methods Of Inhibiting Il-18 Activity
  • Compositions And Methods For Diagnosing And/Or Treating Influenza Infection
  • Genetic Engineering; Complementarity Zones
  • Production Of A Multimeric Protein By Cell Fusion Method
  • Methods And Compositions For Modulating T Helper (Th) Cell Development And Function
  • Have A Cysteine Available For Disulfide Bonding To Targeting Molecules
  • Anti-C-Met Antibody
  • Anti-C-Met-Antibody Formulations
  • Protective Proteins Of S. Agalactiae, Combinations Thereof And Methods Of Using The Same
  • Antibodies To Matrix Metalloproteinase 9
  • Antibodies To B7-H1
  • Modified Polynucleotides For The Production Of Oncology-Related Proteins And Peptides
  • Bh3 Peptides And Methods Of Use Thereof
  • Fcγriib-Specific Antibodies And Methods Of Use Thereof
  • Pd-1-Binding Molecules And Methods Use Thereof
  • Ddr1-Binding Agents And Methods Of Use Thereof
  • Anti-Igf-Ir Antibodies And Uses Thereof
  • Methods For Treating Melanoma
  • Catheter For In Vivo Imaging
  • Monoclonal Antibodies (Mabs) Against Tumor-Associated Antigens, The Preparation And Use Thereof
  • Nucleotide Sequences For Use In The Diagnosis Of Inflammatory, Immunological And Nervous System Disorders
  • Polypeptides And Immunizing Compositions Containing Gram Positive Polypeptides And Methods Of Use
  • B-Cell Reduction Using Cd37-Specific And Cd20-Specific Binding Molecules
  • Antibodies Inhibiting C-Met Dimerization, And Uses Thereof
  • Cellulases; Beta-Glucosidases; Hydrolases; Conversion Of Cellulose To Sugars And/Or Ethanol; Laundry Detergents
  • Method To Generate Antibodies To Ion Channels
  • Antibodies For The Treatment Of Synucleinopathy
  • Human Antibodies That Bind Human Madcam
  • Adam-9 Modulators
  • Antibody-Drug-Conjugate And Its Use For The Treatment Of Cancer
  • Decreasing Lipid Absorption And Increasing Lipid And Fat Accumulation In Vacuoles In Intestinal Epithelial Cells By Administering An Anti-Hedgehog Antibody; Treating Obesity
  • Rsv Specific Binding Molecule
  • Erbb3 Binding Antibody
  • Anti-Cd74 Immunoconjugates And Methods
  • Assembly Of Bispecific Antibodies
  • Heterodimeric Human Igg1 Polypeptides With Isoelectric Point Modifications
  • Anti-Vegf Antibodies
  • Multispecific Antigen Binding Proteins And Methods Of Use Thereof
  • Engineered Il-2 Fc Fusion Proteins
  • Antibodies Specific For Hyperphosphorylated Tau For The Treatment Of Ocular Diseases
  • Human Protein Tyrosine Phosphatase Inhibitors And Methods Of Use
  • Homeobox Gene
  • Alpha-Fetoprotein Immu31 Antibodies And Fusion Proteins And Methods Of Use Thereof
  • Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use
  • Methods For Diagnosing And Treating Inflammatory Bowel Disease
  • Nucleic Acid Constructs Containing Hybrid Promoters
  • Use Of Antibodies Targeting The Mn Oncoprotein Conjugated To An Anticancer Therapeutic Agent Such As Drug Or Toxin For Tissue Targeted Cancer Therapy
  • Universal Method To Capture And Analyze Adcs For Characterization Of Drug Distribution And The Drug-To-Antibody Ratio In Biological Samples
  • Cd3 Specific Recombinant Antibody
  • Anti-Vegf Antibodies
  • Recombinant Human Anti-Cd18 Antibodies
  • Antibodies Against Human Csf-1r
  • Method For Making Humanized Antibodies
  • Antibodies Directed To Angiopoietin-1 And Angiopoietin-2 And Uses Thereof
  • B7-H1 And Methods Of Diagnosis, Prognosis, And Treatment Of Cancer
  • Covalent Diabodies And Uses Thereof
  • Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
  • Method Of Detection Of Il1rap On Cells Expressing The Protein
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Chimeric L Chain Comprising An L Chain C Region Of A Human Antibody And An L Chain V Region Of A Mouse Monoclonal Antibody Against A Human Parathyroid Hormone Related Protein; May Be Used Widely In Hypercalcemia Associated With Various Cancers
  • Nsp4 Inhibitors And Methods Of Use
  • Methods Of Diagnosing Acute Cardiac Disorders Using Bnp-Sp
  • Specific Antibodies Against Human Cxcl4 And Uses Thereof
  • Aptamer Therapeutics Useful In The Treatment Of Complement-Related Disorders
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Use Of Anti-Cd83 Agonist Antibodies For Treating Autoimmune Diseases
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Humanized Antibodies That Bind Lgr5
  • C35 Tumor Antigen Specific Monoclonal For Use In Diagnosis, Prevention And Treatment Of Cell Proliferative Disorders
  • Cd37 Immunotherapeutics And Uses Thereof
  • Uses Of A Chemokine Receptor Able To Bind To Mcp-1, Mip-1Α And/Or Rantes
  • Monoclonal Antibody Capable Of Binding Integrin Alpha 10 Beta 1
  • Detection Methods Employing Hcv Core Lipid And Dna Binding Domain Monoclonal Antibodies
  • High Affinity Anti-Gd2 Antibodies
  • Bispecific Antigen Binding Proteins
  • Therapy For Metastatic Urothelial Cancer With The Antibody-Drug Conjugate, Sacituzumab Govitecan (Immu-132)
  • Human M2e Peptide Immunogens
  • Polypeptides And Immunizing Compositions Containing Gram Positive Polypeptides And Methods Of Use
  • Il-D80 Polynucleotides
  • Modified Von Willebrand Factor Having Improved Half-Life
  • Treatment Of Allergic Diseases With Recombinant Antibodies
  • Modified Polynucleotides Encoding Aquaporin-5
  • Use Of Complement Inhibitors To Treat Ocular Diseases
  • Methods For Diagnosing And Treating Inflammatory Bowel Disease
  • Monoclonal Anti-Alpha-Synuclein Antibodies For Preventing Tau Aggregation
  • Anti-Cd74 Immunoconjugates And Methods Of Use
  • Chimeric Fibroblast Growth Factors With Altered Receptor Specificity
  • Humanized Anti-Erbb2 Antibodies And Treatment With Anti-Erbb2 Antibodies
  • Liquid Protein Formulations Containing Thiamine Pyrophosphate (Tpp)
  • Compositions And Methods For Tcr Reprogramming Using Fusion Proteins
  • Combination Immune Therapy And Cytokine Control Therapy For Cancer Treatment
  • Therapeutic Targets In Cancer
  • Anti-Cd33 Antibodies And Methods Of Use Thereof
  • Anti-Gd2 Antibodies
  • Method Of Treating An Ischemia-Reperfusion Injury-Related Disorder By Administering Gpcr Ligands
  • Antibodies To Tgf-Β
  • Comprises A Filamentous Bacteriophage Particle Displaying On Its Surface A Binding Molecule Which Has A Binding Domain Able To Bind Target Epitope Or Antigen; Genetic Engineering
  • Kits For Detecting Antibodies With Sensitivity To Preferential Antigens; Generate Solid Support, Join Antibodies To Support, Incubate With Antigen, Detect Bound Antigen, Recover Bound Antigen
  • Formulation And Delivery Of Plga Microspheres
  • Bgl4 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Neuropilin Antagonists
  • Anti-Siglec-8 Antibodies And Methods Of Use Thereof
  • Lo-Cd2a Antibody And Uses Thereof For Inhibiting T Cell Activation And Proliferation
  • Endoglin Antibodies
  • Vegf/Dll4 Binding Agents And Uses Thereof
  • Methods Of Producing Two Chain Proteins In Bacteria
  • The Optimal 225actinium--213bismuth Generator For Alpha-Particle Radioimmunotherapy
  • Method For Making Antibody Fc-Region Conjugates Comprising At Least One Binding Entity That Specifically Binds To A Target And Uses Thereof
  • Modified Polynucleotides For The Production Of Cytoplasmic And Cytoskeletal Proteins
  • Separate-Cistron Contructs For Secretion Of Aglycosylated Antibodies From Prokaryotes
  • Heterodimeric Proteins
  • Antibody-Drug-Conjugate And Its Use For The Treatment Of Cancer
  • Humanized Antibodies
  • Production Of Secreted Therapeutic Antibodies In Microalgae
  • Covalent Diabodies And Uses Thereof
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Anti-Vegf Antibodies
  • Compositions And Methods For Diagnosing And/Or Treating Influenza Infection
  • Chimeric Il-1 Receptor Type I Antagonists
  • Humanized Antibodies That Recognize Beta Amyloid Peptide
  • B7-H1 Antibodies And Method Of Use
  • Rage Fusion Proteins And Methods Of Use
  • Multispecific Domain Exchanged Common Variable Light Chain Antibodies
  • Prevention And Treatment Of Amyloidogenic Disease
  • Formulations With Reduced Oxidation
  • Systems And Methods For Generating Images Of Tissue
  • Methods Of Producing Two Chain Proteins In Bacteria
  • Junctional Adhesion Molecule-C (Jam-C) Binding Compounds And Methods Of Their Use
  • Muc1 Antibodies
  • Zanamivir Phosphonate Congeners With Anti-Influenza Activity And Determining Oseltamivir Susceptibility Of Influenza Viruses
  • Antigen Binding Constructs To Target Molecules
  • Engineered Anti-Il-23p19 Antibodies
  • Particle-Based Immunoassay Using A Pegylated Analyte-Specific Binding Agent
  • Target Cell-Specific Non-Viral Vectors For Inserting Genes Into Cells, Pharmaceutical Compositions Comprising Such Vectors And Their Use
  • Antibody Therapy
  • Mammalian Genes Involved In Toxicity And Infection
  • Bispecific Antigen Binding Proteins
  • Methods For The Treatment Of Disease Using Immunoglobulins Having Fc Regions With Altered Affinities For Fcγractivating And Fcγrinhibiting
  • Feeding Formula Appliance
  • Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells Activity
  • Removal Of A-Scan Streaking Artifact
  • Bacterially Derived, Intact Minicells Encompassing Regulatory Rna
  • Anti-Amyloid Beta Antibodies Binding To A Cyclic Amyloid Beta Peptide
  • Pseudomonas Exotoxin A With Less Immunogenic B Cell Epitopes
  • Autocrine Growth Factor Receptor Antibodies And Methods
  • Antibodies Against Human Csf-1r And Uses Thereof
  • Anti-Cd74 Immunoconjugates And Methods
  • Bivalent, Bispecific Antibodies
  • Pharmaceutical Composition For Treatment And/Or Prophylaxis Of Cancer
  • Anti-Pd-1 Antibodies
  • Psma Antibodies And Uses Thereof
  • B Cell Maturation Antigen Binding Proteins
  • Methods For Treating Bone Cancer By Administering A Nerve Growth Factor Antagonist Antibody
  • Methods For Treating And/Or Preventing Graft-Versus-Host Disease And/Or Diffuse Alveolar Hemorrhage And/Or Veno-Occlusive Disease Associated With Hematopoietic Stem Cell Transplant
  • Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor And An Antigen Expressed By A Cell Infected By A Virus And Uses Thereof
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Human-Murine Chimeric Antibodies Against Respiratory Syncytial Virus
  • Modified Antibodies With Human Milk Fat Globule Specificity
  • Methods Of Generating Bioactive Peptide-Bearing Antibodies And Compositions Comprising The Same
  • Anti-B7-H3 Antibodies And Antibody Drug Conjugates
  • Compositions And Methods For Treatment And Detection Of Cancers
  • Method For Treating Joint Damage
  • Monoclonal Antibodies To Growth And Differentiation Factor 15 (Gdf-15)
  • Therapeutic Vitamin D Conjugates
  • Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, And Uses Thereof
  • Anti-Ige Antibodies
  • Methods For Treating Pain By Administering A Nerve Growth Factor Antagonist And An Nsaid
  • Bispecific Antibodies
  • Hgf Β Chain Variants
  • Optimized Antibody Variable Regions
  • Methods Of Determining Patient Response By Measurement Of Her-3 And P95
  • Compositions And Methods In Cancer Associated With Altered Expression Of Kcnj9
  • Kid31 And Antibodies That Bind Thereto
  • Reshaped Monoclonal Antibodies Against An Immunoglobulin Isotype
  • Antigen Binding Constructs To Cd8
  • Inhibitors Of Neuroligin 4-Neurexin 1-Beta Protein-Protein Interaction For Treatment Of Liver Disorders
  • Glucanases/Glucosidase/Hydrolases; Conversion Of Cellulose To Sugars And/Or Ethanol; Laundering Detergents
  • Covalently Linked Polypeptide Toxin-Antibody Conjugates
  • Polymorphs And Uses Thereof
  • Treatment Of Inflammatory Bowel Disease By Inhibiting Binding And/Or Signalling Through Α 4 Β 7 And Its Ligands And Madcam
  • Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor
  • Taurine Supplemented Cell Culture Medium And Methods Of Use
  • Anti-Il1rap Antibodies And Methods Of Use Thereof
  • Polypeptide Constructs Including Vhh Directed Against Egfr For Intracellular Delivery
  • Antibodies And Other Molecules That Bind B7-H1 And Pd-1
  • Anti-Sortilin Antibodies And Methods Of Use Thereof
  • Method Of Treating Cancer By Administering A Monoclonal Antibody That Binds Human Notch2 And Notch3
  • Human Antibody Specific To Toxin Produced From Clostridium Difficile, Or Antigen-Binding Fragment Thereof
  • Humanized Anti-Lt-Β-R Antibodies
  • Humanised Antibody Against Hepatitis
  • Multi-Specific Binding Proteins For Cancer Treatment
  • Lymphotropic Retrovirus Disease Treatment And Diagnosis Such As Acquired Immunodeficiency Syndrome (Aids); Specifically Binds With High Specificity And Affinity A Particular Human Apm:Pathogen-Derived Antigen Complex
  • Immunoglobulin For Use In Treatment And Prevention Of Immunological And Cancer Disorders; Immunotherapy
  • Hepatitis C Antibodies And Uses Thereof
  • Anticoagulant Antidotes
  • Genetic Engineering; Production Of Macrophage Derived Chemokine; Drug Screening For Antiinflammatory Agents
  • Human Monoclonal Antibodies Against Cd25
  • Human Monoclonal Antibodies To Ctla-4
  • Rsv-Specific Binding Molecules And Means For Producing Them
  • Modified Polynucleotides For The Production Of Proteins
  • Heterodimeric Proteins
  • Methods Of Single-Cell Barcoding And Sequencing
  • Anti-Fatty Acid Amide Hydrolase-2 Antibodies And Uses Thereof
  • Generation Of Therapeutic Radioconjugate; Load Isotope Onto Binding Support, Elute Long Lived Isotopes, Join Isotope To Targeting Particle, Recover Radioconjugate
  • Comprising A Variant Heavy Chain Variable Framework Domain And Complementary Determining Regions; Useful For Identifying Novel Polypeptides, Antibody, Antibody Fragments, And Antibody Variable Domains That May Be Used Therapeutically Or As Reagents
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Methods Of Treating Diabetes And Compositions Capable Of Same
  • Bispecific Antibodies That Bind To Cd38 And Cd3
  • Prevention And Treatment Of Amyloidogenic Disease
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Anti-Alpha-Synuclein Antibodies
  • Administering Mixtures Of Antibodies And Tumor Necrosis Factors, Immunosuppressants, Antibiotics, Antiinflammatory Agents, Cytokines, Angiogenesis Inhibitors Or Fibroblast Growth Factors; Prophylaxis Of Graft Versus Host Disease
  • Anti-Ceacam5 Antibodies And Uses Thereof
  • Treating A Mammal With A Formulation Comprising An Antibody Which Binds Ige
  • Antibody Capable Of Specifically Recognizing Transferrin Receptor
  • Human Monoclonal Antibodies Against Cd25
  • Enzymatic Conjugation Of Polypeptides
  • Bifunctional Cytotoxic Agents
  • Polynucleotides Encoding Antibodies That Bind To The C35 Polypeptide
  • Methods Of Treating Or Preventing Alzheimer's Disease And Associated Conditions
  • Rsv-Specific Binding Molecule
  • Method Of Treatment Comprising Purified Recombinant Il-13 Antibody
  • Methods Of Improving Stem Cell Homing And Engraftment
  • Anti-Fzd10 Monoclonal Antibodies And Methods For Their Use
  • Multispecific Binding Constructs Against Checkpoint Molecules And Uses Thereof
  • Combination Therapies For Treatment Of Cancer
  • Compositions And Methods For Treatment And Detection Of Cancers
  • Modified Polynucleotides For The Production Of Cytoplasmic And Cytoskeletal Proteins
  • Autocrine Growth Factor Receptor Antibodies And Methods
  • Antibodies Directed Against Cd4 For The Treatment And Functional Cure Of Hiv
  • Nsp4 Inhibitors And Methods Of Use
  • Multimodal Segmentation In Intravascular Images
  • Treatment For Inflammatory Bowel Disease With A Vcam-1/1gg Fusion Protein
  • Method For The Production Of A Glycosylated Immunoglobulin
  • Fc Variants And Methods For Their Production
  • Humanized Anti-Tau(Ps422) Antibodies And Methods Of Use
  • Antibodies Against Claudin 18.2 Useful In Cancer Diagnosis
  • Anti-Spla2-Iia Antibodies And Uses Thereof
  • Cell Culture Media And Methods Of Antibody Production
  • Compound Comprising A Methyl Ecgonine Group Chemically Attached To A Phenylphosphonic Group Which Is An Analog To An Intermediate Of The Hydrolysis Transition-State Of A Cocaine Benzoyl Ester Group
  • Antibodies Reactive With B7-H3 And Uses Thereof
  • Receptor Coupling Agents And Compositions Thereof
  • Oct-Ivus Catheter For Concurrent Luminal Imaging
  • Compositions Of Psma Antibodies
  • Antibodies That Bind Il-4 And/Or Il-13 And Their Uses
  • Insulin Vitamin D Conjugates
  • Methods And Compositions Of Matter Concerning April/G70, Bcma, Blys/Agp-3 And Taci
  • Epitope Bound By Mabs A, B, C Or D, Where Mabs A, B, C And D Have Given Variable Domains; Chimeric Or Humanized For Side Effect Reduction; Polymerase Chain Reaction
  • Anti-Rankl Antibodies And Methods Of Use
  • Gpr30 Estrogen Receptor In Breast Cancers
  • Antibodies To Oncostatin M Receptor
  • Labeled Peptides, Proteins And Antibodies And Processes And Intermediates Useful For Their Preparation
  • Antibodies That Bind The Glutamate Ligand Binding Region Of Notch3
  • Compositions And Methods In Cancer Associated With Altered Expression Of Prlr
  • Magneto-Motive Ultrasound Detection Of Magnetic Nanoparticles
  • Detection Methods Employing Hcv Core Lipid And Dna Binding Domain Monoclonal Antibodies
  • Production Of Proteins In Glutamine-Free Cell Culture Media
  • N-Terminal Epitopes In Amyloid Beta And Conformationally-Selective Antibodies Thereto
  • Dexamethasone To Reduce Stem Cell Accumulation In The Spleen
  • Dll3-Cd3 Bispecific Antibodies
  • Monoclonal Antibodies Against Tumor-Associated Antigens, Processes For The Preparation Thereof And The Use Thereof
  • Fgf21 Polypeptides Comprising Two Or More Mutations And Uses Thereof
  • Engineered Proteins And Methods Of Use
  • Genetically Modified Human Natural Killer Cell Lines
  • Monoclonal Antibodies That Specifically Block Biological Activity Of A Tumor Antigen
  • Treating Psoriasis, Graft Versus Host Diseace And Asthma
  • Trichoderma Β-Glucosidase
  • System And Method For Graphical Processing Of Medical Data
  • Drosophila G Protein Coupled Receptors, Nucleic Acids, And Methods Related To The Same
  • Covalent Diabodies And Uses Thereof
  • Modified Polynucleotides Encoding Aryl Hydrocarbon Receptor Nuclear Translocator
  • Methods For Generating Monovalent Igg
  • Fcγriib Specific Antibodies And Methods Of Use Thereof
  • Anti-Cancer Antibodies With Reduced Complement Fixation
  • Antigen Binding Complex Having Agonistic Activity And Methods Of Use
  • Targeted Heterodimeric Fc Fusion Proteins Containing Il-15 Il-15alpha And Antigen Binding Domains
  • Prostaglandin E2 Dual Variable Domain Immunoglobulins And Uses Thereof
  • Monoclonal Antibody Which Binds To Human Breast Cancer Antigen; Useful In Specific Binding Assays, Immunoaffinity Purification Techniques, Drug Or Toxin Targeting, Tumor Imaging, Or As Anticarcinogenic Agents
  • Compositions And Methods For Detecting And Quantifying Host Cell Protein In Cell Lines And Recombinant Polypeptide Products
  • Modified Polynucleotides
  • Hcv Core Lipid Binding Domain Monoclonal Antibodies
  • Human Inkt Cell Activation Using Glycolipids
  • Antibody-Based Molecules Specific For The Truncated Asp421 Epitope Of Tau And Their Uses In The Diagnosis And Treatment Of Tauopathy
  • Anti-Pd-L1 Antibodies, Compositions And Articles Of Manufacture
  • Delivering Functional Nucleic Acids To Mammalian Cells Via Bacterially-Derived, Intact Minicells
  • Nucleic Acids Encoding, And Methods Of Producing, Antibodies Specific For Transforming Growth Factor (Tgf)-Β
  • Treatment With Anti-Erbb2 Antibodies
  • Caninized Anti-Nerve Growth Factor Antibodies
  • Method For Reduction Of 1->2 Reading Frame Shifts
  • Humanized Anti-Cd4 Antibody With Immunosuppressive Properties
  • Anti-Mesothelin Immunoconjugates And Uses Therefor
  • Liquid Pharmaceutical Formulations For Injection Comprising Yellow 5 Or Orange G And Uses Thereof
  • Aβ Conformer Selective Anti-Aβ Globulomer Monoclonal Antibodies
  • Flt4 (Vegfr-3) As A Target For Tumor Imaging And Anti-Tumor Therapy
  • Bispecific Anti-Vegf/Anti-Ang-2 Antibodies And Their Use In The Treatment Of Ocular Vascular Diseases
  • Antigen-Presenting Complex-Binding Compositions And Uses Thereof
  • Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
  • Benzocyclooctyne Compounds And Uses Thereof
  • Arl-1 Specific Antibodies And Uses Thereof
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Anti-C10orf54 Antibodies And Uses Thereof
  • Glycosyl-Etoposide Prodrugs, A Process For Preparation Thereof And The Use Thereof In Combination With Functionalized Tumor-Specific Enzyme Conjugates
  • Optimized Anti-Tl1a Antibodies
  • Immunoaffinity Isolation Of Modified Peptides From Complex Mixtures
  • Il-17 Binding Proteins
  • Hydrazinyl-Pyrrolo Compounds And Methods For Producing A Conjugate
  • The Optimal 225actinium--213bismuth Generator For Alpha-Particle Radioimmunotherapy
  • Anti-Il-12/Il-23 Antibodies
  • Production Of A Multimeric Protein By Cell Fusion Method
  • Antibody Therapy
  • Pdgf Receptor Beta Binding Polypeptides
  • Minimum Recognition Unit Of A Pem Mucin Tandem Repeat Specific Monoclonal Antibody And Detection Method Using Same
  • Mucosal Vascular Addressins And Uses Thereof
  • Methods Of Treating Of Diabetes And Obesity Using Fgf21 Mutants
  • Method Of Treating Cancer By Administering Csf-1r Antibodies And A Tlr9 Agonist
  • Psma Antibodies And Uses Thereof
  • Il-I Binding Proteins
  • Recombinant Protein Production In A Human Cell Comprising At Least One E1 Protein Of Adenovirus
  • Antibodies That Bind To Epha2 And Methods Of Use Thereof
  • Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens
  • 88kda Tumorigenic Growth Factor And Antagonists
  • Humanized Anti Cxcr4 Antibodies For The Treatment Of Cancer
  • Polynucleotides Encoding Anti-Cd20 Antigen Binding Molecules With Increased Fc Receptor Binding Affinity And Effector Function
  • Anti-Cd19 Antibodies With Reduced Immunogenicity
  • Egvii Endoglucanase And Nucleic Acids Encoding The Same
  • Activatable Interleukin 12 Polypeptides And Methods Of Use Thereof
  • Antibodies That Bind To Mhc Class I Polypeptide-Related Sequence A
  • Constrained Immunogenic Compositions And Uses Therefor
  • Peptides, Derivatives And Analogs Thereof, And Methods Of Using Same
  • Human Alpha-Folate Receptor Chimeric Antigen Receptor
  • Egvii Endoglucanase And Nucleic Acids Encoding The Same
  • Her2/Neu-Specific Antibodies And Methods Of Using Same
  • Antibody For Use In The Treatment Of Rheumatic And Osteoarthritis
  • Recombinant Prion-Like Proteins And Materials Comprising Same
  • Cd36 Immunoadhesins And Their Use In Selectively Killing Plasmodium Falciparum Infected Erythrocytes
  • Anti-Cmet Antibodies
  • Anti-Bv8 Antibodies And Uses Thereof
  • Antibody Therapy
  • Antigen Binding Constructs To Cd8
  • Il-1 Binding Proteins
  • Anti-Cd19 Antibodies With Reduced Immunogenicity
  • Polypeptide Fusion Comprising Complementary Determining Regions For Use As Tool In Immunotherapeutic And/Or Diagnostics; Bioassay
  • Apo-2 Receptor Agonist Antibodies
  • Multispecific Antibodies
  • Cell Culture Compositions With Antioxidants And Methods For Polypeptide Production
  • Targeted Delivery Of Drugs, Therapeutic Nucleic Acids And Functional Nucleic Acids To Mammalian Cells Via Intact Killed Bacterial Cells
  • Method Of Antithrombotic Therapy Using Anti-Gpiib/Iiia Antibodies Or Fragments Thereof, Including C7e3
  • Calicheamicin Derivative-Carrier Conjugates
  • Bispecific Checkpoint Inhibitor Antibodies
  • Methods For The Treatment Of Vascularizing Cancers
  • Dosages For Treatment With Anti-Erbb2 Antibodies
  • Il13rα2 Binding Agents And Use Thereof In Cancer Treatment
  • Improvements In Or Relating To Antibodies
  • Branched-Chain Amines In Electrochemiluminescence Detection
  • Rsv-Specific Binding Molecule
  • Yersinia Spp. Polypeptides And Methods Of Use
  • Immunoglobulins And Variants Directed Against Pathogenic Microbes
  • High Affinity Antibodies That Neutralize Staphylococcus Enterotoxin B
  • Angiogenesis Inhibiting Molecules, Their Selection, Production And Their Use In The Treatment Of Cancer
  • Notch1 Receptor Binding Agents And Methods Of Use Thereof
  • Anti-Her2 Glycoantibodies And Uses Thereof
  • Co-Use Of A Clusterin Inhibitor With An Egfr Inhibitor To Treat Cancer
  • Bispecific Immunomodulatory Antibodies That Bind Costimulatory And Checkpoint Receptors
  • Pharmaceutical Composition For Treatment And/Or Prevention Of Gallbladder Cancer
  • Antibody-Sn-38 Immunoconjugates With A Cl2a Linker
  • Immunoglobulin For Detecting Inflammation And Bacterial Infections In Mammals
  • Hydrazinyl-Pyrrolo Compounds And Methods For Producing A Conjugate
  • Ilt3 Binding Molecules And Uses Therefor
  • Sbp Members Displayed In Functional Form At The Surface Of A Secreted Recombinant Genetic Display Package Containing Dna Encoding The Member; Libraries Of Dna Encoding Respective Chains Of Such Multimeric Sbp Members May Be Combined, Thereby Obtaining A Much Greater Genetic Diversity In The Sbp Members
  • Antibody Which Preferential For Human Polymorphic Endothelial Mucia; For The Diagnosis And Treatment Of Cancer; Anticarcinogenic Agents
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Split Dose Administration
  • Combination Therapies For Treatment Of Cancer
  • Methods For Stimulating Hematopoietic Recovery By Inhibiting Tgfβ Signaling
  • Anti-Dengue Virus Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use
  • Immunocytokine Sequences And Uses Thereof
  • Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target
  • Method Of Treating Asthma Using An Il-13 Antibody
  • Tau Imaging Ligands And Their Uses In The Diagnosis And Treatment Of Tauopathy
  • Anti-Pdl1 Antibody Formulations
  • Anti-Fgfr3 Antibodies And Methods Using Same
  • For Therapy Of Cancer And For Diagnosing Tumorigenicity And Other Diseases
  • Anti-Vegf Antibodies
  • Dual Variable Domain Immunoglobulin And Uses Thereof
  • Predicting Response To Alvocidib By Mitochondrial Profiling
  • Chimeric Antibodies; Lymphocytes; Genetic Engineering; For Treatment Of Myeloma
  • Immunoreactive With Polymorphic Eithelial Mucin Antigen Associated With Tumors Selected From Breat, Ovarian And Prostrate Carcinomas And Lung Adenocarcinomas; An Expression Vector
  • Methods And Compositions For Immunizing Against Chlamydia Infection
  • Klrg1 Binding Compositions And Methods Of Use Thereof
  • Cd40l Binding Polypeptide
  • Il-17 Binding Proteins
  • Method For Detecting Pancreatic Cancer
  • Dual Variable Domain Immunoglobulins And Uses Thereof
  • Il-1 Binding Proteins
  • Conjugate Of An Antibody Against Ccr5 And An Antifusogenic Peptide
  • Infectious Clone Of Human Parvovirus B19 And Methods
  • Dkk1 Antibodies And Methods Of Use
  • Fully Human, Anti-Mesothelin Specific Chimeric Immune Receptor For Redirected Mesothelin-Expressing Cell Targeting
  • Cd3 Binding Polypeptides
  • Cytotoxicity-Inducing Theraputic Agent
  • Anti-Amyloid Beta Antibodies Binding To A Cyclic Amyloid Beta Peptide
  • Polypeptide For Use In The Treatment Of Allergenic Disorders
  • Antibodies Against Human Csf-1r And Uses Thereof
  • Modified Polynucleotides For The Production Of Biologics And Proteins Associated With Human Disease
  • Antibody-Drug-Conjugate And Its Use For The Treatment Of Cancer
  • Immunoglobulin Variat For Use In Diagnosis, Prevention And Treatment Of Infection, Nervous System, Skin, Inflammatory And Cell Proliferative Diseases
  • Supramolecular High Affinity Protein-Binding System For Purification Of Biomacromolecules
  • Methods Of Treating With Anti-Factor D Antibodies
  • Therapy Of Small-Cell Lung Cancer (Sclc) With A Topoisomerase-I Inhibiting Antibody-Drug Conjugate (Adc) Targeting Trop-2
  • Reactive Labelling Compounds And Uses Thereof
  • Generating Targeted Sequence Diversity In Fusion Proteins
  • Method For Screening For An Anti-Cd4 Antibody Suitable For Use In Immunotherapy
  • Methods And Compositions For Immuno-Histochemical Detection
  • Detection Methods Employing Hcv Core Lipid And Dna Binding Domain Monoclonal Antibodies
  • Kinase Insert Domain-Containing Receptor (Kdr) Specific Immunoglobulin For Monitoring Tumor Angiogenesis
  • Methods For Treating Diseases Mediated By Erbb4-Positive Pro-Inflammatory Macrophages
  • Monoclonal Antibody Produced By Hybridoma With Idac Accession Number 180706-02; Competitive Binding Of Monoclonal Antibody, Humanized-, Chimeric- Or Cancerous Disease Modifying Antibodies (Cdmab) With Tissue Sample Induces Cytotoxicity; Anticarcinogenic, Antitumor, And Antimetastasis Agents; Diagnosis
  • Il-1 Binding Proteins
  • Manual Calibration Of Imaging System
  • Methods For Treating Liver Diseases
  • Antibody-Drug Conjugates And Uses Thereof
  • Anti-Siglec-7 Antibodies And Methods Of Use Thereof
  • Treatment And Sustained Virologic Remission Of Hiv Infection By Antibodies To Cd4 In Haart Stabilized Patients
  • Bh3 Peptides And Methods Of Use Thereof
  • Antibodies For The Treatment Of Synucleinopathy
  • Antibody Therapy
  • Method For Controlling The Activity Of Immunologically Functional Molecule
  • Binding Domains Of Proteins Of The Repulsive Guidance Molecule (Rgm) Protein Family And Functional Fragments Thereof, And Their Use
  • Prokaryotic Host Cells Comprising A Library Of At Least 103 Different Rna Molecules Each Having A Dicistronic Coding Region; For Screening A Larger Portion Of The Immunological Repertoire For Receptors Having A Preselected Activity
  • Anti-Lap Antibody Variants
  • Multivalent Antibodies And Uses Therefor
  • Free Psa Antibodies As Diagnostics, Prognostics And Therapeutics For Prostate Cancer
  • Methods And Biomarkers For Predicting Efficacy And Evaluation Of An Ox40 Agonist Treatment
  • Covalently-Associated Diabody Complexes That Possess Charged Coil Domains And That Are Capable Of Enhanced Binding To Serum Albumin
  • Glycan Conjugates And Use Thereof
  • Vegf/Dll4 Binding Agents And Uses Thereof
  • Natural Human Antibody
  • Hedgehog And Patched Antagonists For Inhibiting Cell And Tissue Growth And Differentiation And Uses Therefor
  • Methods And Compositions For Treating Perennial Allergic Conjunctivitis And Keratoconjunctivitis
  • Antibodies And Other Molecules That Bind B7-H1 And Pd-1
  • Filipil Compositions And Methods For Treating Cancer
  • Methods For Diagnosing And Treating Inflammatory Bowel Disease
  • Antibodies And Derivatives Thereof
  • Antibodies Against Human Csf-1r And Uses Thereof
  • Expansion Of Stem Cells; Prevent Cell Differentiation; Culturing
  • Anti-Human Interleukin-1 Receptor Accessory Protein Antibody And Its Use For Treating Cancer
  • Tau-Binding Antibodies
  • Dual Specific Binding Proteins Directed Against Il-1Β And/Or Il-17
  • Bacterially-Derived, Intact Minicells That Encompass Plasmid-Free Functional Nucleic Acid For In Vivo Delivery To Mammalian Cells
  • Antibodies To Madcam
  • Blocking Il-9 Signaling In Conjunction With Chemotherapy To Treat Cancer
  • Multispecific Antibodies Comprising Full Length Antibodies And Single Chain Fab Fragments
  • Method For Purifying Active Polypeptides Or Immunoconjugates
  • Production Of Anti-Self Antibodies From Antibody Segment Repertories And Displayed On Phage
  • Therapeutic Dll4 Binding Proteins
  • Antibody Fc Variants
  • Anti-Fzd10 Monoclonal Antibodies And Methods For Their Use
  • Anti-Neoplastic Uses Of Artemin Antagonists
  • Ccr8 Antibodies For Therapeutic Applications
  • Anti-Cd79b Antibodies And Immunoconjugates And Methods Of Use
  • Gdf-15 As A Diagnostic Marker To Predict The Clinical Outcome Of A Treatment With Immune Checkpoint Blockers
  • Anti-Ox40l Antibodies
  • Anti-Biotin Antibodies And Methods Of Use
  • Apo-2li And Apo-3 Polypeptides
  • Specific Expression Of Half-Trna In Cancers
  • Identifying Sclerostin Antagonist Via Abilty To Prevent Apoptosis; Treating Osteoporosis
  • Dynamic Bh3 Profiling
  • Nucleic Acid Molecules Encoding Chimeric Antigen Receptors Targeting B-Cell Maturation Antigen And Uses Thereof
  • Expressing Dna Encoding A Genetically Diverse Population Of Such Specific Bindng Pair (Sbp) Members In Recombinant Host Cells In Which The Sbp Members Are Displayed In Functional Form At The Surface Of A Secreted Recombinant Genetic Display Packag Containing Dna Encoding The Sbp Member Or A Polypeptide
  • Il-6 Binding Molecules
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Antibodies Reactive With B7-H3 And Uses Thereof
  • Stra6 Polypeptides
  • Monoclonal Antibodies That Specifically Block Biological Activity Of A Tumor Antigen
  • Methods And Assays For Measuring P95 And/Or P95 Complexes In A Sample And Antibodies Specific For P95
  • Bi-Specific Monovalent Diabodies That Are Capable Of Binding Cd123 And Cd3, And Uses Thereof
  • Cancer Therapy
  • Stirred Tank Bioreactor
  • Selecting Variable Region Framework Sequences From Human Antibody Genes By Comparing Canonical Cdr Structure Types For Corresponding Cdrs From A Library Of Human Germline Antibody Sequences; Converting An Antibody Sequence Of Any Subject Species To A Less Immunogenic Form
  • Chimeric Antigen Receptors Targeting B-Cell Maturation Antigen And Uses Thereof
  • Anti Ceacam1 Antibodies And Methods Of Using Same
  • Modified Polynucleotides For The Production Of Proteins Associated With Blood And Lymphatic Disorders
  • Endoglin Antibodies
  • Method For Using Antibodies For Inhibiting Blood Coagulation
  • Bispecific Anti-Tnf-Related Apoptosis-Inducing Ligand Receptor 2 And Anti-Cadherin 17 Binding Molecules For The Treatment Of Cancer
  • Metal Salts And Uses Thereof
  • Polypeptides And Immunizing Compositions Containing Gram Positive Polypeptides And Methods Of Use
  • Monoclonal Anti-Il-1racp Antibodies
  • Human Cdr-Grafted Antibody And Antibody Fragment Thereof
  • Bgl6 Beta-Glucosidase And Nucleic Acids Encoding The Same
  • Chimeric Ospa Genes, Proteins And Methods Of Use Thereof
  • Designated As ?Pro19598? Polypeptides; Diagnosis And Treatment Of Tumors
  • Antibody Molecules For Cancer Treatment
  • Tumor Necrosis Factor (Tnf) Receptor Superfamily (Tnfrsf) Receptor-Activating Antibody Fusion Proteins With Fcγr-Independent Agonistic Activity (Tnfrsf Receptor-Activating Antibody Fusion Proteins With Fcγr-Independent Agonistic Activity; Traaffiaa)
  • Therapeutic Vitamin D Conjugates
  • Anti-Vla-4 Antibodies
  • Humanized Antibody Against Cd18
  • Rsv-Specific Binding Molecules And Means For Producing Them
  • Methods Of Treating Hedgehog-Related Diseases With An Anti-Lgr5 Antibody
  • Therapeutic Dll4 Binding Proteins
  • Anti-Nerve Growth Factor Antibodies And Methods Of Preparing And Using The Same
  • Integrated System Architectures And Methods Of Use
  • Enhanced Protein Purification Through A Modified Protein A Elution
  • Selectively Delivering Interleukin-12 (Il-12) To A Target Antigen In A Mammal
  • Il-17 Binding Proteins
  • Anti-Ctla4 Antibodies
  • Chromatography Method For Quantifying A Nonionic Surfactant In A Composition Comprising The Non-Ionic Surfactant And A Polypeptide
  • Abeta Conformer Selective Anti-Abeta Globulomer Monoclonal Antibodies
  • Human Anti-Pd-1, Pd-L1, And Pd-L2 Antibodies And Uses Therefor
  • Treating Rotator Cuff Conditions
  • Polynucleotide Derived From Fungal Source Which Comprises A Nucleotide Sequence Encoding An Enzyme Having Beta-Glucosidase Activity
  • Biomarkers
  • Treatment Of Cerebral Amyloid Angiopathy
  • Compositions And Methods For Treating And Diagnosing Pancreatic Cancer
  • Antibody For The Diagnosis And/Or Prognosis Of Cancer
  • Antibody Fragments Against The Insulin Receptor And Uses Thereof To Treat Hypoglycemia
  • Method To Treat Inflammation With Humanized Anti-Il-8-Antibodies
  • Isolated Polypeptides Of Cd44 And Uses Thereof
  • Cd3-Binding Molecules Capable Of Binding To Human And Non-Human Cd3
  • Deimmunized Monoclonal Antibodies For Protection Against Hiv Exposure And Treatment Of Hiv Infection
  • Antibodies Directed Against Amyloid-Beta Peptide
  • Anti-Trem2 Antibodies And Methods Of Use Thereof
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Agents, Uses And Methods For The Treatment Of Synucleinopathy
  • Fcγriib—Specific Antibodies And Methods Of Use Thereof
  • Multispecific Antigen-Binding Proteins
  • Anti-Cancer Antibodies With Reduced Complement Fixation
  • Anti-Fgfr2/3 Antibodies And Methods Using Same
  • Antibodies Against N-Acetylglucosamine And N-Acetyl-Galactosamine
  • Uses Of Antibodies To Aminophospholipids For Cancer Treatment
  • Production Of Anti-Self Antibodies From Antibody Segment Repertoires And Displayed On Phage
  • Haemorrhagic Disorder Due To Ventricular Assist Device
  • Monoclonal Antibodies Against Amyloid Beta Protein And Uses Thereof
  • Method Of Treatment Of A Solid Tumor With Interleukin-1 Accessory Protein Antibody
  • Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use Thereof
  • Nucleic Acids Encoding Antibodies Against Human Csf-1r
  • Altered Antibodies And Their Preparation
  • Crystal Structure Of The Complex Between One Such Antibody And The Alpha 1-I Domain Of Vla-1, And To The Use Of This Structural Information For Computational Drug Design
  • Modified Polynucleotides For The Production Of Proteins Associated With Blood And Lymphatic Disorders
  • Aptamer Therapeutics Useful In The Treatment Of Complement-Related Disorders
  • For Drug Screening Tl-Gamma Modulators; Solid Phase Synthesis
  • Cell Death-Inducing Agent
  • Nucleic Acid Constructs For The Cell Cycle-Regulated Expression Of Genes And Therapeutic Methods Utilizing Such Constructs
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • High Concentration Protein Formulations With Reduced Viscosity
  • Methods, Compositions And Apparatuses For Detection Of Gamma-Hydroxybutyric Acid (Ghb)
  • Detection Of Antibody Variants; Mix Primers And Nucleotide Sequences Coding Antibody Or Antigen-Binding Segment, Perform Polymerase Chain Reaction And Generate Variant Nucleotide Sequences, Express Variants And Detect Binding Preferentials
  • Dna Encoding Antibody Molecules Which Bind Il-17a And Il-17f
  • Stabilizer For Protein Preparation Comprising Meglumine And Use Thereof
  • Anti-Vla1 (Cd49a) Antibody Pharmaceutical Compositions
  • Antigenic Gm-Csf Peptides And Antibodies To Gm-Csf
  • Peptides Which Bind To G Protein-Coupled Receptors
  • Novel Anti-Human Gpvi Antibodies And Uses Thereof
  • Tri- Or Tetraspecific Antibodies
  • Humanized Anti-Factor D Antibodies And Uses Thereof
  • Multimeric Bispecific Binding Molecules Specific For Cd20 And Cd3
  • Dosages Of Immunoconjugates Of Antibodies And Sn-38 For Improved Efficacy And Decreased Toxicity
  • Anti-A(Β) Oligomer Humanized Antibody
  • Treating Rotator Cuff Conditions
  • Transferrin Receptor Specific Antibody-Neuropharmaceutical Or Diagnostic Agent Conjugates
  • Synergistic Effect Of Anti-Trop-2 Antibody-Drug Conjugate In Combination Therapy For Triple-Negative Breast Cancer When Used With Microtubule Inhibitors Or Parp Inhibitors
  • Her2/Neu-Specific Antibodies And Methods Of Using The Same
  • Multivalent Molecules Comprising Dr5-Binding Domains
  • Anti-Cxcr4 Antibodies And Their Use For The Treatment Of Cancer
  • Nucleic Acid Molecules Encoding A Humanized Antibody
  • Dual Specific Binding Proteins Directed Against Il-13 And Il-17
  • Humanized Antibodies Against Ceacam1
  • Monoclonal Antibodies Immunospecific For Human Interleukin-8 That Have Humanized Framework Regions So As To Be Compatible With The Human Immune System, Comprises Specific Amino Acid Sequence Of Heavy Chain And Light Chain
  • Nanoshell-Structured Material As Co-Matrix For Peptide Characterization In Mass Spectrometry
  • Fgf21 Mutants And Uses Thereof
  • Administering With Steroid
  • Elucidation Of Ion Exchange Chromatography Input Optimization
  • Immunoconjugates Targeting Adam9 And Methods Of Use Thereof
  • Systems And Methods For Narrowing A Wavelength Emission Of Light
  • Combination Therapy With Anti-Hla-Dr Antibodies And Kinase Inhibitors In Hematopoietic Cancers
  • Tumor Necrosis Factor-Gamma
  • Chimeric Anti-Vegf-D Antibodies And Humanized Anti-Vegf-D Antibodies And Methods Of Using Same
  • Aptamer Therapeutics Useful In The Treatment Of Complement-Related Disorders
  • Anti-Cd3 Epsilon Antibodies And Methods Of Use Thereof
  • Chimeric Immunoglobulins Specific For P55 Tac Protein Of The Il-2 Receptor
  • Cell Engaging Binding Molecules
  • Method For Making Heteromultimeric Molecules
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/332323a0

    DOI

    http://dx.doi.org/10.1038/332323a0

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1016704652

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/3127726


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Immunology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Amino Acid Sequence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Monoclonal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Base Sequence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Binding Sites, Antibody", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Genes, Synthetic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunoglobulin G", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunoglobulin Heavy Chains", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunoglobulin Light Chains", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunoglobulin Variable Region", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lymphocytes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Molecular Sequence Data", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rats", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Recombinant Fusion Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Recombinant Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Species Specificity", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "MRC Laboratory of Molecular Biology, Hills Road, CB2 2QH, Cambridge, UK", 
              "id": "http://www.grid.ac/institutes/grid.42475.30", 
              "name": [
                "MRC Laboratory of Molecular Biology, Hills Road, CB2 2QH, Cambridge, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Riechmann", 
            "givenName": "Lutz", 
            "id": "sg:person.01266242006.84", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266242006.84"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "MRC Laboratory of Molecular Biology, Hills Road, CB2 2QH, Cambridge, UK", 
              "id": "http://www.grid.ac/institutes/grid.42475.30", 
              "name": [
                "MRC Laboratory of Molecular Biology, Hills Road, CB2 2QH, Cambridge, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Clark", 
            "givenName": "Michael", 
            "id": "sg:person.014106626612.98", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014106626612.98"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "MRC Laboratory of Molecular Biology, Hills Road, CB2 2QH, Cambridge, UK", 
              "id": "http://www.grid.ac/institutes/grid.42475.30", 
              "name": [
                "MRC Laboratory of Molecular Biology, Hills Road, CB2 2QH, Cambridge, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Waldmann", 
            "givenName": "Herman", 
            "id": "sg:person.0633233513.49", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633233513.49"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "MRC Laboratory of Molecular Biology, Hills Road, CB2 2QH, Cambridge, UK", 
              "id": "http://www.grid.ac/institutes/grid.42475.30", 
              "name": [
                "MRC Laboratory of Molecular Biology, Hills Road, CB2 2QH, Cambridge, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Winter", 
            "givenName": "Greg", 
            "id": "sg:person.014527734325.48", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014527734325.48"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/256495a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001387921", 
              "https://doi.org/10.1038/256495a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/300709a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042192921", 
              "https://doi.org/10.1038/300709a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/314268a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027818224", 
              "https://doi.org/10.1038/314268a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/312643a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017996216", 
              "https://doi.org/10.1038/312643a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/328731a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018042438", 
              "https://doi.org/10.1038/328731a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/321522a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007617918", 
              "https://doi.org/10.1038/321522a0"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1988-03", 
        "datePublishedReg": "1988-03-01", 
        "description": "Abstract A human IgGI antibody has been reshaped for serotherapy in humans by introducing the six hypervariable regions from the heavy- and light-chain variable domains of a rat antibody directed against human lymphocytes. The reshaped human antibody is as effective as the rat antibody in complement and is more effective in cell-mediated lysis of human lymphocytes.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/332323a0", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0028-0836", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "6162", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "332"
          }
        ], 
        "keywords": [
          "rat antibodies", 
          "human antibodies", 
          "human lymphocytes", 
          "cell-mediated lysis", 
          "antibodies", 
          "lymphocytes", 
          "light chain variable domains", 
          "hypervariable region", 
          "serotherapy", 
          "therapy", 
          "variable domains", 
          "lysis", 
          "humans", 
          "complement", 
          "region", 
          "Abstract", 
          "domain"
        ], 
        "name": "Reshaping human antibodies for therapy", 
        "pagination": "323-327", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1016704652"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/332323a0"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "3127726"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/332323a0", 
          "https://app.dimensions.ai/details/publication/pub.1016704652"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-11-24T20:46", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_197.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/332323a0"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/332323a0'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/332323a0'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/332323a0'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/332323a0'


     

    This table displays all metadata directly associated to this object as RDF triples.

    191 TRIPLES      21 PREDICATES      66 URIs      52 LITERALS      24 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/332323a0 schema:about N1357f0739ec9423ebb00a95808264e0f
    2 N3a496d9551bc44b19ba2cdf3f6a4673b
    3 N4e8a76371f13480a9f8a6a70226e9c05
    4 N577dcd0ca77340658643d49ac7035301
    5 N5aad217fdbca4c7c85118b1e1c23ad62
    6 N626789857c2b4d79a61e74d0eb1dc8f5
    7 N67b6c8b2612f4250be99118ffa8ec532
    8 N8e18aad1508041f78f7cdbaec6c0ea33
    9 N93ac7a29a6a04e33ab2392bb99f45381
    10 Naa8f3a0e25484d039795f7958ba898b3
    11 Nb0e4ef1e5c764620ae204921440092f0
    12 Nc1fdba340de44039ad224ec813569f1a
    13 Nc4d6b0fba98a478cbdc94995d2bef5d5
    14 Ndae793e8aa2342fc89baece0a848d702
    15 Nea367c7825b64d2baae5775b7bc93299
    16 Nf5e4f76c852c4032b9b3d23f3260414b
    17 Nf6d39844635845c785362e9aeac91fa3
    18 anzsrc-for:11
    19 anzsrc-for:1107
    20 schema:author N90ef33c042d04dcab20288a34285236c
    21 schema:citation sg:pub.10.1038/256495a0
    22 sg:pub.10.1038/300709a0
    23 sg:pub.10.1038/312643a0
    24 sg:pub.10.1038/314268a0
    25 sg:pub.10.1038/321522a0
    26 sg:pub.10.1038/328731a0
    27 schema:datePublished 1988-03
    28 schema:datePublishedReg 1988-03-01
    29 schema:description Abstract A human IgGI antibody has been reshaped for serotherapy in humans by introducing the six hypervariable regions from the heavy- and light-chain variable domains of a rat antibody directed against human lymphocytes. The reshaped human antibody is as effective as the rat antibody in complement and is more effective in cell-mediated lysis of human lymphocytes.
    30 schema:genre article
    31 schema:isAccessibleForFree false
    32 schema:isPartOf N98c07f4d34a145868221106e0e858af5
    33 Nc14370c976534b3ab3f3406ccd3ea4e1
    34 sg:journal.1018957
    35 schema:keywords Abstract
    36 antibodies
    37 cell-mediated lysis
    38 complement
    39 domain
    40 human antibodies
    41 human lymphocytes
    42 humans
    43 hypervariable region
    44 light chain variable domains
    45 lymphocytes
    46 lysis
    47 rat antibodies
    48 region
    49 serotherapy
    50 therapy
    51 variable domains
    52 schema:name Reshaping human antibodies for therapy
    53 schema:pagination 323-327
    54 schema:productId Na7a5fa8fb8894deeaa3484113b42e81c
    55 Nb045d982c87e4e648a068bde435d24f9
    56 Nd910a26abcda4604bee92d42a74fe86b
    57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016704652
    58 https://doi.org/10.1038/332323a0
    59 schema:sdDatePublished 2022-11-24T20:46
    60 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    61 schema:sdPublisher N472b849734094b6e969fefcd696a1d98
    62 schema:url https://doi.org/10.1038/332323a0
    63 sgo:license sg:explorer/license/
    64 sgo:sdDataset articles
    65 rdf:type schema:ScholarlyArticle
    66 N1357f0739ec9423ebb00a95808264e0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    67 schema:name Antibodies, Monoclonal
    68 rdf:type schema:DefinedTerm
    69 N25627022415f498992056cc8a3eeb47d rdf:first sg:person.0633233513.49
    70 rdf:rest Ndd210fec3b9c4fe8ad46c29c6c4b0bc1
    71 N3a496d9551bc44b19ba2cdf3f6a4673b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    72 schema:name Recombinant Proteins
    73 rdf:type schema:DefinedTerm
    74 N472b849734094b6e969fefcd696a1d98 schema:name Springer Nature - SN SciGraph project
    75 rdf:type schema:Organization
    76 N4e8a76371f13480a9f8a6a70226e9c05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    77 schema:name Immunoglobulin Light Chains
    78 rdf:type schema:DefinedTerm
    79 N524ef79cabdd424ea93bfdf341b5c072 rdf:first sg:person.014106626612.98
    80 rdf:rest N25627022415f498992056cc8a3eeb47d
    81 N577dcd0ca77340658643d49ac7035301 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    82 schema:name Animals
    83 rdf:type schema:DefinedTerm
    84 N5aad217fdbca4c7c85118b1e1c23ad62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    85 schema:name Immunoglobulin Variable Region
    86 rdf:type schema:DefinedTerm
    87 N626789857c2b4d79a61e74d0eb1dc8f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    88 schema:name Lymphocytes
    89 rdf:type schema:DefinedTerm
    90 N67b6c8b2612f4250be99118ffa8ec532 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    91 schema:name Rats
    92 rdf:type schema:DefinedTerm
    93 N8e18aad1508041f78f7cdbaec6c0ea33 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    94 schema:name Immunoglobulin Heavy Chains
    95 rdf:type schema:DefinedTerm
    96 N90ef33c042d04dcab20288a34285236c rdf:first sg:person.01266242006.84
    97 rdf:rest N524ef79cabdd424ea93bfdf341b5c072
    98 N93ac7a29a6a04e33ab2392bb99f45381 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    99 schema:name Binding Sites, Antibody
    100 rdf:type schema:DefinedTerm
    101 N98c07f4d34a145868221106e0e858af5 schema:issueNumber 6162
    102 rdf:type schema:PublicationIssue
    103 Na7a5fa8fb8894deeaa3484113b42e81c schema:name dimensions_id
    104 schema:value pub.1016704652
    105 rdf:type schema:PropertyValue
    106 Naa8f3a0e25484d039795f7958ba898b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    107 schema:name Species Specificity
    108 rdf:type schema:DefinedTerm
    109 Nb045d982c87e4e648a068bde435d24f9 schema:name doi
    110 schema:value 10.1038/332323a0
    111 rdf:type schema:PropertyValue
    112 Nb0e4ef1e5c764620ae204921440092f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    113 schema:name Immunoglobulin G
    114 rdf:type schema:DefinedTerm
    115 Nc14370c976534b3ab3f3406ccd3ea4e1 schema:volumeNumber 332
    116 rdf:type schema:PublicationVolume
    117 Nc1fdba340de44039ad224ec813569f1a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    118 schema:name Recombinant Fusion Proteins
    119 rdf:type schema:DefinedTerm
    120 Nc4d6b0fba98a478cbdc94995d2bef5d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    121 schema:name Humans
    122 rdf:type schema:DefinedTerm
    123 Nd910a26abcda4604bee92d42a74fe86b schema:name pubmed_id
    124 schema:value 3127726
    125 rdf:type schema:PropertyValue
    126 Ndae793e8aa2342fc89baece0a848d702 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    127 schema:name Molecular Sequence Data
    128 rdf:type schema:DefinedTerm
    129 Ndd210fec3b9c4fe8ad46c29c6c4b0bc1 rdf:first sg:person.014527734325.48
    130 rdf:rest rdf:nil
    131 Nea367c7825b64d2baae5775b7bc93299 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Genes, Synthetic
    133 rdf:type schema:DefinedTerm
    134 Nf5e4f76c852c4032b9b3d23f3260414b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Base Sequence
    136 rdf:type schema:DefinedTerm
    137 Nf6d39844635845c785362e9aeac91fa3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Amino Acid Sequence
    139 rdf:type schema:DefinedTerm
    140 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    141 schema:name Medical and Health Sciences
    142 rdf:type schema:DefinedTerm
    143 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
    144 schema:name Immunology
    145 rdf:type schema:DefinedTerm
    146 sg:journal.1018957 schema:issn 0028-0836
    147 1476-4687
    148 schema:name Nature
    149 schema:publisher Springer Nature
    150 rdf:type schema:Periodical
    151 sg:person.01266242006.84 schema:affiliation grid-institutes:grid.42475.30
    152